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Abstract.
The aim of this project was to investigate the cellular events mediated by the tumour 
suppressor gene p53. Initially we chose to look in vitro at the response of p53 wild type 
and knockout keratinocyte cells to transforming growth factor beta (TGF(31) and 
ionising radiation, as p53 has been implicated in the cellular response to these agents. In 
vitro analysis showed that wild type p53 is not essential for mouse skin keratinocytes to 
execute a block in DNA synthesis in response to TGFpi. Furthermore, we found that 
the presence of wild type p53 does not alter the survival of mouse skin keratinocyte cells 
after exposure of up to lOGy of ionising radiation.
As the growing number of reports of p53 mediated cell type specific responses to 
ionising radiation became apparent, we decided to further our initial in vitro analysis of 
mouse skin keratinocytes and their response to ionising radiation by looking at specific 
keratinocyte populations in mouse epidermis after exposure to ionising radiation in 
vivo. We choose the relatively low dose of 4Gy for our in vivo experiments to avoid the 
complications of p53 independent cell death by necrosis at higher radiation doses.
In epidermis, distinct populations of keratinocytes where identified which responded to 
p53 stabilisation by entering the apoptotic pathway or executing a cell cycle block. 
Cells within the matrix population of the hair follicle underwent p53 mediated apoptosis 
after exposure to radiation.
The creation of p53 reporter mice allowed us to analyse the transcriptional activity of 
p53 induced by a number of agents in mouse epidermis. We found no evidence of p53 
transcriptional activity in any population of keratinocytes in the skin after treatment with 
ionising radiation or tumour promoters.
As an extension to the original study we looked at chemically induced tumour 
development in mouse skin pre treated with radiation which contained fewer matrix 
cells. The number of carcinogenic lesions which developed was significantly more than in 
normal mouse skin untreated with radiation. This was the case for both p53 wild type 
and knockout mouse skin. This led us to re-examine the role of mouse skin stem cells in 
tumour formation.
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Our results demonstrate that p53 induction and downstream events are regulated in not 
just a tissue specific manner but also a cell type specific manner within a tissue. These 
findings are of significant importance in the evaluation of sensitivity of individual cell 
types to DNA damaging agents, and are also relevant to the assessment of therapeutic 
treatment of tumours of varying origins.
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Chapter 1. Introduction
1.1 The discovery of p53
p53 was originally discovered as a protein complexed to SV40 T antigen in SV40 
transformed cells. Antisera to the SV40 T antigen was used to demonstrate that T 
antigen formed a protein complex with the p53 protein (Lane and Crawford, 1979). 
Shortly after the cloning of mouse p53 it was reported that cotransfection of p53 with 
activated ras oncogene caused the transformation of primary rat fibroblasts (Eliyahu et 
al, 1984). The p53 gene was also found to be able to act on its own to immortalise 
early pass rat Chondrocytes (Jenkins et al, 1984). The conclusion from these studies, 
was that uncontrolled expression of normal p53 was a major step in cellular 
transformation. The p53 gene, as a result of these initial discoveries, was classified as a 
cellular oncogene and was classed alongside myc, myb, and fos. This definition proved 
to be incorrect. The p53 constructs used in the early experiments contained mutations in 
the coding region of the p53 gene that were subsequently found to affect the biological 
properties of the p53 protein (Eliyahu et al, 1988; Hinds et al, 1989). When the initial 
experiments were repeated with genes coding for wild type p53, it was found that wild 
type p53 not only failed to transform the cells, but was able to suppress cellular 
transformation mediated by other oncogenes.
Reintroduction of wild type p53 into tumour cells was shown to result in the reversal of 
tumorigenicity, and often the transformed phenotype of the tumour cell (Wolf et al, 
1984). p53, was next classified as a tumour suppressor gene. It was subsequently shown 
that reintroduction of p53 into a tumour or transformed cell led to growth arrest of the 
cells in G1 of the cell cycle. As a result of these experiments wild type p53 was termed a 
negative regulator of cell growth, and elimination of wild type p53 function was assumed 
to be required for unregulated cellular proliferation to occur. Deletions or mutations of 
the p53 gene were subsequently found to be very common in mouse and human 
tumours. (Hollstein et al, 1996).
Cellular proliferation is very tightly controlled. Cell growth occurs in a series of steps 
which includes a period of DNA synthesis (S) where the DNA replicates, a period of 
mitosis (M) in which the chromosomes are separated, and temporal gaps in between 
these two events termed G1 and G2. It is now firmly established that a family of protein 
kinases, called cyclin dependent kinases (cdks), controls the transitions between
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successive phases of the cell cycle in eukaryotic cells (Pines et al, 1993). All the cdks are 
structurally related to each other and require associated cyclin proteins for activity. 
Cyclins are frequently classified as G1 cyclins or mitotic cyclins depending on when they 
function in the cell cycle. In vertebrates D type cyclins (Dl, D2, D3) are considered to 
be key regulators of G1 progression (Sherr, 1993). Formation of active complexes 
between D type cyclins and cdk4 / cdk6 are thought to be needed for G1 progression. 
Cyclin E in association with cdk2 is required for Gl/S transition (Knoblich et al, 1993) 
and cyclin A, in complex with cdk2 is essential for progression through S phase 
(Reviewed in Fisher, R. P. 1997). Both A and B type cyclins associate with cdc2 to 
promote entry into mitosis. (Knoblish et al, 1993).
The Gl/S and S phase substrates of cdk/cyclin complexes fall into two classes. They are 
either transcriptional regulators involved in controlling the expression of S phase genes, 
or they are components of the DNA synthesis machinery itself. The most intensely 
studied Gl/S substrate is the Retinoblastoma gene product (pRb). Early in the cell cycle, 
pRb sequesters transcription factors, of the E2F/DP family, which are involved in 
regulating genes required for S phase progression. During progression through G1 pRb 
becomes phosphorylated by cyclin dependent kinases, which causes the release and 
activation of E2F/DP transcription factors (Hinds and Weinberg, 1994).
p53 knockout mice were created by the introduction of a null mutation into the p53 
gene by homologous recombination in murine embryonic stem cells (Donehower et al, 
1992; Clarke et al. 1993; Lowe, et al 1993a.; Tsukuda et al 1993). As p53 had been 
implicated in cell cycle control it was thought it may be an essential component in the 
regulation of development. However mice homozygous for the p53 null allele developed 
normally but were prone to spontaneous development of neoplasms at an early age. 
Mice heterozygote for the inactivated p53 allele also showed an increased incidence of 
spontaneous malignancies compared to p53 wild type mice. In the vast majority of 
tumours in heterozygote animals, the wild type p53 allele was deleted in tumours 
(Donehower et al, 1992). Initial analysis of the p53 null mice did not support the 
hypothesis that p53 is important in the cell cycle regulation of normal cells, as the mice 
developed normally with no defects. Although p53 is mainly regarded as the guardian of
4
the genome, recent results suggest a role for p53 in normal development of the neural 
tube and ocular structures. (Sah, et al 1995 & Armstrong, et al 1995)
It was finally concluded that p53 is dispensable for the growth and development of 
normal cells, but is required to prevent the occurrence of malignant genetic alterations. 
Consistent with the role of p53 as guardian of the genome, fibroblasts from p53 deficient 
mice show chromosomal abnormalities that become apparent at early passage. 
Aneuploidy and evidence of chromosomal instability has also been shown in to exist in 
tumours from p53 null mice. Embryonic fibroblasts derived from p53 null mice possess 
(1) shorter doubling time (2) increased ability to grow under conditions of low cell 
density, (3) a lack of senescence even at high passage, compared to equivalent p53 wild 
type cells.(Harvey et al, 1993).
The p53 protein is now widely described as a negative regulator of cell growth whose 
inactivation is a major contribution for the development of malignancy.
The amino terminus of p53 has the ability to modulate the transcription of other genes 
by interaction with transcription factors such as the TATA box binding protein, a 
component of the general transcription factor TFIIH as well as several TATA box 
binding protein associated factors (Horikoshi et al, 1995). Wild type p53 can bind to 
TBP and act as transcriptional repressor for a number of target genes, including PCNA 
(Proliferating Cell Nuclear Antigen), c-fos ,c-jun, IL-6 and bcl2 (Horikoshi et al, 1995).
p53 is present predominantly as tetramers, with dimers and monomers accounting for 
less than 5% of the total p53 molecules in a cell. This observation is important in the 
evaluation of the interaction of p53 with TBP. Given the low fraction of monomeric p53 
in cells and that wild type p53 is present in low amounts of about 100 molecules per cell, 
p53 mediated transcriptional repression by binding to TBP is most likely an effect of 
grossly overexpressed p53.
The central core of the p53 gene contains the sequence specific DNA binding domain 
(Barogonetti et al, 1993; Halazonetis and Kandil, 1993; Pavletich et al, 1993; Wang et 
al, 1993). Intrinsic to the function of p53 is its ability to regulate transcription through
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sequence specific DNA binding. P53 tetramers bind specifically to a p53 responsive 
element that contains repeats of the consensus binding sequence Pu-Pu-Pu-C-A/T-T/A- 
G-Py-Py-Py where Pu and Py are purine and pyrimidine nucleotides respectively. (El- 
Deiry et al, 1992) The binding of wild type p53 to its cognate response elements 
regulates transcription of nearby promoters.
The carboxyl terminus of p53 is capable of binding non-specifically to different forms of 
damaged DNA and re annealing complementary strands of RNA and DNA (Wang et al, 
1993; Balkalkin et al, 1994; Bayle et al, Lee et al, 1995; Reed et al, 1995). The C- 
terminus of the p53 gene can be subdivided into three regions. The linker region which 
spans around 300 residues connects the DNA binding domain to the tetramerisation 
domain. This is followed by a small region which is rich in basic residues.
1.2 p53 and phosphorylation.
P53 protein is extensively post-translationally modified, mostly by phosphorylation. The 
major phosphorylation sites in p53 have been mapped within two distinct domains at the 
N- and C- termini of the protein. Most of the phosphorylation sites are clustered in the 
transactivation domain, and in a region containing PEST sequences which are thought to 
mediate rapid protein turnover. (Samad et al, 1986).
Several protein kinases are known to modify p53 at its N terminus. One of these is the 
double stranded DNA activated protein kinase (DNA-PK) (Lees-Miller et al, 1990). 
This nuclear kinase is potently activated by linear double stranded DNA. Activation of 
DNA-PK by DNA breaks is of special interest as a p53 kinase since p53 itself is 
stabilised in response to DNA damage. Phosphorylation of p53 by DNA-PK may play a 
major role in the response of p53 to DNA damaging agents.
Casein kinase 1 (CK1) phosphorylates p53 at three N terminal sites (Milne et al, 1992). 
It is interesting to note that a DNA repair defective mutation in the yeast S. cerevisiae 
lies in a gene encoding a protein kinase with a high similarity to CK1 (Hoekstra et al, 
1991). This represents another potential link between DNA damage and p53 
phosphorylation.
6
r
o
n
O
A third protein kinase, Mitogen Activated Protein (MAP) kinase phosphorylates p53 at 
its N-terminus (Milne et al, 1994). MAP kinase encompasses a family of related protein 
kinases which are thought to play a role in mediating the effect of various mitogens and 
differentiation factors acting through protein tyrosine kinase receptors. MAP kinase is 
activated following exposure of cells to ultraviolet radiation, (Devary et al, 1992). It is 
possible that regulation of gene transcription following UV damage is mediated through 
the MAP kinase pathway. Phosphorylation of p53 by MAP kinase may therefore be 
important in the response of p53 to DNA damage, or changes in the cellular environment 
which occur as a result of mitogenic or differentiating signals.
Protein kinase C is thought to play an important role in the phosphorylation of p53, 
particularly at the C terminus. The site of PKC phosphorylation is believed to lie in the 
region of the protein which is important for oligomerisation. At the cellular level, 
stimulation by phorbol esters, which are potent activators of PKC leads to increased 
phosphorylation of p53. This may be direct or indirectly through the activation of a PKC 
activated kinase such as MAP kinase ( Baudier, et al 1992).
Relatively little is known about the enzymes which catalyse the dephosphorylation of 
p53 in vivo. However protein phosphatase 2A has been shown to dephosphorylate 
several phosphorylated sites on p53 in vitro ( Scheidtmann, et al 1991).
1.3 P53 induction, apoptosis, cell cycle arrest, and the development of cancer.
Genomic integrity is continuously under threat from environmental factors. p53 is 
thought to be involved in maintaining stability of the genome. In cell culture systems, 
exogenous wild type p53 expression has been shown to be capable of eliciting cessation 
of growth, increased apoptosis, or increased cellular differentiation.
The disruption of the p53 gene in a high percentage of tumours highlights the 
importance of disabling p53 dependent pathways in order to achieve cellular 
transformation. Abnormalities in p53 function are thought to contribute to the 
development of transformed phenotypes in two ways: l)Loss of p53 function in cells 
where p53 mediates cell cycle arrest after DNA damage is most likely to result in the
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replication of a damaged DNA template and the development of heritable genetic 
changes in daughter cells (Kastan et al, 1991); 2) Loss of p53 mediated cell death leads 
to survival of cells in inappropriate physiological conditions (Kinzler et al, 1996). The 
latter situation is particularly detrimental since the cell escapes death despite DNA 
damage. These two factors are thought to work together to contribute to the genetic 
alterations associated with cancer development as a result of DNA damage. P53 has also 
been implicated in the development of cancer by its proposed involvement in growth 
factor signalling and angiogenesis.
1.4 p53 stabilisation after DNA damage.
After DNA damage, p53 protein levels rise in cells (Kuerbitz et al, 1992). The amount 
and kinetics of p53 induction vary greatly depending upon the genotoxic agent. UV light 
produces an increase in p53 levels in cultured cells almost immediately. The extent of the 
increase is over ten fold and is maintained for 30 hours post UV exposure before falling 
back to levels observed in control cells. In contrast, in response to ionising radiation 
p53 levels increase by three fold in the space of an hour and return to background levels 
within three hours. 3-Aminobenzidine can inhibit poly-ADP ribose polymerase and 
hence prevent DNA repair. In a series of experiments, Lu et al (1993) showed that the 
p53 response lasts until 3- Aminobenzidine is removed and that DNA repair commences 
upon withdrawal of the drug. These observations suggest that the presence of DNA 
damage prolongs the p53 response.
DNA strand breaks are an adequate signal for p53 stabilisation in response to DNA 
damage (Hartwell et al, 1989). The nature of the break that induces p53 stabilisation 
was discovered using microinjection techniques. Defined plasmids of DNA were used in 
microinjection studies to show that double stranded ends of linear DNA longer than 27 
base pairs, circular DNA with large gaps and single stranded circular DNA all possessed 
signalling ability. Dilution experiments led to the conclusion that as little as one double 
strand break per cell can initiate the p53 pathway. (Huang et al 1996)
Cells derived from Ataxia telangiectasia (AT) patients have helped to unravel the 
signalling pathway between DNA damage and p53. AT cells are hypersensitive to DNA 
damaging agents, such as irradiation and restriction enzyme digestion which induces
double strand DNA breaks (Thacker et al, 1994) Furthermore the ability of AT cells to 
induce cell cycle arrest following DNA damage is deficient, indicating defects in cell 
cycle checkpoint control (Meyn et al, 1995).
The signal for apoptotic induction may involve cytoplasmic events as well as DNA 
damage. A number of cellular events following the exposure of cells to non - ionising 
radiation are independent of the nucleus and radiation induced DNA damage. For 
example the response to ultraviolet light depends on the activation of Src like kinases in 
the cytoplasm, and can occur in enucleated cells (Devary et al, 1992). Consistent with 
this, high levels of membrane tyrosine phosphorylation are observed seconds after 
exposure of mammalian lymphocytes to y radiation. The rapidity of this response makes 
it unlikely that the initiating signal involves the nucleus. It is also interesting to note that 
inhibition of the membrane phosphorylation reactions blocks radiation induced 
apoptosis. This is again consistent with the initiation of apoptosis occurring outside the 
nucleus.
Exposure of cells to hypoxic conditions results in increased p53 protein levels and can 
lead to p53 dependent apoptosis (Graeber et al, 1996). It is widely believed that this 
induction of p53 occurs in the absence of DNA strand breaks. It has been recently 
shown that depletion of ribonucleotide triphosphates (rNTP) using inhibitors of purine 
and pyrimidine biosynthesis, is sufficient to induce p53 and p53 - dependent G1 arrest 
(Linke, et al 1996). It may be the case that an inadequate supply of rNTPs results in 
changes in the RNA macromolecule population, analogous to the way that dNTP 
inhibitors lead to DNA strand beaks. This suggests a common link in p53 signalling 
which is dependent on changes in nucleic acid macromolecules.
1.5 p53 induction and cell cycle arrest
Most cells delay transit through the cell cycle in response to DNA damage. This is 
thought to allow the repair of damaged DNA before replication and chromosome 
segregation. Cell cycle delay in mammalian cells in response to DNA damage has been 
observed in Gl, S and G2 phases of the cell cycle (Maity et al, 1994). Early studies 
showed exposure of mammalian cells to ionising radiation prolongs both S and G2 
phases (Leeper et al, 1972), the delay in S phase lasting only a few hours, while the G2
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delay is much longer. A delay in G1 was not observed in early studies with ionising or 
UV radiation. This was probably due to the fact that cultured cells are very commonly 
deficient in this pathway (Domon et al, 1968).
Studies with primary cultures were the first to reveal the existence of a G1 block (Little, 
1986). Subsequently other cell lines have been shown to block in G1 after DNA damage 
(Kastan et al, 1991). Using a subtractive hybridisation technique, a gene highly induced 
by wild type, but not mutant p53 was discovered . The gene was named WAF1 for wild 
type p53 activated fragment. (El-Diery et al, 1993). Simultaneously Harper el al (1993) 
identified a gene that they called CIP1 whose product was found to bind to cyclin 
complexes and inhibits the function of cyclin dependent kinases. The two labs soon 
realised they had characterised the same gene by different methods. WAF1/CIP1 proved 
to be identical to a p21 protein found complexed with cyclin and cyclin dependent 
kinases in normal cells. Yet another group had independently discovered the same 
protein, denoted it Sdil and described the protein as being involved in growth arrest 
accompanying cellular senescence (Noda et al, 1994).
ip2\waf  mRNA levels, as well as protein levels, increase following exposure of cells to
ionising radiation in a p53 dependent manner (Xiong et al, 1993). p21 waf  can inhibit the 
growth of human tumour lines as well as normal diploid fibroblasts when it is introduced
via transfection. Cells which lack functional p53 do not show an increase in y2 \waf  
levels after radiation, nor do these cells arrest at Gl/S following irradiation (Dulic et al,
1994). p21 waf  knockout mice show no abnormal development. However fibroblasts 
from these animals are impaired in their ability to undergo G1 arrest following DNA 
damage. (Brugarolas et al, 1995).
As an inhibitor of cyclin dependent kinase complexes, p21 waf  may contribute to DNA 
damage induced G1 arrest by preventing the phosphorylation of the Retinoblastoma
gene product (pRb). p21 waf  can also arrest cell cycle progression by direct inhibition of 
DNA replication, independent of interactions with cyclin cdk complexes (Luo et al,
1995). \i2\waf  is found in complexes in normal cells. These complexes consist of a cdk, 
and the essential DNA replication factor, PCNA, which is a 36Kd protein capable of
10
interacting with DNA polymerase a. When separately overexpressed in cells the Cdk
binding domain and the PCNA binding domain of p21 waf  both prevent DNA replication.
This suggests a dual role for p21 waf  as a cell cycle inhibitor in vivo (Lou et al, 1995).
The binding of p21 waf  to PCNA does not affect the DNA repair activity of PCNA but is 
thought to alter the availability of PCNA for DNA replication.
In summary, p53 can control cell cycle progression at the Gl/S boundary, at least in part
through the transcriptional activation of p21 waf.  p21 waf  appears to be the most 
pleiotropic mediator of p53 dependent cell cycle arrest However other genes 
transcriptionally activated by p53 may play a role in DNA damage arrest.
Cyclin G was identified in a differential screen experiment as a gene whose expression is 
induced by wild type p53 (Okamoto and Beach, 1994). Little is known about the 
function of cyclin G. It may be involved in DNA repair by complexing with a cdk 
responsible for phosphorylating and activating repair proteins. Cyclin G is unlikely to be 
involved directly in cell cycle arrest as overexpression does not result in a cell cycle 
block.
Another good candidate for a p53 response gene involved in DNA damage induced 
growth arrest is the proto-oncogene mdm-2 (Barak et al, 1993). mdm2 is amplified in 
40% of human sarcomas (Oliner et al, 1992). The gene encodes a protein that has the 
ability to complex with p53 and inhibit its transcriptional activity. mdm2 is 
transcriptionally activated by wild type p53 in response to UV irradiation. It is thought 
that an auto regulatory feedback loop exists between mdm2 and p53 Overexpression of 
mdm2 inhibits p53 dependent G1 arrest in response to irradiation (Barak et al, 1993; 
Perry et al, 1993). Recently it was been shown that mdm2 promotes the degradation of 
p53. This is though to be an important mechanism in ensuring that the p53 signal is 
quickly terminated. (Haupt, et al 1997)
GADD45 (Growth Arrest and DNA damage) (Kastan et al, 1992), like mdm2 and
p21 waf  is induced when cells are exposed to DNA damaging agents leading to G1 
arrest. This damage induced gene also contains a p53 binding site and has been shown to
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be induced by p53 (Lu et al, 1993). Recent evidence suggests that GADD45 can 
interact with PCNA and block DNA replication co-ordinately enhancing nucleotide 
excision repair of damaged DNA. (Smith et al, 1994)
The insulin-like growth factor binding protein 3 gene has also been identified as a p53 
target gene that is induced in cells after DNA damage (Buckbinder et al, 1995). IGF- 
BP3 protein has the ability to inhibit the signalling of insulin- like growth factor 
receptors and so plays an antimitogenic role in the cell. This represents another possible 
way by which p53 can suppress growth.
Several other candidate response genes have also been identified, including transforming 
growth factor a  (Shin et al, 1995), thrombospondin (Dameron et al, 1994), fas/APOl 
(Owen- Schaub et al, 1995), PCNA (Shivakumer et al, 1995), and the epidermal growth 
factor receptor gene (Deb et al, 1994). However these genes have not yet met as many 
criteria as those described previously and so it is not clear if they are true p53 target 
genes.
p53 also has the ability to repress transcription of cellular and viral genes with 
promoters that lack p53 binding sites. Transcriptional repression may represent another 
mechanism that p53 uses to elicit cell cycle arrest.
1.6 P53 and cell cycle arrest at G2.
G2 delay after DNA damage presumably prevents problems in chromosome 
condensation and segregation. The possibility that G2 delay may be critical in preventing 
irreversible fixation of DNA damage is suggested by the correlation between delay in G2 
and increased radioresistance in cells transfected with various oncogenes. However in 
fission yeast radiosensitivity and G2 delay share common pathways but have separable 
phenotypes.
Bouffler, et al (1995) looked at chromosomal abnormalities in p53 null and wild type 
mice. They found that the frequency of spontaneous aberrations in bone marrow cells 
was greatly elevated in p53 null and heterozygote mice compared to wild type mice. 
They did not observe any increased induction of stable aberrations after y radiation,
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however they found that lack of p53 resulted in increased radiation induced hyperploidy. 
No effect of p53 status was observed on sister chromatid exchange or G2 chromatid 
damage, however they did observe a p53 mediated effect on post irradiation entry into 
mitosis. This led them to suggest a G2/M checkpoint role for p53 in mouse bone 
marrow cells after irradiation.
Stewart et al (1995) also found evidence of p53 involvement at G2/M. Using REF52
v 1135cells transfected with temperature sensitive p53 v they showed a conditional block 
at Gl/S and G2/M when wild type p53 expression was induced. These results are 
comparable to a study by Martinez et al who showed a modest peak of G2/M cells 
when wild type p53 expression was induced (Lu et al, 1994).
Many studies have failed to observe any evidence of p53 induced G2/M block. The 
G2/M transition is the shortest part of the cell cycle, so the number of cells at this point 
in the cycle is small at any given time (Baserga, 1985). This may provide some 
explanation as to why some have failed to recognise the block. Kulez-Martin et al
recently found a p53 splice variant (p53as) that is preferentially expressed at G2 (Lu et
al , 1994). Stewart et al used a p53 clone capable of producing p53as in their 
transfection studies. However much of the work on p53 induced cell cycle arrest made
use of p53 cDNA clones that are not capable of making the G2 p53as variant. This may 
be another explanation as to why there are few reports of p53 mediated arrest at G2. As 
yet very few G2 specific p53 transcriptional target genes have been identified, Cyclin G 
perhaps being the most attractive possibility.
1.7 Cell cycle arrest in S phase.
Cell cycle arrest in S phase after DNA damage, presumably acts to prevent the 
propagation of genetic lesions during DNA synthesis. The p53 induced cell cycle
inhibitor p21 waf  can inhibit cyclin A-cdk2 which is active at the Gl/S cell cycle 
boundary. It can also inhibit cyclin A-CDC2, which is active in S and early G2 phase 
(Dulic et al, 1994). This led to the hypothesis that P53 may be involved in establishing S
phase arrest by switching on the transcription of p21 waf.  However, S phase delay after
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radiation is observed in virally transformed cells in which p53 is non functional. p21 waf  
may be involved in the establishment of S phase arrest, but it is probably induced by a 
pathway independent of p53.
1.8 P53 - a direct role after DNA damage?
As well as transcriptional activation and/or repression, a direct involvement of p53 in the 
regulation of cellular DNA synthesis should be considered as a possible method of p53 
mediated growth regulation. Lane et al showed that p53 associates with viral replication 
complexes in Herpes virus infected cells (Lane, et al 1979). It has also been shown that 
addition of wild type p53 in vitro to DNA replication assays inhibits SV40 DNA 
replication. Expression of p53 in SV40 transformed monkey cells inhibits in vivo 
replication of plasmids containing the SV40 origin of replication (Mercer et al 1990). 
Mutant p53 is not capable of reproducing these functions. The inhibitory function of 
wild type p53 in SV40 replication is thought to be due to the binding of p53 to the 
SV40 large T antigen, resulting in the inhibition of the large T intrinsic DNA helicase 
activity (Wang, e ta l 1989).
It should be noted that p53 levels in these experiments were grossly elevated and far 
higher than normal physiological levels. However it is interesting to note that lytic 
infection with SV40 leads to stabilisation of p53. It may be the case that the abnormally 
high levels of p53 in infected cells directly mediates inhibition of viral DNA replication.
p53 can bind to replication protein A (RPA). RPA is a multisubunit complex which 
contains three polypeptides of molecular weight 70,000, 34,000, and 13,000. The 
binding of RPA to single stranded DNA is believed to be an initial step in DNA 
replication and is thought to be required for the unravelling of cellular origins of 
replication and for DNA excision repair (Dutta et al, 1993; He et al, 1993). Interaction 
of p53 with RPA inhibits the ability of RPA to bind to single stranded DNA in vitro. 
RPA also binds to mutant p53 proteins which are unable to induce G1 arrest. However 
the binding of mutant p53 also abolishes the binding of RPA to single stranded DNA. 
Wild type and mutant p53 may exert different functions when bound to RPA.
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1.9 P53, DNA damage, and apoptosis.
Apoptosis, or programmed cell death, is the process by which a cell actively commits 
suicide under a tightly controlled cascade of events. Apoptosis is recognisable 
microscopically by characteristic condensed basophilic cytoplasm, darkly staining 
karyorrhectic nuclei, and the presence of apoptotic cell bodies, which are usually 
phagocytosed by macrophages or by neighbouring cells. DNA from cells undergoing 
apoptosis is cleaved into fragments of roughly 200 base pairs. However, there are a 
number of reports that cell death can occur without DNA fragmentation (Shuze-Osthoff 
etal, 1994).
The signals that trigger apoptosis, occurring either naturally during development or as a 
response to insults imposed on the cell include the presence of DNA damage, growth 
factor or nutrient withdrawal, disruption of cell matrix interactions, altered expression of 
potent cellular oncogenes such as myc, and viral infection.
In mammalian cells, many of the gene products that activate or suppress apoptosis have 
been identified. p53 is known to be responsible for directing apoptosis in some systems 
(Clarke et al, 1993; Lotem and Sachs, 1993; Lowe et al, 1993). In tumorigenesis of the 
brain choroid plexus epithelium for example, the absence of p53 correlates with 
aggressive tumour growth and a decrease in apoptosis, suggesting that p53 dependent 
apoptosis normally acts as a check to tumour growth and progression in the tissue.
p53 independent apoptosis has also been observed. The induction of apoptosis in mouse 
thymocytes treated with glucocorticoid and calcium, and proliferating lymphoid cells 
treated with genotoxic agents is p53 independent. It is important to note that p53 
knockout mouse embryos do not exhibit any gross abnormal cell death patterns in 
development, although some neural abnormalities have recently been discovered (Sah, 
et al 1995; Armstrong et al 1995). This suggests that apoptosis in normal development, 
in the absence of any abnormal stress occurs largely through p53 independent pathways.
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1.10 p53, and effectors of apoptosis
The most common genetic alteration in human B cell lymphoma is a chromosome 
translocation that juxtaposes the bcl-2 gene with the immunoglobulin heavy chain gene 
(Tsujimoto, et al 1985). The high incidence of p53 loss and accompanying high levels of 
bcl-2 in human tumours prompted exploration of the effects of p53 on bcl-2 gene 
expression. p53 protein was found to be capable of transcriptional repression of the bcl- 
2 gene (Miyashita et al, 1994). bcl-2 was subsequently characterised as a cell survival 
gene. BCL-2 protein is an intracellular membrane protein that resides in the outer 
mitochondrial membrane, nuclear envelope and parts of the endoplasmic reticulum. The 
protein has been shown to block cell death induced by numerous stimuli including
2+growth factor deprivation, Ca ionophores, reactive oxygen species, some viruses, heat 
shock, and irradiation (Reviewed in White 1997). BCL-2 levels have been shown to 
correlate in vitro with sensitivity to apoptosis. In clinical studies, high levels of BCL-2 
protein or alterations which lead to deregulation of the protein production are 
associated with poor responses to therapy.
Transgenic mice which harbour an expression construct in which the bcl-2 gene is under 
the transcriptional control of the IG heavy chain enhancer show accumulation of B 
lymphocyte cells as a result of prolonged cell survival. The mice also develop high grade 
malignant lymphomas (McDonnel et al, 1989). bcl-2 knock out mice show stunted 
growth and post natal mortality. Initially, haematopoietic development is normal but 
soon complete apoptotic involution of the primary lymphoid organs takes place. The 
animals also develop polycystic kidneys and renal failure. Due to the lack of 
development of pigment in the second hair cycle the mice turn grey at about six weeks 
old ( Kamada, et al 1995).
BCL-2 is one of a growing family of related proteins that have been conserved 
throughout multicellular evolution. This family includes Ced-9 of C.elegans (Spector et 
al, 1992), the mammalian proteins BCL-Xs and BCL-X1 (Biose et al, 1993), MCL-1 
(Kozopaz et al, 1993), Al(Lin et al, 1988), BAX (Oltvai et al 1993), and viral proteins 
which include P30 (baculovirus) (Clem et al, 1991), BHRF1 (Epstein Barr Virus)
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(Pearson et al, 1987), VG16 (Herpesvirus) (Albrecht et al, 1987), LMW5 (African 
Swine Virus) (Neilan et al, 1993), and pl9ElB  (Adenovirus) (White et al, 1992).
Members of this growing family can be divided into two groups. BCL-2, BCL-XL, 
BHRF1, pl9EIB, MCLland CED-9 all have the ability to inhibit programmed cell death. 
However BAX , and BCL-Xs antagonise the anti apoptotic activity of BCL-2. p53 can 
transactivate box (Selvakumaran et al, 1994) which contrasts with its ability to repress 
transcription of bcl2.
It has been proposed that when BCL-2 is in excess, BCL-2 homodimers predominate 
and cells are protected and when BAX is in excess, BAX homodimers predominate and 
cells are susceptible to apoptosis (Oltvali et al, 1993). BCL-2 and EIB 19K proteins can 
block apoptosis that is both p53 dependent and independent, suggesting that both 
function downstream of p53 and inhibit multiple pathways.
It was presumed that the prime function of p53 would be to control the relative levels of 
BAX and other cell death/ survival proteins by transactivation and or repression of the 
gene promoters. However p53 mediated apoptosis has been reported in cells treated 
with the protein synthesis inhibitor cycloheximide. Caelles et al showed that GHFT1 
cells expressing a temperature sensitive p53 mutant could undergo p53 mediated 
apoptotic cell death in response to UV damage, which was independent of protein 
transcription or translation (Caelles et al, 1994).
Two recent papers reported contradictory results with a p53 mutant that abrogates the 
transcriptional activating function of p53. Based on the results from transient 
transfection assays it was concluded that p53 mediated apoptosis does not require 
transcription function in HeLa cells (Yonish-Rouach et al, 1994; Haupt et al, 1995). In 
contrast, the White laboratory demonstrated that BRK cells stably expressing E l A plus 
temperature sensitive p53 vail35 underwent apoptosis after temperature shift to 32°C, 
whereas cells expressing the same mutant used in the HeLa cell experiments did not 
(Sabbatini etal, 1995).
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Cisplatin treatment of Epstein-Barr virus immortalised human B lymphocyte cell lines 
results in p53 mediated apoptosis which occurs in cells at the Gl/S cell cycle boundary. 
Transfection studies showed a correlation between p53 transcriptional activation and the 
induction of apoptosis. Mutant alleles that were incapable of transactivation caused 
apoptosis to occur in the G2/M after cisplatin treatment. The results of this study 
suggest that DNA damage can induce apoptosis from Gl/S when p53 is transactivation 
competent, and from G2/M when it is transactivation defective in certain cell types. 
(Allday et al, 1995).
Ludwig et al analysed the transcriptional activity of a number of p53 mutants, and 
showed that not all p53 responsive cell promoters are equally sensitive to different p53 
mutants. They identified two mutants that whilst retaining the ability to induce cell cycle 
arrest through transactivation of p21w^  have defective ability to transactivate box and 
IGF-BP3. The amino acid substitutions present in these mutants are in the DNA binding 
domain. Transcriptional activity of both correlated with their ability to bind DNA 
containing the p53 binding site present in each of the promoters tested. (Ludwig, et al
1996) It seems likely that modifications which effect DNA binding capacity of p53 such 
as phosphorylation may also play a role in the transcriptional targets of p53 in a given 
cell.
The generation of transgenic mice, in which a Lac Z  transgene is driven by a p53 
response element allowed the analysis of the transcriptional activity of p53 protein in 
vivo (McCallum et al 1996). In the spleen of irradiated p53 lac Z reporter mice, p53 
was induced in all the cells of the tissue. Although apoptosis was observed in both the 
red and white pulp of the tissue, LacZ expression was only apparent in the red pulp. 
These results suggest that not all p53 dependent apoptosis is the result of transcriptional 
activation by p53. These results are similar to results published recently (Gottlieb, et al,
1997)
1.11 Apoptosis or cell cycle arrest in vitro?
Irradiation induced cell cycle arrest and apoptosis appears to be cell type specific. 
Mouse embryo fibroblasts derived from homozygous and heterozygous wild type p53 
mice respond to DNA damage with growth arrest as do cell lines that contain wild type
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p53. Fibroblasts from p53 knockout mice fail to arrest. It seems that in normal 
fibroblasts p53 functions to produce growth arrest in response to DNA damage. 
However thymocytes from homozygous and heterozygous wild type p53 undergo 
apoptosis in response to radiation and thymocytes from p53 knockout animals do not. 
The evidence to date suggests different cell types respond to DNA damage and p53 
accumulation with either cell cycle arrest or apoptosis (Kastan et al, 1992, Clarke et al, 
1993; Lowe et al, 1993; Slichenmyer etal, 1993).
When p53 dependent apoptosis was first observed some reports suggested that small 
amounts of DNA damage resulted in cell cycle arrest while significant amounts of DNA 
damage resulted in apoptosis. It was later proposed that p53 induction by DNA damage 
results in cell cycle arrest in some physiologic settings and apoptosis in other settings, 
that is at a given low amount of damage, some cells are programmed to die and some 
programmed to arrest. However this is not to imply that a cell cannot be overwhelmed 
with a massive DNA insult which results in cell death.
Kastan et al looked at the decision fork between cell cycle arrest and apoptosis in vitro 
in the non malignant cell line Baf-3, an interleukin 3 dependent (IL3) murine lymphoid 
lineage cell line. Exposure of this cell line to ionising radiation results in apoptosis in the 
absence of IL3. However when IL3 is present no apoptosis occurs. (Canman et al, 
7995). It was shown that in the presence of IL3 the cells arrested in both G1 and G2/M 
phases of the cell cycle. The G1 arrest observed was dependent on p53 function. In 
contrast, in the absence of IL3 at the time of radiation the cells did not arrest in G1 and 
entered the apoptotic pathway rapidly. Irradiation and p53 induction caused an increase
in p21 waf  levels in the absence of IL3, however, the levels were significantly less than
levels found in irradiated cells with IL3. p21 waf  mediated inhibition of cyclin dependent
kinases is thought to be dependent on absolute levels of y l \ waf  in the cell. This may
explain why, despite an increase in \>2\waf  levels in the cells subjected to irradiation and 
growth factor withdrawal, the cells fail to arrest. No changes in BCL- 2, BAX or BCL- 
X were observed that may have accounted for the modulation of G1 arrest versus 
apoptosis. This suggests that modulation of the level of these proteins is not responsible 
for dictating cellular outcome after p53 induction by radiation. However alterations in
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the activity, rather than levels of these proteins may play a role in the determination of 
cell fate after radiation.(Kastan et al, 1995). The results of Kastan are comparable to 
recent results from the Vogelstein lab which demonstrated that loss of p21vra-/7 causes a 
switch in cell fate after DNA damage from cellular growth arrest to apoptosis.
As a result of these studies it was suggested that cellular outcome after irradiation of 
cells with wild type p53 was modulated by factors that determine the differentiation 
programme for individual cell types. This cellular specificity may be required since it is 
probably not desirable for epithelial derived cells to die upon exposure to DNA damage 
since these cells encounter frequent genomic insults in their normal physiological 
environment. However it is probable that epithelial stem cells responsible for 
repopulation of the epithelial tissue enter the apoptotic pathway after DNA damage to 
prevent the propagation of mutated cells
The proto-oncogene product c-Myc, which is transcriptionally repressed by p53, 
induces cell cycle progression and, in the absence of survival factors, apoptosis. Two 
models have been proposed to explain the induction of apoptosis by c-Myc following 
serum deprivation. Cell death may be due to a conflict of cellular proliferation signals 
from c-Myc and cytostatic effects of low serum from low serum levels. Alternatively 
proliferation and apoptosis may be naturally tightly coupled and for cellular proliferation 
to occur, the cell may need a signal to trigger proliferation as well as a separate signal to 
suppress apoptosis (Reviewed in Harrington, 1994). It is interesting to note that c-Myc 
has been implicated in the abrogation of p53 induced cell cycle arrest through
modulation of ^2 \waf.  c-Myc interferes with the inhibitory actions of y2 V af 7on 
cdk/cyclin complexes by inducing a heat labile inhibitor of p21Wfl-/7. (Hermeking et al
1995)
1.12 p53 apoptosis or cell cycle arrest in vivo
The accumulation of p53 in response to DNA damage in vitro is now well documented 
to induce cell cycle arrest and apoptosis. However p53 induction in vivo seems to be 
more complex. Ultraviolet irradiation of human skin leads to in induction of p53 in a 
large proportion, but not all cells of the dermis and epidermis. (Hall, et al 1995). In the
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mouse intestinal epithelium, radiation induced apoptosis, cell cycle arrest and p53 
induction are temporally and spatially co-ordinated. (Merritt et al, 1994 Clarke et al,
1994). By looking at p53 induction in vivo in the tissues of irradiated mice Midgely et al 
found that some tissues show p53 induction after radiation whilst others, e.g. liver for 
show no response. They also showed that p53 induction does not always lead to p53 
dependent apoptosis. In the spleen and thymus induction of p53 is associated with 
apoptosis, however in bone osteocytes p53 induction does not lead to apoptosis. These 
results are comparable with those of Hall et al and Merritt et al, all of which suggest 
that the induction of p53 and the p53 response are tightly regulated in a tissue specific 
manner.
The recently created p53-Lac Z  reporter mice highlighted further the complex 
relationship between p53 induction and apoptosis in vivo MaCallum et al (1996) 
observed cell populations that induce p53 protein and undergo apoptosis after exposure 
to radiation such as thymus, spleen, bone marrow, choroid plexus, and intestinal crypts, 
and cell populations that induce p53 but do not enter apoptosis i.e. salivary gland, 
myocardium, adrenal, lung parenchyma and kidney as well as cell populations that do 
not induce p53 protein or apoptosis. This classification becomes even more complex 
within tissues. For example, in the salivary gland the ductal cells induce p53 while the 
acinar cells do not. The mechanism of this selectiveness is still unclear. However cell 
cycle status appears not to play a role in whether a cell induces p53 since proliferating 
and quiescent cell populations both induce p53 protein. The results generated from the 
p53 reporter mice do not rule out p53 mediated transcriptional repression
1.13 P53 and transforming growth factor beta induced cell cycle arrest
It is widely accepted that the development of malignant tumours involves aberrations in 
the regulation of the response to positive and negative growth regulators (Kinzler et al, 
1996). TGFpl is a potent growth inhibitor of epithelial cells (Masui et al, 1986). 
Keratinocytes produce and secrete TGF pi and express cell surface receptors for this 
growth factor. The biological actions of TGFpl include the inhibition of DNA synthesis 
and cell proliferation as well as the stimulation of keratinocyte differentiation (Spom & 
Roberts, 1985; Goustin et al ,1986).
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In vitro TGFpl can potently inhibit the growth of a variety of primary cells by inducing 
growth arrest at the Gl/S boundary of the cell cycle. Many types of carcinomas, 
including squamous carcinomas of various origin are often refractory to growth 
inhibition by TGFpi. In some cases the growth and tumorigenicity of tumour cells can 
be enhanced by TGF pi. This provides the tumour cells with selective growth advantage 
over normal cells (Hsu et al, 1994).
Malignant cancers are the result of complex and lengthy genetic changes (Kinzler et al,
1996). They progress through a series of benign precancerous stages to malignant, 
metastatic stages. Due to the step wise nature of malignant cancer development it seems 
logical that there may be a progressive loss of growth control by TGF p i in cancer 
development. Each step on the way to loss of growth regulation may be attributable to a 
different genetic or epigenetic alteration that accumulate during malignant tumour 
progression.
The mouse skin carcinogenesis model is an ideal system to investigate the regulation of 
TGF pi response in tumour development due to its stepwise progression (Brown et al,
1995). Initiation of mouse skin with DMBA results in the induction of a specific point 
mutation at codon 61 of the H ras gene. After initiation tumour promotion results in the 
formation of benign papillomas. Further genetic changes including the loss of p53 
function and overexpression of mutant H ras cause a proportion of the benign lesions to 
progress to malignant carcinomas.
Haddow et al (1992) showed that activation of ras by DMBA treatment of mouse skin 
does not alter the epithelial cells response to the growth inhibitory action of TGFpl. 
Several other studies looked at the effect of activated ras in TGFp 1 signalling. Filmus et 
al, (1993) showed that rat intestinal cells expressing high levels of H ras oncogene lose 
sensitivity to the growth inhibitory actions of TGFpi. Furthermore the loss of sensitivity 
was related to the degree of H ras expression. Bums et al showed that mutant H ras 
was able to transform primary thyroid epithelial cells, and that this transformation was 
associated with loss of responsiveness to TGF pi and greatly increased nuclear levels of
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p53. Mulder et al (1992) also showed ras is involved at some point in the TGFpi 
signalling pathway by showing that rat intestinal cells treated with TGBpi show 
activated ras within 10 minutes of treatment. In general, oncogenic ras induces some 
degree of resistance to the growth inhibitory effects of TGF p i, however the effect 
seems to be cell type and dose specific
H  ras has also been implicated in changes in tumour cell invasiveness in response to 
TGF/?1. It has been shown that TGFpl and mutant H ras  collaborate in modulating the 
phenotypic plasticity and invasiveness of epithelial tumours. In ras transformed cells 
TGFpi treatment results in increased invasiveness which is dependant on epithelial 
stromal interactions. Normal epithelial cells do not show any change in invasiveness (Oft 
et al 1996). These observations highlight the diverse effects of TGFpi on cell growth 
and regulation as well as the importance of the H ras protooncogene in maintaining 
tight control of this pathway.
Haddow et al (1992,)also investigated TGFftl response in papilloma cell lines derived 
from tumours at various stages of the mouse skin tumorigenesis model. They reported 
that loss of response to TGFpi occurred at a stage in the system close to where p53 
function is lost. More direct support for the role of p53 in TGFpl signalling came from 
results generated by Gerwin et al, 1992 and Reiss et al, 1993 who reported that the 
sensitivity of epithelial cell lines to TGFpl was reduced when vectors expressing mutant 
p53 were introduced. Transfection of mutant p53 into a pancreatic epithelium cell line 
with wild type p53 was also shown to cause resistance to the growth inhibitory effects 
of TGFpl. The same construct also caused resistance to TGFpi in murine keratinocytes.
143However transfection of the same p53 mutation into a lung carcinoma cell line 
resulted in no significant reduction in response to TGFpl
Blaydes et al (1995J analysed human thyroid cancer cell lines containing wild type or 
mutant p53 and a rat thyroid cell line with mutant H ras and high levels of wild type p53 
but loss of p53 mediated cell cycle control. They found that loss of responsiveness to 
TGFpi was found in all the lines bearing mutant or non functional p53. They also
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showed that introduction of a dominant negative mutant p53 into TGFpi responsive cell 
lines did not reduce responsiveness.
Recent discoveries have highlighted some of the ways that mutant p53 may be able to 
affect TGFpl signalling. As previously discussed in cells that sustain DNA damage p53 
expression leads to G1 arrest or apoptosis. The increased levels of p53 transactivates 
p2 ivra/7  ^ which inhibits cyclin dependent kinase activity. This in turn inhibits the 
phosphorylation of pRb preventing cell cycle progression. In cells that are rendered 
resistant to TGFpi by mutant p53, wild type p53 function may be abrogated causing the 
prevention of transcriptional activation of p2\wafl gene, thus allowing unregulated 
phosphorylation of pRb and unregulated cell cycle progression. This circuitry suggests 
that TGFpl may suppress growth by inducing p21wafl via p53. It seems likely that the 
expression of p2lwa^  may represent an important mediator of TGFpi activity 
irrespective of p53 status.
Malliri et al, (1996) highlighted the importance of p21 wafl in TGFpi signalling. In an 
study of cell lines derived from squamous cell carcinomas they showed that TGFpi 
activates numerous cell cycle inhibitory pathways connected with p21.vra-/7 The same 
study also reported that expression of the cell cycle inhibitor p lS ^ ^ w a s  unnecessary 
for TGFpl mediated growth arrest in the cells analysed.
Two other mechanisms for TGFpl inhibition of pRb phosphorylation have been 
described, both involving members of cyclin-cdk complexes, one of which implicates 
p53 in TGFpi signalling. In Mink lung epithelial cells which express wild type p53 and 
are highly responsive to TGFpi mediated growth arrest, the synthesis and activity of 
cdk4 is downregulated by TGFpl treatment. This indirectly inhibits the activity of 
cyclin E-cdk2 complexes. Mutant p53 confers resistance to TGFpi in these cells by 
interfering with the down regulation of cdk4 in response to TGFpi, furthermore wild 
type p53 is capable of repressing translation of cdk4 (Ewen et al 1996/ Furthermore, 
HaCaT cells which express mutant p53 do not down regulate cdk4 expression after 
exposure to TGFpi. These findings suggests that regulation of cdk4 translation by p53 
may be involved in the control of G1 progression. In response to TGFpi wild type p53
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may prevent cdk4 translation, and ultimately result in the accumulation of 
hypophosphorylated pRb, causing G1 arrest. Mutant p53, by complexing to its wild type 
counterpart may act to confer resistance to cdk4 translational repression, and hence to 
TGFB1 mediated growth arrest. Additionally, in Mink lung epithelial cells TGFpi 
causes an inhibition of cdk2 kinase activity. This inhibition involves the cdk inhibitor
p27kipl which is induced by TGFpi. p27^Pl binds to and inactivates cyclin E- cdk2
complexes. No link has been established between p53 and p27^pl- It should be noted 
however, that changes in cyclin cdk4, D l, and pRb, and p27kipl were found to occur 
occurs late in the TGFpi response and was not needed in some cell types at all after 
exposure to TGFpi by Malliri, et al 1996.
It seems likely, in view of the experimental evidence, that as in the case of H ras, p53 is 
involved in TGFpl signalling in a cell type and dose specific manner. However care 
should be exercised in the interpretation of in vitro experiments utilising well established 
cultured cell lines. Cell lines are usually devoid of normal p53 function or some 
downstream pathway, and are often, more genetically complex than their in vivo 
counterparts, making interpretation of signalling pathways difficult.
It is probable that other cellular oncogenes and tumour suppressor genes in addition to 
p53 and H ras, co-operate to induce an increased level of resistance to TGFpi. The 
MAD-related family of proteins are essential components in the signalling pathways of 
serine threonine kinase receptors for the TGFpl superfamily. It has been shown that the 
madr22 gene is a tumour suppressor gene located on human chromosome 18q near 
dpc4, yet another potential component in TGFpi signalling. Mutations in madr2 and/or 
loss of chromosome 18q are thought to function to disrupt TGFpl signalling in human 
colorectal cancer (Frank, et al 1997). The collaborative effect of H ras mutation, loss of 
p53 and alterations on MAD related genes may well vary from cell type to cell type. 
The availability of a range of knockout animals and skin targeted H  ras transgenic 
animals provide an ideal model with which to study the factors that co operate to induce 
total resistance to the growth inhibitory effects of TGFpi in mouse skin keratinocytes.
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1.14 P53 in mouse skin tumorigenesis
Three major concepts underlie the theory of skin tumorigenesis. The first is the current 
understanding of how populations of cells, such as the epidermis, reproduce. The second 
is the current concept of multistage carcinogenesis which involves distinct steps of 
initiation, promotion, and conversion. The last relates to the role of the hair follicle and 
the interfollicular epidermis in skin cancer formation.
The earliest event in skin carcinogenesis, initiation, is mutational and requires 
carcinogen treatment. It has been shown in vitro that initiated keratinocytes have an 
altered response to differentiation signals, which is thought to provide a selective growth 
advantage. At the molecular level, mutation of the H ras proto-oncogene has been 
shown to be an initiating event in skin tumours, particularly in tumours produced by 
9,70-dimethylbenzathracene (DMBA) (Quintanilla et al, 1986).
Exogenous tumour promotion causes the selective clonal expansion of initiated cells, 
giving rise to numerous benign papillomas. A single tumour is thought to arise from the 
clonal expansion of one initiated cell. However models of polyclonality have been 
proposed (Winton etal, 1989).
Potent tumour promoters of the phorbol ester class such as 12-0- tetradecanoylphorbol- 
B- acetate (TPA) activate protein kinase C (PKC) (Nishizuka et al, 1986) This enzyme 
activity accelerates epidermal terminal differentiation (Yuspa et al, 1982). Initiated cells 
resist the induction of terminal differentiation by activators of PKC and, this confers a 
selective growth advantage in these cells in response to promotion. Common genetic 
changes during skin tumour promotion include trisomy of chromosomes 6 and 7 (Aldaz 
et al, 1989). Trisomy of chromosome 7 involves the duplication of the chromosome 
harbouring the mutant H-ras allele induced by initiation.
Malignant conversion of benign tumours is a relatively rare event. The risk of conversion 
is variable between benign tumours; subpopulations of papillomas with a much higher 
risk of malignant progression have been identified. Differences in phenotypic markers 
such as TGFpl, (X6P4 integrin and keratin expression have been used to distinguish
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between high and low risk papillomas. (Glick et al, 1993; Tennenbaum et al, 1992; 
Gimenaz et al, 1990) Genetic alterations associated with malignant conversion include 
the loss of the remaining normal H ras gene and mutations in the p53 gene (Bremner et 
al, 1990). A further stage in mouse skin tumorigenesis is progression to spindle cell 
tumour, this is associated with an increase in the ratio of mutant to normal H ras genes 
(Buchman etal, 1991).
P53 loss has also been shown to be involved in tumour progression in vitro. Grafting 
experiments showed that mice grafted with p53 wild type keratinocytes harbouring 
oncogenic H ras develop papillomas, whereas mice grafted with p53 null keratinocytes 
with the same ras mutation develop squamous cell carcinomas. P53 heterozygous 
keratinocytes with mutant H ras caused rapidly growing papillomas of which more than 
50% progressed to carcinomas in a short space of time. Thus in vitro the loss of p53 in 
combination with mutant H ras is associated with the malignant conversion stage of 
epithelial carcinogenesis (Weinberg et a l , 1994).
The number and nature of events before p53 loss becomes causal has been assessed 
through transgenic mating experiments. p53 null mice were bred to HKl.ras mice, which 
harbour an oncogenically active form of H ras targeted to the epidermis. In newborn
HKl.ras/p53_/'mice no accelerated progression of papillomas to malignancy due to p53
loss was observed. Instead, tumorigenicity was repressed. HK1. ras/ p53 mice 
developed no skin tumours even after multiple applications of TPA however
HKl.ras/P53+/+ mice were extremely sensitive to TPA promotion, developing large 
tumours following only two or three applications of TPA, as did their hemizygous p53 
progeny. The hemizygous epidermis exhibited rapid hyperplasia/hyperkeratosis with the
beginnings of papilloma formation following one or two TPA applications. P53‘/“ 
epidermis on the other hand, exhibited only the acute TPA associated hyperplasia similar 
to that of normal skin following TPA treatment. (Greenhalgh, 1996)
It seems likely, based on the in vitro and in vivo evidence that p53 loss does not appear 
to have an effect on H ras expression in the early stages of papillomagenesis. This is 
consistent with a role for p53 loss late in mouse skin tumorigenesis and is in agreement
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with the results of Kemp et al, who looked at the occurrence of chemically induced skin 
tumours in normal mice compared to p53 knock out mice or hemizygous mice. They 
observed that papilloma yield was similar in wild type and hemizygous mice, but was 
reduced in p53 null mice. They also noted that the rate of carcinoma development was 
increased in p53 null and heterozygote mice compared to wild type mice. In addition, 
they found that carcinoma development in heterozygous mice was associated with the 
loss of the remaining wild type p53 allele (Kemp, et al 1993).
Thus loss of p53 does not increase the incidence or shorten the latency of papilloma 
development, however it does enhance the rate of malignant progression. It was 
proposed that, in the absence of p53 cell cycle regulation, the initiated cells progress into 
S phase with a burden of unrepaired DMBA induced mutations, which acts to prevent 
successful completion of the cell cycle and results in cell death, corresponding with a 
reduction in the number of tumours observed in p53 null mice. In support of this idea 
TPA promotion of DMBA initiated null mouse skin has been shown to display areas of 
necrotic tissue and epidermal cell loss. This scenario is unlikely to apply to the HK1 
transgenics as only a single genetic hit is present, therefore putative DNA damage is 
reduced.
The results from the mouse skin model of carcinogenesis lend support to the idea that 
p53 is involved in tumour progression. Loss of p53 and its guardian of the genome 
function, probably allows the faster accumulation of additional genetic lesions in 
tumours. However loss of p53 may have a more subtle affect on tumour progression. 
The ability of tumours to grow is dependent on their ability to develop new blood 
supplies. Angiogenesis, the formation of new blood vessels, is controlled by the balance 
between stimulatory and inhibitory influences. Wild type p53 expression results in the 
secretion of inhibitors of angiogenesis (Dameron, et al 1994). This may represent one 
way in which the presence of wild type p53 inhibits tumour progression. Low oxygen or 
hypoxic conditions, such as those in a tumour cell with inadequate blood supply, induce 
accumulation of p53 protein.(Graeber et al 1996) Furthermore mutant but not wild type 
p53 has been shown to synergize with PKC in inducing the expression of the angiogenic 
vascular endothelial growth factor (VEGF) (Kieser et al 1994) In this way mutation of 
the p53 gene may be a critical event in tumour progression not only for allowing
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aberrant cell growth due to lack of cell cycle control and altered growth factor response 
but also for regulating tumour expansion by stimulating vascularization.
1.15 Mouse skin cell populations and chemically induced mouse skin 
tumorigenesis.
The skin is composed of two parts, the epidermis and dermis separated by the basement 
membrane. The dermis is composed of mainly fibroblasts. The epidermis is a stratified 
squamous epithelium, whose primary cell type is the keratinocyte. As well as 
keratinocytes and fibroblasts there are more than 20 other cell types in the skin. A large 
number of Langerhans cells, lymphocytes, granulocytes, macrophages, and eosinophils 
either permanently reside in the skin, or can be recruited to it. The epidermal cells in the 
skin can be divided into cells of the hair follicle and cells of the interfollicular epidermis.
Multiplying keratinocytes, as identified by 3H thymidine labelling are located in the basal 
layers of the epidermis, as well as in the matrix cell population. Distinct populations of 
dividing keratinocytes differing in their growth capacity are thought to be responsible for 
the renewal of the epidermis. These distinct populations consist of a population of skin 
keratinocytes with extensive growth capacity (stem cells) and an alternative population 
with a limited proliferative capacity (transit amplifying cells). Further evidence for 
proliferative heterogeneity has come from studies of cultured human keratinocytes. 
Autologous grafts of cultured keratinocyte sheets persist on the recipient for many years, 
which suggests stem cells are not lost in culture (Gallico et a l;  1984; Compton et al.; 
1989). In culture keratinocytes are classified in their capacity for self renewal as 
l)holoclones with high reproductive capacity; 2) paraclones, in which all cells quickly 
undergo terminal differentiation; 3)meroclones which are intermediates between 
holoclones and paraclones in their behaviour (Barrandon and Green, 1987). Holoclones 
are most likely founded by stem cells (Barrandon and Green 1987) and paraclones by 
transit amplifying cells. The proof that colony forming cells are indeed stem cells, that is 
that they have extensive growth potential cannot be examined in rodents since rodent 
cells routinely immortalise after a short length of time in culture.
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Mice initiated with DMBA can be promoted even after a time gap of more than one year 
after the initial insult, leading to the conclusion that initiation must involve a population 
of long lived cells, i.e. stem cells present in the skin (Loehrke et al’ 1983). It seems 
likely that the stem cells responsible for populating the interfollicular epidermis are also 
capable of populating the hair follicle. When epidermal tissue is transplanted from 
hairless sites on the body on to the dermis from a hair producing site the transplanted 
epidermis starts to produce hair. A system that operates via multipotential stem cells has 
the advantage of reducing the size of the stem cell compartment. The size of a stem cell 
population is believed to be critical. Stem cells are by definition long lived. This may 
render them sensitive to carcinogenic transformation. The smaller the stem cell pool the 
fewer the number of targets in which this transformation can occur.
Cell cycle kinetic data has provided indirect evidence that stem cells reside in the basal 
layer (Sheremer et al 1886), the outer root sheath (Lenoir et al., 1988) and bulge region 
of hair follicles (Cotsarelis et al., 1990). In mouse skin, suprabasal keratinocytes are 
arranged in columns (Mackenzie, 1970; Christophers, 1991). It has been proposed that 
one stem cell lies at the base of each column, and is surrounded by transit amplifying and 
post mitotic cells (Potten, 1974, 1981). The stem cells of the skin probably reside in an 
optimal microenvironment, and it seems likely that behaviour of stem cell progeny is 
controlled by environmental factors.
1.16The hair follicle and development of skin cancer.
It is widely accepted that a population of hair follicle cells with stem cell like 
characteristics are the target cells that interact with carcinogens and eventually undergo 
cellular transformation. The hair follicle forms a bulb around the specialised 
mesenchymal structure, the dermal papilla. The relatively undifferentiated matrix cells 
give rise to concentric rings of differentiated cell types. The hair is surrounded by two 
root sheaths. The inner root sheath is composed of three cell types: the inner root sheath 
cuticle, Huxley's layer, and Henle's layer. The outer root sheath is composed of a few 
layers of a single cell type. The hair and inner root sheath extend to the dermal papilla. 
The outer root sheath cells do not come into direct contact with the dermal papilla. They 
are contiguous with the basal layer epidermis, but they are distinct and self propagating.
( Reviewed in Lavker et al, 1993)
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Early work suggesting a role for hair follicles in skin cancer development was carried out 
in haired versus hairless mouse skin (Lacassagne and Lataijet, 1946). Scarification of the 
backs of mice showed that scars that healed without hair follicles, did not develop 
tumours after treatment with carcinogens. Only the periphery of the scar region where 
hair follicles were present developed tumours. Later tumour development was examined 
in strains of hairless and haired mice (Giovanella et al, 1970). These studies concluded 
tumours could arise from hairless skin, probably because rudimentary follicles studied 
were present in the skin of the hairless mice.
Administration of 3H-thymidine for one week twice a day from birth is sufficient to label 
cells in the basal layer and in the hair follicle. Four weeks later label retaining cells can be 
found in the bulge area of the outer root sheath of the hair follicle. No label retaining 
cells are visible in the matrix area of the hair near the dermal papilla. This observation 
led to the proposal that the slow cycling hair follicle cells are located in the bulge area of 
the outer root sheath and that the cells surrounding the hair bulb near the dermal papilla 
belong to a transit amplifying population. Similar results have also been observed in two 
specialised hair structures- vibrissae and eyelash follicles. Slow cycling cells are localised 
to the outer root sheath of the vibrissa follicle in an area analogous to the bulge region. 
Similarly, in the eyelash slow cycling cells are exclusively observed in the outer root 
sheath in a region corresponding to the bulge (Cotsarelis et al, 1990; Lavker et al, 
1991). No slow cycling cells are present in the matrix keratinocytes.
Bulge cells have been distinguished as carcinogen retaining cells, and are also stimulated 
to divide by the application of TPA (Cotsarelis et al, 1990). Cells in the bulge area of the 
outer root sheath express few differentiation markers. They have a high 
nuclear: cytoplasmic ratio and sparse expression of keratin proteins. Outer root sheet 
cells are also capable of shifting their differentiation to form cells with an interepidermal 
phenotype when cultured under suitable conditions. It is possible that the basal layer 
stem cells are temporary stem cells which are replaced by the division of cells in the 
follicle. There are obvious advantages of positioning stem cells in the bulge area of the 
outer root sheath. The bulge area is well vascularised which may help maintain the stem 
cells in a stable, well nourished environment (Schofield, 1983). The bulge is also a
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permanent structure which does not undergo cyclic degradation during the catagenic 
phase of the hair follicle, unlike the cells of the bulb near the dermal papilla.
At the beginning of the growing phase (anagen), the normally slow cycling cells of the 
bulge area undergo transient proliferation, giving rise to transiently amplifying (TA) 
cells, which subsequently form the new downgrowth (Andreasen, 1953; Sun et al, 
1991). The formation of tumours during chemical carcinogenesis is strongly correlated 
with the stage of the hair cycle the mice are in at the start of carcinogen treatment. 
Tumour number increases when the treatment is started in the growing phase of the cell 
cycle when the cells of the outer root sheath are more accessible to carcinogenic insults 
(Argyris, 1963). This further supports the idea that a high number of tumours derived 
chemical carcinogenesis come from the hair follicle.
Although many studies have identified the outer root sheath as the location of stem cells 
in the hair follicle, others have suggested alternative locations within the follicle. 
Reynolds et al proposed that stem cells of the skin were located in the cell layer directly 
opposite the dermal papilla, known as the germinative layer (Reynolds & Jahoda et al, 
1991b). Cells from this layer can proliferate and form organotypic structures when 
cultured with dermal papilla cells. Outer root sheath cells do not possess this ability. 
However, the only slow cycling cells found in the hair follicle are in the outer root 
sheath, and germinative cells are not located in the permanent portion of the hair follicle. 
Outer root sheath cells are thought to be capable of regenerating the population of 
germinative cells when the lower end of the follicle is removed (Jahoda and Reynold, 
1993). Germinative cells however are not thought to be capable of differentiating 
towards the interfollicular phenotype. It seems unlikely that germinative cells are the 
stem cell for both the follicle and the interfollicular epidermis. The germinative cells may 
be a transit amplifying population derived from the outer root sheath cells.
The existing data from diverse approaches support the bulge location of follicular stem 
cells. During early anagen the normally slow cycling bulge stem cells may be activated 
by the abutting dermal papilla cells to undergo transient proliferation giving rise to 
keratinocytes of the lower follicle. This hypothesis has received further support from 
labelling studies which clearly show the bulge cells proliferating in early anagen.
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1.17 Cells outwith the follicle stem cell compartment and the development of skin 
cancer.
Barrandon et al showed that relatively differentiated cells from renewing epithelia such 
as skin can acquire immortality in culture. Moreover telomerase activity, which is closely 
related to the ability of a cell to survive in culture, is not present in the vast majority of 
adult human cells but it can be detected in a large proportion of human tumour biopsies. 
Based on these observations it seems reasonable to propose that cells which no longer 
reside in the stem cell compartment and are in a more differentiated state would be 
capable of giving rise to malignant tumours providing they encounter sufficient genetic 
changes. In a further extension of this proposal it may be the case that a continuum of 
target cells may exist in a tissue whose stage of differentiation determines the number of 
genetic hits required for malignancy to develop.
Brown et al (In Press 1997) showed that the expression of mutant H ras within the 
interfollicular compartment of mouse skin induced the formation of benign papillomas 
which very rarely progressed to malignancy However when the same H ras construct 
was targeted to the hair follicle it stimulated the development of regions of acanthotic 
areas in newborn skin, later in development the mice developed papillomas and 
keratoacanthomas which showed a high frequency of malignant transformation to 
squamous and spindle carcinomas. The authors concluded from these transgenic mouse 
experiments that the nature of the target cell in chemically induced mouse skin 
tumorigenesis is a major factor in the malignant potential of the resulting tumour.
Perhaps the most logical interpretation of the data available is that that a continuum of 
target cell populations exists in the epidermis. The most primitive stem cells, probably 
situated in the bulge region, are likely to be capable of giving rise to the most malignant 
tumour types. This risk is minimised by the small number of these cells and their 
maintenance in a protected environment. The cells furthest removed from the stem cells 
in terms of differentiated phenotype, may be capable of undergoing transformation 
resulting in low risk benign tumours which very rarely progress to malignancy. The role 
of the basal stem cells and their capacity for malignant transformation remains unclear. 
In this model, proposed by Brown et al the stem cells of the basal layer may undergo
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transformation giving rise to a less malignant tumour than one derived from the hair 
follicle stem cell.
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Chapter 2. Materials and Methods
2.1 Materials
Restriction enzymes were obtained from Boehringer Mannheim, Lewes, East Sussex; or 
from Gibco BRL, Paisley. Taq polymerase was purchased from Promega, Southampton. 
Deoxynucleotides were from Pharmacia. All radioisotopes came from Amesham 
International P.L.C. Amersham, Buckinghamshire.
DNA size markers for gel electrophoresis, were supplied by Gibco P.L.C. Paisley. As 
was the Ultrapure tm agarose. Nitro-cellulose was supplied by Sartororious Instruments 
Ltd., Belmont, Surrey; and Amersham International.
Phenol was delivered as a water saturated liquid from Rathbum Chemicals Ltd., 
Walkerbum, Peebleshire. Ethanol was supplied by James Burroughs (F.A.D) LTD., 
Witham. Essex. All other chemicals were obtained from BDH Laboratory supplies, 
Poole, or Sigma Chemical Cp .Ltd., Poole, Dorset.
Serum, media (excluding KBM) and supplements for cell culture were obtained from 
Gibco BRL, Paisley. Plastic-ware for cell culture was supplied by Nunc Intermed, 
Roskilde, Denmark; Sterlin Ltd., Feltham, Middlesex; or by Falcon tm, Becton 
Dickinson, Dublin. Mice were from Harlan Olac Ltd., Bicester,Oxon. KBM medium 
was obtained from Clontech ( USA)
2.2 Oligonucleotide synthesis.
Oligonucleutides were synthesised on an Applied Biosystems 381A Synthesiser, using
the manufacturer's protocol and reagents. After deprotection in ammonia at 55°C 
overnight, the oligonucleotides were precipitated and used without further purification.
2.3 Restriction enzyme digest of DNA
Genomic DNA was digested overnight with 10 units/ug DNA. Digestions were analysed 
for completeness, by gel electrophoresis.
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2.4 Agarose gel electrophoresis
Agarose gel electrophoresis of DNA was performed using the appropriate horizontal gel 
electrophoresis apparatus, with concentrations of agarose concentrations between 0.7- 
0.2% w/v, depending on the desired fragment resolution. The agarose was cast in TAE 
buffer (40mn Tris.Cl pH 7.8; 20mn Sodium Acetate; lmn EDTA) which was also used 
as the running buffer. Ethidium Bromide 1 pg/ml was either added direct to the molten 
agarose, or in the case of southern blotting, the gel was soaked in an Ethidium Bromide 
solution, prior to UV illumination and photography.
2.5 Purification of fragments from Agarose Gels
The fragment of interest was excised under UV illumination The geneclean technique ( 
Stratech Scientific Ltd) was used under manufactures instructions.
2.6. General culture of mammalian cells.
2.6.1. Medium and Supplements
Cell lines were grown routinely in Special Liquid Medium (SLM, GibcoBRL) 
supplemented with 10% foetal calf serum and 4mm glutamine. Cells were grown in 25,
75, or 125 cm^ flasks or 9cm dishes gassed with 5% CO^ and placed in 5% CO2 37°C 
incubators. Cells were washed in phosphate buffered saline or PBS ( 0.14mm NaCl ; 
27mm KC1 ; 10mm Na2HP04; and 15mm K2HP04). Trypsin for cell disaggregation 
was used at 0.025% w/v in PE (1mm EDTA pH 7.8 in PBS). Trypsin was inactivated 
with 10- fold volume of serum containing medium. Cell numbers were estimated using a 
Coulter Counter.
2.6.2. Freezing and storage of cell lines.
Cells to be frozen were grown to 90% confluence, trypsinised and centrifuged at 1000 
rpm for 5 minutes. The cells were the resuspended in equal proportions of growth 
medium and freezing medium (25% foetal bovine serum; 20% DMSO; 55%growth 
medium). Cells were stored in 1ml Nunc TM vials in liquid Nitrogen.
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2.6.3. Preparation of retroviruses and infection of cultured cells.
Vims producer cell lines were grown to 70% confluence. The medium was replaced with 
a minimal volume of fresh medium -ensuring the culture surface was completely 
covered. After 24hrs the medium was removed and filtered through several 0.2 micron
syringe filters. The cells to be infected were seeded in 25cm^ flasks (5 x 10^) 24hrs
before viral infection. 50 pis of viral supernatant, 150pl of polybrene (0.8mg ml"l) and 
5mls of growth factor medium was added to each flask. 24hrs later the cells were
expanded in to 75cm^ flasks.
2.6.4. Production of fibroblast primary cultures and cell lines.
Dorsal skin was removed from three day old mice. The skins were placed in 0.05% 
Worthington Trypsin in PBS and placed at 4% overnight. The dermis was then separated 
from the epidermis using scalpels. The dermis was chopped into small pieces and placed
in 9cm^ dishes and left to adhere to the tissue culture plastic for 10 minutes. SLM 
supplemented with 20% FBS was then added. The medium was changed every three 
days until fibroblast outgrowth from the pieces of tissue could be seen. The cells were
then expanded into 50cm2. After two weeks the remaining cells were single cell cloned.
2.6.5. Production of keratinocyte cell lines and primary cultures.
Dorsal skin was removed from three day old mice. The skins were placed in 0.05%
Worthington Trypsin and placed overnight at 4°C The epidermis was removed from the 
dermis using scalpels. The epidermis was then washed three times with SLM. The SLM 
was then removed and the epidermis was finely chopped using scalpels. Fresh SLM was 
then added and the pieces of epidermis drawn through a wide bore syringe needle three 
times. The cell suspension was then centrifuged at 600RPM for 3 minutes. After 
suspension in SLM the cells were again passed through a wide bore needle tree times.
After further centrifugation the cells were plated in 9cm^ dishes and left for seven days 
before fresh KBM was added. After 10 days. Keratinocyte colonies were ring cloned 
and expanded into small flasks. After several weeks in culture KBM medium was 
replaced with SLM and the cells were then routinely cultured in SLM medium.
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2.6.6 Isolation of carcinoma cell line.
Carcinomas were removed and placed in PBS. The tissue was washed several times in 
serum containing medium. The tumours were then cut into small pieces and allowed to
adhere to 9cm^ tissue culture dishes. Serum containing medium was then added to the 
dishes. After a week the medium was changed. The cells were allowed to grow out from 
the tissue pieces. Individual colonies were ringcloned.
2.6.7 Radiation of cell lines
Cells for irradiation were grown to 70% confluence before radiation exposure using a 
CO60 source. (Dose rate O^Gy/m in'1) After this the cells were harvested as required.
2.7 Section preparation.
Tissue samples were fixed overnight in 4% phosphate buffered formalin. The samples 
were then washed in PBS, 50%PBS/ethanol, then 70%PBS/ethanol (30mins each).The 
fixed tissue samples were then sent to the Pathology Department at Glasgow University 
Veterinary School. They were dehydrated, and embedded in paraffin wax. For 
histological examination sections were cut from the samples before being dewaxed and 
stained with Eosin. The sections were mounted and visualised by light microscopy.
2.7.1 P53 Staining.
Immuohistochemistry was performed as described using CM5 as the primary antibody 
(see Midgeley, e ta l 1995)
2.7.2 Apoptotic analysis.
Sections were prepared as above and stained with Hematoxylin and Eosin. Apoptotic 
cells were identified using the characteristic markers of apoptosis; cell shrinkage, loss of 
cell contact, and condensation of chromatin. Additional apoptotic analysis was 
performed using a fluorescent in situ apoptosis detection kit from Boeheringer 
Mannheim according to manufacturers instructions.
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2.7.3 Bromodeoxyuridne (BrdU) analysis
One hour before sacrifice the mice were injected intraperitonally with 50pl of BrdU 
stock solution (25fag/ml). Samples were removed and fixed in phosphate buffered 
formalin overnight. After this the samples were washed in PBS, 50% ethanol /PBS and 
70% ethanol /PBS (30mins in each) BrdU detection was carried out using BrdU 
antibody (Amersham RPN202) and horseradish peroxidase labelled second antibody.
2.7.4 TPA treatment of mouse skin.
The dorsal skin of the mice was shaved 2 days prior to treatment. Two hundred
microliters of 10"^m TPA solution in acetone was then applied to mice in anagen phase 
of the cell cycle based on hair regrowth.
2.7.5 Whole body irradiation of mice
The resting hair follicles of adult p53 wild type and knockout NIH mice were stimulated 
into activity by shaving. This was not required for two week old mouse skin since most
of the follicles are in anagen. Five days after shaving the mice received 4Gy ^ C o  with a
dose rate of 0.96Gy/min"l. Skins were removed and sections cut to give good 
longditudinal sections of hair follicles. The H&E stained sections were examined and 
counted under a X20 objective lens. Non irradiated animals served as controls.
2.7.6 Staining frozen sections
Frozen sections were cut by Ian Millan in the Pathology Department at Glasgow 
University. The frozen sections were washed in 0.02% glutaraldehyde, 2mm MgCl2,
5mm EGTA, and 0.02% NP-40 in PBS for 5 minutes. The samples were then washed 
twice with 0.02% NP-40 in PBS. The sections were then stained with 1 mg/ml-1 X-GAL, 
5mmK3Fe(CN)6, 5mM K4Fe(CN)6 .6H20 and 2mMMgCl, 0 .01%sodium deoxycholate,
and 0.02% NP-40 in PBS. The staining was carried out for 24hrs in a humid 37oc 
incubator in the dark. After staining the samples were stained with Eosin, dehydrated 
and mounted. The tissue sections were visualised by light microscopy.
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2.8 Southern blot analysis
DNA fragments were separated by agarose gel electrophoresis then transferred onto 
nylon membranes (Hybond-N TM) (as described by Rigaud et al 1987). The agarose gel 
was soaked in ethidium bromide before being photographed. The gel was then emersed 
in 1.5M NaCL, 0.5M NaOH for 2 x20 minutes, and then in 1M NH40AC / 0.02 MNaOH
for 2 x 30 minutes. Transfer of the gel onto nylon membrane was achieved by capillary 
transfer overnight in NKLjOAC/NaOH transfer solution. The membrane was fixed by
baking for 80°C for 2 hours and hybridised as described. Membranes were pre
hybridised for a minimum of 4hrs at 42°C in glass bottles with pre heated solution. 
Radio labelled probe was denatured by boiling for lOmins and added directly into the pre 
hybridisation solution. Membranes were hybridised for a minimum of 16hrs. After this 
membranes were washed on a rotating shaker in lxSSC / 0.1%SDS, followed by 
0.5xSSC / 0.1%SDS for 15 minutes each at room temperature. Membranes were finally
washed with O.lxSSC / 0.1%SDS at 65°C until background levels fell to the expected 
levels as measured by a Geiger counter. The filters were exposed to Kodak X-OMAT
AR film at -70°C in cassettes containing intensifying screens
2.9 Preparation of radiolabelled probes
The p53 probe was as descibed in Kemp, et al 1993. It was labelled by random priming 
(Feinberg and Vogelstein 1984) 50ng of purified insert DNA was boiled for 10 minutes 
to allow denaturation and was subsequently labelled in a total volume of 50ul which
contained lOpl OLB buffer, 2ul of BSA (lOpl g/ml stock). Finally 1.85x10^ MBequerel 
of a  32P dCTP and 5 units of klenow enzyme were added. The reaction was incubated 
at room temperature for 6hr. Unincorporated nucleotides were removed by running the 
probe through a nick column (Pharmacia) and the specific activity estimated using a 
scintillation counter.
Oliginucleotide buffer 
62pl 1M Tris pH 7.4 
6 pi 1M MgCL2 
lpl 2- Mercaptoethanol
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2jal 15mM dATP 
2ul 15mM dGTP 
2ul 15mM dTTP 
125ul 2MHEPES
50|iL 150od/ml Calf Thymus Hexanucleotides 
stored in aliquots at -200c
2.10 Ras western blot analysis.
Protein samples were prepared as described. The protein content was estimated using 
the Bio-rad assay (see manufacturers instructions). For detection of H ras specific bands 
the samples were first treated with 50% IgPAS (Protein A Sepharose), and then 
immunoprecipitated with antibody 172 (H-ras specific antibody Oncogene Science 
Inc),as described below lmg/ml of protein was made up with lysis buffer. lOOpl of 50% 
IgPAS was spun down, and the lysates added directly onto PAS. The samples were
incubated on a rotator at 4°C for 4hrs. The supernatant was removed and respun to 
remove residual PAS. A dilution of 1:100 of antibody 172 and lmg/ml f/c BSA was
added to the pre cleared lysates this was incubated overnight at .4°C 100|iil of 50%PAS 
was added to the lysates and incubated for 2 hours at 4°C on a rotator. The tubes were 
spun and the final pellets resuspended in a volume of 35jalof western sample buffer ( 10% 
B-mercaptoethanol; 2%(w/v) SDS; 30%(w/v) glycerol; 0.025% bromophenol blue, a 
few crystals of methyl green in 0.05M Tris-Hcl pH 6 .8). The samples were boiled for 
5mins and the supernatant transferred to a fresh tube. The samples were run on a vertical 
17.5% polyacrylamide gel (17.5%acrlyamide; 375mMTris-HCL pH 8.8; 0.1% SDS; 
0.1% Ammunium Persulphate; 1 pl/ml TEMED with a 5% polyacrylamide stacking gel) 
in Tris glycine running buffer (1 litre 3.025g Tris base; 14.4g Glycine; lg SDS pH 8.5) 
Amersham rainbow protein molecular weight markers (2350-46000 molecular weight) 
were used.
The gel was cut to size (using the molecular markers as a guide) and placed in an 
electroblotter. Six sheets of whatman paper cut to size soaked in Anode solution 1 (0.3 
Tris / 20%methanol pH 10.4)
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2.11 p21, BCL2 and BAX western blot analysis
Cells were lysed for 20mins on ice in 50mM HEPES (pH 7.0, 250mMNaCl, 0.5% 
NP40, 5mM EDTA, 50mM NaF, 200 pM sodium orthovanadate, 2mM benzamidine, 
50mM B- glycerolphosphate, ImM PMSF,10pg/ml leupeptin, and lpg/ml soyabean 
trypsin inhibitor. Lysates were spun at 14000 rpm at 4°C for 5mins. Protein 
concentration determination was carried out by diluting the samples 1:10 in copper 
sulphate, bicinchoninic acid solution (Sigma) 20ug of extract was fractionated by SDS- 
PAGE before being transferred to immobilon-P filters (Millipore). The filters were then 
blocked in 5% Marvel solution in the presence of 0.1% Tween 20. The filter was then 
probed with appropriate antibodies. Goat anti-rabbit IgG was used as a secondary 
antibody at 1/5000 dilution.
p2 iw af antibody was used at 1/1000 dilution in the blocking solution 
(Santa Cruz cat no.397)
BAX antibody was used at 1/1500 dilution in the blocking solution 
(Santa Cruz cat no. 578)
BCL2 antibody was used at 1/500 dilution in the blocking solution 
(Santa Cruz cat no 526)
Visualisation of resulting bands was achieved using an ECL detection kit from 
Boeheringer Mannheim according to manufacturers instructions.
2.12 Tritiated Thymidine incorporation assay
Cells were trypsinised and plated out at a density of 2x10^ cells/well into 96well plates 
and allowed to attach overnight in control medium The next day the cells were incubated 
for 24hrs with various concentrations of TGFpl in SLM. The cells then received a pulse
for four hours of 0-33pCi/well thymidine (26Ci/mmol;Amersham Corp., 
Buckinghamshire UK). After which the cells were trypsinised and harvested using a
Pharmacia Cell Harvester. ^H Thymidine incorporation was measured with a Pharmacia 
liquid scintillation counter.
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2.13 Clonogenic assay
Clonogenic assays were performed as follows: Cells were seeded into 25cm^ flasks and 
irradiated in suspension. Cell numbers were chosen to give approximately 100 colonies 
in each flask. Plates were prepared in triplicate for each dose point. Both NK and C5N 
cells required 10-14 days to form colonies. The cells were stained by carbol fiishin 
(Lamb London) after removal of the medium. Colonies were counted microscopically, 
using the standard definition that a colony consists of 50 or more cells. Survival Fraction 
(For dose of X Gy) = PE irradiated (X Gy) divided by PE unirradiated where PE is 
defined as the percentage of cells plated which formed colonies.
2.14 Long term effects of TGFpi on keratinocyte proliferation.
Cells were plated in 35mm culture dishes in triplicate in SLM medium. After 24hrs the 
medium was replaced with either fresh medium in the untreated controls or medium 
containing TGFpl. Medium with or without TGFpi was replaced every 48hrs until the 
end of the experiment.
2.15 Long term mouse skin tumorigenesis
Six week old female p53 wild type and knockout mice maintained in the CRC Beatson 
Labs on an NTH background were shaved and initiated with DMBA two days later. The
mice were subsequently treated with 5X10 '^mM TPA solution in acetone twice a week 
for twenty weeks Papilloma and carcinoma development was recorded weekly.
2.16 PCR analysis of p53 LAC Z A FOS, mice
DNA was amplified according to Saiki et al (1988). A 50pl reaction usually contained 
lug of genomic DNA in commercial reaction buffer (Promega) : 50mM KCL; 50mM 
Tris-Cl pH 9.0, 7.5mM MgCl2; 0.01% gelatin w/v; 0.1% Triton X-100; each DNA
amplimer was at adjusted to a concentration of 140|ig/ml"l ; dNTPs were added as 
follows: 2.5mM stock mix, 4pl in 50jj1 reaction were combined in a 0.5ml PCR tube. 2.5 
units of thermostable DNA polymerase from themus aquaticus (Taq polymerase), was 
added to the mixture. Thermal cycling was controlled by a programmable heating block 
(Perkin Elmer Cetus, DNA thermal cycler ).
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Chapter 3. Results
3.1 The role of p53 in mouse skin cells.
As discussed in the chapter 1 p53 has previously been implicated in, amongst other 
cellular activities, TGFpi signalling, cell cycle arrest and /or apoptosis after DNA 
damage in a wide variety of cell lines and tissues both in vitro and in vivo. Loss of any of 
these functions is proposed to enhance the development of tumours. In chemically 
induced mouse skin tumours, loss of p53 is thought to be a major event in the 
development of malignant tumours. This observation prompted the present study into 
the role of p53 in mouse skin keratinocytes. By using wild type or p53 knockout 
keratinocyte cell lines and skin tissue the effect of loss of p53 in mouse skin 
keratinocytes on TGFpl signalling, and on cellular out come after DNA damage was 
investigated.
3.2 The role of p53 in cell immortalization.
Unlike normal embryonic stem cells that have the ability to permanently divide, normal 
somatic cells are endowed with a limited doubling capacity when placed in culture 
(Bradley et al., 1984; Suda et al., 1987a). The period of limited proliferation for normal 
cells varies from species to species and from cell type to cell type (Todaro, 1964; 
Hayflick, 1961).
Results from cell fusion experiments are consistent with the hypothesis that 
immortalization involves changes in specific identifiable genes. (Pereira- Smith & Smith, 
1983, 1988). The tumour suppressor gene p53 has been implicated in the 
immortalization process on the basis of a number of observations. Mutations are 
common in both cDNA and genomic clones of p53 from immortal rodent cells and 
also many human cancer cells (Finlay et al, 1988; Nigro et al, 1989 ). p53 also has the 
ability to inhibit growth or induce apoptosis when induced into established cell lines 
(Baker et al, 1990; Yonish-Rouach et al, 1991). Furthermore, it has been shown that 
rodent cells can be immortalised by genes whose protein products bind to wild type p53 
(Rovinski & Benchimol, 1988).
Rather than look at p53 mutations in immortal cells the aim of this study was to 
investigate the characteristics of otherwise normal cells which lack p53. We chose to
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look at populations of keratinocytes which were derived from either wild type, p53 
knockout, or heterozygous newborn mouse skin. (Donehower et al, 1992).
The p53 status of newborn mice obtained from a crossing of p53 heterozygous mice was
established by Southern blotting (Figure 3.1). Primary keratinocytes were isolated from
individual mouse pups as described in chapter 2 . After two days in culture, cells derived
from all three genotypes flattened out on the tissue culture surface and started to divide.
. / •  + /-
Primary keratinocytes derived from p53 and p53 mice had a similar morphology to
+/+
keratinocytes derived from p53 mice. The keratinocytes grew exponentially for 7-8
days before entering crisis. Although keratinocytes from all three genotypes entered a
- / -  + /-
phase of cell death after 8 days, p53 and p53 cells showed an increased ability to 
emerge from the death phase and become established as immortal cell lines. This 
phenomenon was more pronounced in p53 cultures. Healthy keratinocyte colonies
were visible in cultures derived from p53'7' mice skins after two weeks in culture, this 
was also the case for cultures derived from p53 +/'knockout mouse skins. Very few cells 
could be seen in p53 +/+ cell colonies at the same two week time point. Healthy 
keratinocytes visible in the p53 "A cultures were ringcloned and passaged routinely. Each 
colony became an established immortal cell line. This was also the case for surviving 
colonies from p53 +/' cells. No cell lines could be established from p53 +/+ cultures. 
Fibroblasts from p53 ''' mice also showed increased ability to become immortal cell lines 
compared to fibroblasts derived from wild type mice. The keratinocytes isolated from 
each genotype of mice were non tumorigenic when injected into nude mice.
Several carcinoma cell lines were isolated from chemically induced mouse skin cancers 
from p53 +/+, p53+/‘, and p53 ''' mice (see chapter 2). Carcinoma cells from p53 +/’ and 
p53_/' mice became immortal more readily than cells from p53 +/+ carcinomas. All the cell 
lines established from carcinoma explant cultures were highly tumorigenic when injected 
into nude mice. When normal primary keratinocytes from p53 +/+, p53+/', and p53‘A mice 
were injected into nude mice no tumours developed. Since the initiation of this work 
similar results have been published by other groups. (Tuskada et al, 1993; Harvey, et al 
1993)
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3.3 In vitro analysis of the effect of loss of p53 on the growth inhibitory actions of 
T G F p l.
Having isolated p53 'A keratinocytes the link between p53 and TGFpi signalling was 
investigated. As previously discussed in Chapter 1, loss of p53 has been implicated 
directly and indirectly in the loss of responsiveness to TGFpi (Blaydes et al, 1995 ; Reiss 
et a l , 1993). The relationship between loss of p53 function and loss of responsiveness 
to TGFpl is particularly interesting in chemically induced mouse skin tumour 
development since loss of p53 function during the latter stages of the mouse skin 
tumorigenesis system is closely linked with loss of responsiveness of cells to the growth 
inhibitory effects of TGFpi (Haddow, et al 1992).
The response of keratinocyte cell lines from p53 ' (C5N) and p53 ' (NK) mice to TGFpi 
was analysed. The cell line C5N is an established skin keratinocyte cell line which 
contains wild type p53 (Bums et al 1991). At the onset of this study C5N was
considered to be a suitable p53 +/+ cell line with which to compare p53 NK cells. 
Previous studies within this group had identified C5N as being sensitive to the growth 
inhibitory effects of TGFpi (Haddow et al, 1992). Additionally C5N is capable of 
blocking in G1 after exposure to ionising radiation, which is indicative of functionally 
active wild type p53 (I. Ganly, unpublished results).
In long term tissue culture there was no evidence to suggest that loss of p53 alters the 
response of cells to TGFpi (Figure 3.2). Both cell types were equally inhibited by the 
presence of lng/ml TGFpi in the tissue culture medium. The short term response of the
cell lines to varying concentrations of the growth factor (O.Olng/ml, 0.lng/ml, and
- /-  + /+
lng/ml) was also investigated. Again both p53 and p53 cell lines were equally 
inhibited in ability to incorporate tritiated thymidine in the presence of TGFpi (Figure
3.3 A&C).
Although the p53 status of C5N and NK cells was known, the presence of any additional 
mutations or deletions that in the these cells could not be ruled out. Such changes could
alter the response of these cells to TGFpi independent of p53 status. With this in mind,
- /-  + /-  + /+
the initial study was extended to examine the response of p53 > p53 and p53
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primary cells to TGFpi. Short term assays were used in this investigation since long 
term analysis would have been complicated by the onset of primary cell death after 7 
days.
p53+/+,p53 +l\  and p53 primary keratinocytes were equally inhibited in their ability to 
incorporate tritiated thymidine in the presence of O.Olng/ml, 0. lng/ml and lng/ml TGFp 
1 (Figure 3.4). However the degree of response to the growth factor was less than that 
observed for established cell lines with comparable p53 status. This may have been due 
to the presence of other cell types such as melanocytes or fibroblasts in the primary 
cultures.
These results suggest that p53 is not critical for a cell to respond to the growth 
inhibitory effects of TGFP 1. However, our results do not rule out the possibility that p53 
plays a role in TGFpi signalling which can be completely compensated for by other 
cellular proteins in its absence.
3.4 The effect of loss of p53, combined with mutant H  ras on growth inhibition by 
TGFPI.
Having ruled out a direct role for p53 in TGFpl mediated signalling we went on to look 
at the additive effect of mutant H  ras combined with lack of p53 in TGFpi signalling. 
There are many conflicting results as to the role of H  ras in the TGFpi signalling 
pathway. It has been shown in vitro that activation of H ras by DMBA treatment does 
not alter the response of epithelial cells to TGFpi. (Haddow et al, 1992) In contrast 
Filmus et al, (1993) showed oncogenic H ras provided rat intestinal cells with increased 
resistance to the growth inhibitory actions of TGFp 1
Initial attempts to transfect primary keratinocytes with mutant H  ras were unsuccessful. 
Primary keratinocytes were also toxic to infection with H  ras virus. This may have been 
due to the toxic effect of polybrene on the lipid membranes of primary cells. Toxicity of 
primary cells to polybrene has previously been demonstrated in rat glial cells (S. Barrnett 
unpublished results).
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NK and C5N cells were infected with mutant H  ras virus. Both cell lines showed high 
levels of H RAS protein after virus infection as measured by western blot analysis using 
an H RAS specific antibody 172 from Oncogene Science (Fig 3.5). Equal amounts of 
protein was added to each lane.( Figure 3.5). In 3H-thymidine incorporation assays, 
both NK and C5N cells showed a small drop in responsiveness to TGFpi after infection 
with mutant H ras  virus (Figure 3.3 B&D).
Both cell lines showed increased tumorigenicity when injected subcutaneouly into nude 
mice.That is, both cell types yeilded tumours of between 1-1.5cm within a period of six 
weeks, compared to the uninfected cell lines which showed no tumorigenicity after 
injection into nude mice.
These experiments do not rule out a role for oncogenic H  ras in the TGFpi pathway. 
The slight difference observed between the infected and uninfected cultures may have 
occurred as a result of unequal virus production in individual cells. Virus titration studies 
were not included at the time of experimentation, this made it difficult to draw definite 
conclusions as to the role of mutant ras in TGFB1 signalling. A more definitive answer 
to the role of p53 and oncogenic H ras in the TGFpl signalling pathway of mouse skin 
keratinocytes is likely to be provided by analysis of primary skin keratinocytes 
produced by crossing p53 knockout mice with mice which contain with oncogenic H  
ras targeted to the skin.
wafl
3.5 The role of p21 in the response of cells to TGFpi
After the conclusion of the initial in vitro studies, p21w*'/7 was reported as being a
downstream target gene of p53. p21w"/7 is thought to contribute to DNA damage 
induced G1 arrest by preventing phosphorylation of the pRb gene product. This function 
had been reported to be under the control of wild type p53. (El - Diery et al, 1993; 
Harper e ta l ,  1993; Poon e ta l ,  1994).
The p53 knockout keratinocyte cell lines provided an excellent model system in which 
to study the regulation of p21Wfl-/7. As a result of p2\wafl being identified as a cell cycle 
kinase inhibitor we looked at the regulation of p21wa-^  after TFGpi treatment in p53
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knockout and wild type keratinocyte cells. Western blotting analysis showed that p21 
wa^  was present at increased levels in both p53 ' and p53 +/+ keratinocytes after exposure
w a f l  , /
to TGF(31 (Figure 3.6). Basal levels of p21 in p53" keratinocytes were lower than 
basal levels of the protein in p53+/+ keratinocytes. This is probably a direct result of lack 
of normal p53 activity in the knockout keratinocytes. Equal amounts of protein were 
loaded in each lane, and results were consistent in duplicate experiments. These findings 
suggest that p21vra-/7 is implicated in growth control via a p53 independent mechanism. 
This conclusion has also been reached in experiments using HaCat cells. These cells 
contain two mutant alleles of p53 which are unable to activate transcription from the 
p21 waf] promoter. Even so, HaCat cells show an increase in p21Wflj7 levels after exposure 
to TGF p i (Datto etal, 1995).
3.6 The effect of p53 status on the response of cultured keratinocytes to ionising 
radiation.
Having investigated the role of p53 in TGFpl signalling in mouse skin keratinocytes the 
relationship between p53, p21, BAX, and BCL2 and the cellular response to ionising 
radiation was examined. In vitro studies had shown that certain cell types respond to 
ionising radiation with either cell cycle arrest or apoptosis. Fibroblasts derived from p53 
+/+and p53 +/' mice respond to DNA damage with growth arrest, whilst fibroblasts from 
p53 mice fail to show any arrest. However thymocytes from p53 +/+ and p53 +/' 
undergo apoptosis in response to radiation whilst thymocytes from p53 ''' mice do not 
(Clark et al, 1993; Lowe et al, 1993).
The response of p53 +/+ and p53'7' knockout keratinocytes to a range of ionising 
radiation doses was analysed. Standard radiobiology survival assays were used to assess 
sensitivity to increasing doses of ionising radiation (see Chapter 2). Again, the onset of 
cell death in primary keratinocyte cultures precluded their use in this long term
experiment. Both NK p53 ' and C5N p53 ' cells lines were equally sensitive to cell 
killing by ionising radiation (Figure 3.7). Both types of cells were relatively resistant to 
low doses of ionising radiation. However, this resistance diminished at higher doses. 
This suggests that cells selected for outgrowth from primary cultures of skin epidermal 
cells do not require p53 function in order to survive relatively low levels of ionising
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radiation the short term. Alternatively, the results may reflect loss of apoptotically 
active p53 protein in C5N cells. This a may have occurred in the serial passaging of 
C5N cells
3.7 Regulation of bax, and bcl2 by p53 after exposure of keratinocytes to ionising 
radiation.
Changes in protein levels of the cell survival gene bcl2 and the cell death gene bax in
- /-  + /+
p53 and p53 keratinocytes after exposure to radiation were analysed. Both of these 
genes have been implicated in the cellular response to DNA damage. bcl2 is known to be 
transcriptionally repressed by p53 whilst bax is known to be transcriptionally activated 
by the p53 protein. Relative amounts of BAX and BCL2 are thought to control cellular 
fate after DNA damage (For review see White, 1996).
BAX levels remained constant in both p53'A and p53+/+ keratinocytes after they were 
exposed to 4Gy ionising radiation. The apparent decrease of BAX levels in NK cells 
was not consistent in repeat experiments. BCL2 protein levels reproducibly decreased in 
C5N cells 24hrs after exposure to 4Gy ionising radiation. In contrast, BCL2 protein 
levels remained constant in NK cells after exposure to ionising radiation (Figure 3.8 
A&B). Later time points (up to 72hrs post radiation) showed no changes in either BAX 
and BCL2 levels in either cell type compared to control samples.
These results suggest that the lack of cell death observed previously in cell survival 
assays with p53 wild type and knockout keratinocytes is due to lack of increase of BAX 
protein after DNA damage. Interestingly a difference in electrophoretic migration of the 
BAX protein species between NK and C5N cells was detected. This may be due to 
differences in phosphorylation of the protein in the two cellular environments. Mutations 
in bax have recently been reported in human tumours (Rampino, et al 1997). The 
possibility that the difference in electrophoretic mobility of the BAX protein in NK and 
C5N cell lines is due to a mutation is being investigated currently.
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wafl . . .  . .3.8 Regulation of p21 by p53 in response to ionising radiation.
wafl
p21 protein levels increase 12hrs after exposure to 4Gy in p53 keratinocytes. No 
change was observed in p53 _/' keratinocytes. It was also apparent that basal levels of
p2\wa^  in p53 +/+ keratinocytes are increased in p53+/+ keratinocytes compared to p53 '''
wafl
keratinocytes.(Figure 3.8). This suggests that, in contrast to p21 regulation in
wa f l
response to TGFpi signalling, radiation induced p21 induction is critically dependent 
upon p53. This result also goes some way to explaining our previous results regarding 
cell survival and exposure to ionising radiation. Rather than induction of cell death after 
exposure to ionising radiation, cells selected in culture from p53 wild type newborn
wafl
mouse skin initiate a block in the cell cycle via p53 mediated induction of p21 . The
present finding is in agreement with previous studies showing that p2\wa^  mRNA levels 
increase in cultured cells in response to ionising radiation in a p53 dependent manner 
(Xiong et al, 1993; Dulic et a l , 1994)
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F i g u r e  3.1
p 53 p s u e d o g e n e  
p 53 k n o c k o u t  al lele
p53 wi ld type al lele
Sou t he r n  blot  anal ys i s  of  tail  tip D N A  f rom a p53 
k n o ck ou t  he t e r oz ygo t e  litter.
Table 1
Keratinocyte 
cell lines
Fibroblast 
cell lines
Carcinom a 
cell lines
p53
knockout 5
2 7
p 5 3
heterozygote 1 0 5
p53
w ild type 0 0
2
Table of cell lines established from p53 wild type, 
p53 knockout, and p53 heterozygote mice.
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Figure 3.3 Tritiated thymidine incorporation in the presence of TGFpl 
of p53 wild type and knockout cell lines before and after infection with 
mutant H ras virus
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Figure 3.5 Western blot analysis of H-RAS protein levels in NK and C5N cells 
infected w ith mutant H r a s  virus.
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Figure 3.6. W estern blot analysis of p21 w a f  1 protein levels in p53 wild type and 
knockout keratinocyte cell lines after exposure to 4Gy and TGFB1.
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p2 \ w a f l  p r o t e i n  l e v e l s  r i se  1 2 hr s  a f t e r  r a d i a t i o n  in C 5 N  ce l l s ,  
no  c h a n g e  is o b s e r v e d  in i r r a d i a t e d  N K  c e l l s .  B o t h  ce l l  
l i ne s  s h o w  an i n c r e a s e  in p 2 1 w a f l  l e v e l s  4 h r s  a f t e r  e x p o s u r e  to 
T G F B 1 .
E q u a l  a m o u n t s  o f  p r o t e i n  w a s  a d d e d  to e a c h  l a n e .
Pr e  i n c u b a t i o n  o f  a n t i b o d y  wi t h  c o g n a t e  p e p t i d e  r e s u l t e d  in 
no  i m m u n o r e a c t i v i t y .
Figure 3.7. Survival of p53 wild type and knockout cells in response 
to increasing levels of ionising radiation.
DOSE (Gy)
( A )
.00c
©
r3
-2.50
-3.00
DOSE (Gy)
0 5 10
( B
.00
-2.50
-3.00
( A)  NK
( B ) C 5 N
C 5 N  and N K cel l s  w e r e  e x p o s e d  to i n c r e a s i n g  d o s e s  o f  
i o n i s i ng  r ad i a t i o n .  Ce l l  s u r v i v a l  w a s  a s s e s s e d  as d e s c r i b e d  
in c h a p t e r  2.
Do  v a l u e s  are s i mi l a r  f or  the t wo  cel l  l i nes  
Bo t h  NK and  C 5 N  cel l s  are e q u a l l y  s e ns i t i v e  to 
i n c r e a s i n g  d o s e s  of  r a d i a t i on .
T h r e e  s a m p l e s  we r e  a n a l y s e d  per  t i me  poi nt .
Figure 3.8 W estern blot analysis of BAX and BCL2 protein levels in p53 
wild type and knockout cell lines before and after exposure 
to 4Gy.
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( A)  W e s t e r n  blot  a na l y s i s  of  B A X  pro t e i n  l evel s  
a f t er  e x p o s u r e  of  NK and C 5 N  cel l s  to 4 G y .  T h e r e  
is no s i gn i f i c an t  c h a n g e  in B A X  pro t e i n  l evel s  i n NK 
and  C 5 N  cel l s  a f t er  e x p o s u r e  to 4 G y .
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(B)  We s t e r n  blot  analys i s  of  B CL 2  prot ein levels 
a f t e r e x p o s u r e  o f N K  and C5 N cel ls to 4Gy.  The re  is 
no s i gni f i cant  c ha ng e  in BC L 2  prot ein l evel s  in N K 
cel ls af t er  4Gy.  The re  is a sl ight  r educ t i on  in BCL 2  prot ein 
levels in C5N cel l s 2 4 hrs af t er  4 Gy.
Pre i n c ub a t i o n  of  bot h a n t i b o d i e s  wi th r e s p ec t i v e  c o g n a t e  
pe p t i de s  r es u l t e d  in no i m m u n o r e a c t i v i t y .  Pr ot e i n  l oa di ng  
d e t e r mi n a t i o n  wa s  p e r f o r m e d  as d e s c r i b e d  in c h a p t e r  2.
Chapter 4. Results
4.1 The effect of ionising radiation in vivo on mouse skin
Having examined the response of cells in vitro to ionising radiation, the response of cell 
in vivo to ionising radiation was analysed using mouse skin as a model. A number of 
accounts of cell type specific responses to radiation have been reported. Midgely et al, 
(1995) showed accumulation of p53 protein in mouse splenocytes, thymocytes and 
osteocytes, but not in hepatocytes of irradiated mice. The same authors demonstrated 
that cell type specific apoptosis, as a result of DNA damage, occurred in vivo. They 
found that thymocytes entered the apoptotic pathway after radiation but osteocytes did 
not.
4.2 p53 expression and apoptosis in adult mouse skin after exposure to 4Gy.
Using immunohistochemistry we found very little p53 protein in any of the cells of p53 
wild type adult mouse epidermis. However high levels of p53 were detectable in a large 
proportion of cells in the epidermis of p53 wild type mouse skin 4hrs after exposure to 
4Gy. p53 protein levels remained elevated for up to 72hrs post radiation. (Figure 4.1). 
As expected no evidence of p53 protein in p53 knockout mouse skin was found either 
before or after radiation treatment (Figure 4.2).
Characteristic darkly staining apoptotic bodies were present in H&E stained, p53 wild 
type adult mouse skin sections 4hrs after radiation exposure. Unlike the induced p53 
expression pattern, the apoptotic bodies were restricted to a population of cells in the 
matrix region of the hair follicle (Figure 4.3). The increase in apoptotic bodies observed 
in p53 wild type adult mouse skin after radiation exposure was transient and returned to 
normal 12hrs after radiation exposure (Figure 4.5A). Exposure of p53 wild type mouse 
skin to lOGy produced similar numbers apoptotic bodies than to 4Gy (data not shown).
Analysis of p53 knockout mouse skin did not result in an increase in apoptotic bodies at 
any time point after radiation exposure in any population of skin cells, even after 
exposure to increased radiation doses (Figure 4.4A & 4.5B). p53 heterozygote mouse 
skin responded to radiation with an increase in apoptosis roughly 75% of the increase 
observed in p53 wild type mouse skin (Figure 4.6).
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4.3 p53 induction and apoptosis in two week old mouse skin
Following the initial observations in adult mouse skin, p53 induction and apoptosis in 
two week old mouse skin was investigated. Two week old mouse skin has a larger 
matrix cell population than adult mouse skin. Based on the previous results, a greater 
degree of apoptosis in the two week old follicles than in the adult follicles was 
anticipated.
p53 was present at elevated levels in the epidermis 4hrs after exposure of two week old 
p53 wild type mice to 4Gy (Figure 4.7 A&B and 4.8 A&B). Similarly, there was an 
increase in apoptotic bodies 4hrs after exposure to 4Gy in the matrix region of the hair 
follicle (Figure 4.9 A&B). No change, however, was observed in the interfollicular cell 
population (Figure 4.10 A&B). In contrast, no apoptotic bodies were present in either 
the follicular or interfollicular cell populations of p53 knockout mouse skin after 
exposure to 4Gy (Figure 4.9 C&D and Figure 4.10 C&D)
The increase in apoptosis observed in p53 wild type two week old mouse hair follicles 
after 4Gy was more dramatic than the increase observed in adult mouse skin hair 
follicles. The number of apoptotic bodies remained elevated for up to 24hrs post 
radiation treatment in contrast to the transient increase observed in irradiated adult mice 
4hrs after irradiation (Figure 4.11).
To confirm the presence of apoptotic cells in the hair follicle, a fluorescent in situ DNA 
strand labelling kit (see chapter 2) which detects DNA strand breaks characteristic of 
apoptosis, was used. The position of the fluorescence signal in skin sections taken 4hrs 
after exposure to 4Gy correlated almost exactly with the position of the apoptotic bodies 
observed in the H&E stained sections (Figure 4.13). No increase in staining was 
observed in p53 knockout hair follicles after irradiation (Figure 4.14). This confirmed 
the initial observations that apoptosis occurs in the matrix region of the hair follicle after 
exposure to ionising radiation.
An unexpected pattern of background fluorescence staining was observed in both 
control and irradiated sections. In the hair follicles, long elongated cellular bodies appear 
very strongly stained. The true identity of these bodies remains unclear however the
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strong fluorescent signal may be a result of particularly high keratin levels in these 
specific cells
The results demonstrate that apoptosis occurs in vivo, in not only a tissue specific 
manner but also a cell type specific manner. It may be the case in the skin, as in the 
intestinal epithelium, that it is the more stem like cells that exhibit the highest sensitivity 
to radiation induced apoptosis. This is discussed in more detail in a later chapter where 
the role of the radiation sensitive cells in skin tumorigenesis is investigated.
4.4 Entry into apoptosis and cell cycle status.
The increase in apoptotic bodies observed in p53 wild type two week old mouse skin 
was accompanied by a decrease in the number of mitotic cells visible in H&E stained 
sections (Figure 4.11 A). This prompted an examination of the possibility that a 
proportion of apoptotic bodies present in the sections were derived from cells in mitosis, 
rather than in G1.
Two week old mice were prelabelled with BrdU for lhr (as described in chapter 2 ) 
before being exposed to 4Gy. The mice were subsequently sacrificed at various time 
points (Table 2). Since cells in S phase at the time of labelling would incorporate the 
BrdU label, any BrdU labelled apoptotic bodies present by 4hrs following radiation 
exposure are likely to have come from cells in S, G2 or M of the cell cycle. It is 
considered unlikely that a cell would progress through S, G2 and M and encounter the 
Gl/S checkpoint of the cell cycle, in a period of less than 4hrs.
A number of BrdU labelled apoptotic bodies in mouse skin pre labelled with BrdU 
before exposure to radiation were identified (Fig 4.12). The number BrdU labelled 
apoptotic bodies peaked 4hrs after exposure of the skin to radiation. Table 3 summarises 
these results. Based on these findings, it is likely that at least 15-20% of the apoptotic 
bodies which are present in two week old mouse skin exposed to radiation originate 
from cells in the G2/M phase of the cell cycle rather than in Gl/S. No increase in 
apoptotic bodies, or alterations in mitotic cell numbers were observed at any time point 
in p53 knockout two week old mouse skin following exposure to various doses of 
ionising radiation (Figure 4.11 B).
55
4.5 p53 induction and cell cycle arrest in adult mouse skin
Having observed a cell type specific response to p53 induction and subsequent entry into 
apoptosis, we decided to look at cell cycle arrest and p53 induction in vivo in mouse 
skin. Skin sections were taken at various time points from irradiated adult mice. One 
hour before being sacrificed, each mouse was injected with BrdU (as described in 
chapter 2). Subsequent immunohistochemistry with anti BrdU antibodies made it 
possible to evaluate BrdU incorporation in irradiated and control mouse skins.
A reduced level of BrdU incorporation was observed in p53 +/+ adult mouse skin 24hrs 
after exposure to ionising radiation, compared to unirradiated control p53+/+ skin. The 
drop was not detected 48hrs post radiation treatment (4.15A). The drop in BrdU 
labelled cells after 24hrs was not restricted to a specific cell population of adult mouse 
skin. p53 heterozygous mice also showed a drop in BrdU incorporation 24hrs after 
exposure to radiation. The drop was roughly 25% of that observed in p53 wild type 
mouse skin (Figure 4.16). p53 knockout adult mouse skin showed no change in BrdU 
labelling after radiation exposure (Figure 4.15B). Exposure to increasing levels radiation 
failed to induce a change in BrdU incorporation in p53 knockout mouse skin at any time 
point examined.
4.6 p53 induction and cell cycle arrest in two week old mouse skin.
To establish a clearer link between cell type specific cell cycle arrest in response to 
radiation, two week old mouse skin was used, since it contains more readily 
distinguishable cell populations than adult mouse skin. This is due to the large size of the 
follicles present in young mouse skin. p53 wild type two week old mouse skin treated 
with 4Gy showed a drop in BrdU incorporation after 4hrs in the matrix follicular cells 
compared to unirradiated control skin. This result may have been a consequence of the 
matrix cells entering the apoptotic pathway after DNA damage rather than entering cell 
cycle arrest. The interfollicular cells of two week old mouse skin also showed a drop in 
BrdU labelling. However this occurred 24hrs after exposure to 4Gy (Figure 4.17A). No 
change in BrdU labelling occurred in p53 knockout two week old mouse skin after 
exposure to 4Gy ionising radiation (Figure 4 .17B).
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4.7 P53 induction and cell cycle arrest in proliferating adult mouse skin.
Results from the two week old mouse skin experiments led to an investigation of the 
effect of proliferation rate on cell cycle arrest and apoptosis after DNA damage. The 
possibility that matrix cell were more likely to enter the apoptotic pathway than less 
proliferative cell types was examined. Adult mouse skin stimulated to proliferate with 
TPA (as described in Chapter 2 ) was used to investigate the effect of proliferation on 
cell cycle arrest and apoptosis after exposure to ionising radiation.
TPA treatment induced the proliferation in the interfollicular cells of p53 wild type adult 
mouse epidermis. This proliferation was maximal 36hrs post TPA treatment and 
returned to basal levels 72hrs post TPA treatment. Identical results were obtained for 
p53 knockout animals treated with TPA (Figure 4.18 A&B).
p53 wild type adult mouse skin treated with TPA followed 36hrs later by exposure to 
4Gy shows a drop in BrdU incorporation after 4hrs. This decrease was restricted to the 
proliferating cells of the TPA stimulated interfollicular epidermis. The slower cycling 
cells of the adult hair follicle show a drop in BrdU incorporation 24hrs after exposure to 
ionising radiation. (4.15 A). Adult mouse skin treated with TPA and irradiated after 
72hrs shows a universal drop in BrdU incorporation 24hrs after exposure to 4Gy (Fig 
4.18B). p53 knockout adult mouse skin treated with TPA before exposure to 4Gy 
failed to exhibit a reduction in BrdU incorporation 4hrs post radiation (Figure 4.18 
B).Thus it was possible to clearly identify the drop in BrdU incorporation as being a 
consequence of cell cycle arrest rather than apoptosis, since apoptotic bodies are almost 
never observed in the interfollicular epidermis of mouse skin.
In a reversal of the above experiment, p53 wild type and knockout mice were exposed to 
4Gy followed 4hrs afterwards by treatment with TPA for 36hrs. The mice were labelled 
with BrdU and skins taken 36hrs post TPA treatment.
Both p53 wild type and knockout mouse skin showed an increase in proliferation due to 
TPA, which was maximal 36hrs after treatment. No significant difference in TPA 
induced proliferation was detected between p53 wild type and p53 knockout mice
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In brief, these findings suggest that different cell types respond to radiation with either 
cell cycle arrest or apoptosis. From these initial results it seems that cellular proliferation 
rate does not influence the entry of mouse skin cells into the apoptotic pathway, but can 
affect cell cycle arrest.
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F ig u re  4.1 CIYI5 s ta in e d  p 5 3  w ‘‘ ' V r i; a d u l t  m o u s e  sk in  b e f o r e  a n d  4 h r s  a f t e r  e x p o s u r e  to
( A)
( B)
( A)  C M 5  s t a i n e d  p 5 3  w i l d  t y p e  a d u l t  m o u s e  s k i n  b e f o r e  e x p o s u r e  t o 4 G y .
( B)  C M 5  s t a i n e d  p 5 3  w i l d  t y p e  a d u l t  m o u s e  s k i n  4 h r s  a f t e r  e x p o s u r e  t o  4 G y .
4 h r  a f t e r  e x p o s u r e  t o  4 G y  p 5 3  p r o t e i n  l e v e l s  r i s e  in t h e  f o l l i c u l a r  a n d  i n t e r f o l l i c u l a r  
e p i d e r m i s  o f  p 5 3  w i l d  t y p e  a d u l t  m o u s e  e p i d e r m i s .
C M S  s t a i n i n g  w a s  p e r f o r m e d  as  d e s c r i b e d  in m a t e r i a l s  a n d  m e t h o d s .
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( A)  C M S  s t a i n e d  p 5 3  k n o c k o u t  a d u l t  m o u s e  s k i n  b e f o r e  e x p o s u r e  t o 4 G y .
( B)  C M 5  s t a i n e d  p 5 3  k n o c k o u t  a d u l t  m o u s e  s k i n  4 h r s  a f t e r  e x p o s u r e  t o  4 G y .
C M S  s t a i n i n g  w a s  p e r f o r m e d  as  d e s c r i b e d  in m a t e r i a l s  a n d  m e t h o d s .
M a g n i f i c a t i o n  X 2 0
Figure 4.3. The arrow indicates apoptotic bodies in the matrix region of 
p53 wild type adult mouse skin four hours after exposure to 4Gy.
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( A ) H & E  s t a i n e d  p 5 3  w i l d  t y p e  a d u l t  m o u s e  s k i n  b e f o r e  e x p o s u r e  to 4 G y .
( B ) H & E  s t a i n e d  p 5 3  w i l d  t y p e  a d u l t  m o u s e  s k i n  4 h r s  a f t e r  4 G y .
M a g n i f i c a t i o n  X 4 0
F ig u r e  4 .4  H & E  s ta in e d  p 5 3  k n o c k o u t  a d u lt  m o u s e  sk in  b e fo r e  a n d  4 h r s  a f ter  e x p o s u r e  to 4 ( i y
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( A ) H & E  s t a i n e d  p 5 3  k n o c k o u t  a d u l t  m o u s e  s k i n  b e f o r e  e x p o s u r e  t o 4 G y .
( B ) H & E  s t a i n e d  p 5 3  k n o c k o u t  a d u l t  m o u s e  s k i n  4 h r s  a f t e r  4 G y .
M agnif ica tion  X 40
F i g u r e  4. 5 .  A p o p t o t i c  a n a l y s i s  o f  p 5 3  wi l d  t y p e  a n d  k n o c k o u t  m o u s e  sk i n  a f t e r
e x p o s u r e  to i o n i s i n g  r a d i a t i o n .
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T i m e  a f t e r  e x p o s u r e  to 4 G y  ( H o u r s )
( A)  p 53 h o m o z y g o u s  wi ld  t ype adul t  m o u s e  skin.
(B)  p 53 h o m o z y g o u s  k n o c k o u t  adul t  m o u s e  skin.
Th e  n u m b e r  of  a pop t o t i c  b o d i e s , i n c r e a s e s  f our  h ou r s  af t er  
i r r adi a t i on of  p 5 3 wi ld t ype adul t  m o u s e  skin.  The  i nc r ease  
is t r ans i en t  and fal ls to n o r m a l  bas a l  l evel s  12hrs pos t  
i r r adi a t i on.  No  c h a n g e  is o b s e r v e d  in p53  k n o c k o u t  m o u s e  skin 
af t er  i r r adi a t i on.
Six skin s ec t i ons  wer e  a na l y s e d  per  t i me  poi nt .  S t a i n i ng  wa s  
p e r f o r me d  in t r i pl i cat e for  al l  s a mp l e s .
Ap o p t o t i c  i ndex  = Th e  n u m b e r  o f  a p op t o t i c  b o d i e s  per  sec t ion  
d i v i d ed  by the l engt h in mi l l i me t e r s  of  the sec t i on .
Fi g u r e  4.6 A p o p t o t i c  ana l ys i s  o f  p 53 h e t e r o z y g o t e  adul t  m o u s e
ski n af t er  e x p o s u r e  to 4 Gy .
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T h e  n u m b e r  o f  a p o p t o t i c  b o d i e s ,  i n c r e a s e s  a f t e r  i r r a d i a t i o n  o f  p 5 3  h e t e r o z y g o u s  a d u l t  
m o u s e  s k i n  a f t e r  e x p o s u r e  t o  r a d i a t i o n  T h e  r i se  is m o r e  t h a n  h a l f  t h a t  o b s e r v e d  in p 5 3  
wi l d  t y p e  m o u s e  s k i n  a f t e r  r a d i a t i o n
Si x  s k i n  s e c t i o n s  w e r e  a n a l y s e d  p e r  t i m e  p o i n t
H & E  s t a i n i n g  w a s  p e r f o r m e d  in t r i p l i c a t e  f o r  all  s a m p l e s
A p o p t o s i s  w a s  s c o r e d  b y  t h e  p r e s e n c e  o f  d a r k l y  s t a i n i n g  a p o p t o t i c  b o d i e s
A p o p t o t i c  i n d e x =  T h e  n u m b e r  o f  a p o p t o t i c  b o d i e s  p e r  s e c t i o n  d i v i d e d  b y  t h e  l e n g t h  in 
m i l i m e t e r s  o f  t h e  s e c t i o n .
Figure 4.7 CIV15 stained two week old m ouse skin before and 4hrs after exposure to 4Gy
M a g n i f i c a t i o n  X 2 0
(A )  C M 5  s t a i n e d  P 5 3  w i l d  t y p e  t w o  w e e k  o l d  i n t e r f o l l i c u l a r  e p i d e r m i s  b e f o r e  
e x p o s u r e  t o  4 G y
( B )  C M 5  s t a i n e d  p 5 3  w i l d  t y p e  t w o  w e e k  o l d  i n t e r f o l l i c u l a r  e p i d e r m i s  4 h r s  
a f t e r  e x p o s u r e  t o  4 G y .
4 h r s  a f t e r  e x p o s u r e  t o  4 G y  p 5 3  p r o t e i n  l e v e l s  r i s e  in t h e  i n t e r f o l l i c u l a r  e p i d e r m i s  
o f  p 5 3  w i l d  t y p e  t w o  w e e k  o l d  m o u s e  s k i n .
C M S  s t a i n i n g  a n d  r a d i a t i o n  t r e a t m e n t s  w e r e  p e r f o r m e d  a s  d e s c r i b e d  in m a t e r i a l s  
a n d  m e t h o d s
Figure 4.8. Arrow 1 indicates CM5 stained outer root sheath cells 
Arrow 2 indicates CM5 stained cell in the matrix region of p53 
wild type two week old mouse hair follicles .
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M a g n i f i c a t i o n  X 2 0
(A )  C M 5  s t a i n e d  p 5 3  w i l d  t y p e  t w o  w e e k  o l d  h a i r  f o l l i c l e s  b e f o r e  e x p o s u r e  to 4 G y .
( B ) C M 5  s t a i n e d  p 5 3  w i l d  t y p e  t w o  w e e k  o l d  h a i r  f o l l i c l e s  4 h r s  a f t e r  e x p o s u r e  to 4 G y
4 h r s  a f t e r  4 G y  p 5 3  p r o t e i n  l e v e l s  r i s e  in t h e  h a i r  f o l l i c l e s  o f  p 5 3  w i l d  t y p e  a d u l t  m o u s e  
e p i d e r m i s .
C M 5  s t a i n i n g  w a s  p e r f o r m e d  as  d e s c r i b e d  in m a t e r i a l s  a n d  m e t h o d s .
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Figure 4.9 The arrow indicates apoptotic bodies present in the matrix region of 
p53 wild type two week old mouse skin 4hrs after 4Gy.
F igu re  4.9 H & E  s t a i n c T t w o w c c ^ t k ^ ^ ^ ^ h n ^ n H i m n u io c k o u n u i i ^ o n i c le j ^ e f o n ^ i r K w m c r  
ex p o su re  to 4 G y
M a g n i f i c a t i o n  X 4 0
(A)  H & E  s t a i n e d  p 5 3  w i l d  t y p e  t w o  w e e k  o l d  f o l l i c l e s  b e f o r e  e x p o s u r e  to 4 G y .
(B)  H & E  s t a i n e d  p 5 3  w i l d  t y p e  t w o  w e e k  o l d  f o l l i c l e s  4 h r s  a f t e r  e x p o s u r e  to  4 G y .
(C)  H & E  s t a i n e d  p 5 3  k n o c k o u t  t w o  w e e k  o l d  f o l l i c l e s  b e f o r e  e x p o s u r e  t o  4 G y .
( D ) H & E  s t a i n e d  p 5 3  k n o c k o u t  t w o  w e e k  o l d  f o l l i c l e s  4 h r s  a f t e r  e x p o s u r e  to 4 G y .
4 h r s  a f t e r  e x p o s u r e  to 4 G y  p 5 3  w i l d  t y p e  t w o  w e e k  o l d  m o u s e  s k i n  f o l l i c l e s  s h o w  an  
i n c r e a s e  in a p o p t o t i c  b o d i e s .  N o  c h a n g e  is o b s e r v e d  in t h e  f o l l i c l e s  o f  p 5 3  k n o c k o u t  
t w o  w e e k  o l d  m o u s e  s k i n .
Figure 4.10 H&E stained two week old p53 wild type and knockout m ouse epiderm is before and
after exposure to 4Gy
(A ) (B)
( C )  (D )
M a g n i f i c a t i o n  X  4 0
( A )  H & E  s t a i n e d  p 5 3  w i l d  t y p e  t w o  w e e k  o l d  b a s a l  s k i n  b e f o r e  e x p o s u r e  t o  4 G y .
( B)  H & E  s t a i n e d  p 5 3  w i l d  t y p e  t w o  w e e k  o l d  b a s a l  s k i n  4 h r s  a f t e r  e x p o s u r e  t o  4 G y .
( C )  H & E  s t a i n e d  p 5 3  k n o c k o u t  t w o  w e e k  o l d  b a s a l  s k i n  b e f o r e  e x p o s u r e  t o  4 G y .
( D ) H & E  s t a i n e d  p 5 3  k n o c k o u t  t w o  w e e k  o l d  b a s a l  s k i n  4 h r s  a f t e r  e x p o s u r e  t o  4 G y .
4 h r s  a f t e r  e x p o s u r e  t o  4 G y  p 5 3  w i l d  t y p e  o r  k n o c k o u t  t w o  w e e k  o l d  m o u s e  b a s a l  s k i n  
s h o w s  n o  c h a n g e  in a p o p t o t i c  b o d i e s .
F i g u r e  4 . 1 1 . A p o p t o t i c  a n d  m it ot i c  a n a l y s i s  o f  p 5 3  wi l d  t y p e  a n d  k n o c k o u t  m o u s e
s k i n  a f t e r  e x p o s u r e  to 4 G y .
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■ Apoptosis 
•  Mitosis
(A)  p53  wi ld  type  t w o  w e e k  old m o u s e  skin
( B ) p53  k n o c k o u t  t wo  w e e k  old m o u s e  sk in
T h e  n u m b e r  o f  a p o p t o t i c  b o d i e s  p r e s e n t  in tw o  w e e k  
old wi ld  type  p 53 m o u s e  sk in r i ses  a f t e r  e x p o s u r e  to 
4 G y .  T h i s  is c o n c o m i t a n t  w i th  a d e c r e a s e  in m i t o t i c  ce l l s  
No  c h a n g e  in m i t o t i c  ce l l s  or  a p o p t o t i c  b o d i e s  is 
o b s e r v e d  in p53  k n o c k o u t  m i c e .
M i c e  w e r e  in j e c te d  w i t h  B r d U  as d e s c r i b e d  in m e t h o d s  
Skin  s e c t i o n s  w e r e  s t a i n e d  wi th  H a e m a t o x y l i n  & E os in .  
A p o p t o s i s  w a s  s c o r e d  by the p r e s e n c e  o f  d a r k l y  s t a i n in g  
a p o p t o t i c  b o d ie s .  M i t o t i c  ce l l s  w e r e  c l ea r ly  v i s ib l e  in 
the s t a i n e d  s e c t io n s .
Six sk in  s e c t i o n s  w e r e  a n a l y s e d  p e r  t i m e  p o in t .
A p o p t o t i c  i n d e x  = T h e  n u m b e r  o f  a p o p t o t i c  b o d i e s  p e r  s e c t io n  
d i v i d e d  by the  l eng th  o f  the s e c t i o n  in m i l l i m e t r e s  
M i to tic i nd e x  = T h e  n u m b e r  o f  m i t o t i c  ce l l s  p e r  s e c t io n  d i v i d e d  
by the l en g th  in m i l l i m e t r e s  o f  the s ec t i o n .
Figure 4.12 BrdU labelled apoptotic bodies in the hair 
follicles of p53 wild type adult mouse skin prelabelled with 
BrdU before exposure to 4Gy.
B r d U
l abe l l e d
a p o p t o t i c
cell
N on 
labe l l e d  
a p o p t o t i c  
cell
M i c e  w e r e  i n j e c t e d  w i t h  B r d U  1 h r  p r i o r  
to i r r a d i a t i o n .  S e c t i o n s  w e r e  t a k e n  p o s t  r a d i a t i o n .
B r d U  p o s i t i v e  b o d i e s  w e r e  s c o r e d  on  the  b a s i s  o f  b r o w n  s t a in .
(M a g n i f i c a t i o n  X 4 0  )
Table 2 Incidence of BrdU labelled apoptotic cells in 
p53 wild type adult mouse skin after exposure to 4Gy.
Pe r c e n t a g e  o f  Brd U l abe l l ed  ap o p t o t i c  c e l l s  in p 53 wi ld  
t ype  m o u s e  hair f o l l i c l e s  af t er  e x p o s u r e  to 4 G y  ion i s i ng  
radi at i on.
Ohrs 0 % ( + / -  0 . 1 )
1 hr 0 . 1 % 4- 1 O
2 h rs 0 . 1 % ( + / -  0 . 2 )
3 hrs 3 % ( + / -  0 . 5 )
4hrs 1 7 % ( + / -  1 . 2 )
Figure 4.13 In situ analysis of DNA strand breaks in p53
wild type two week old mouse hair follicles before and
after exposure to 4Gy
( A )  p 5 3  w i l d  t y p e  t w o  w e e k  o l d  m o u s e  h a i r  f o l l i c l e s  
b e f o r e  e x p o s u r e  t o  4 G v
( B )  p 5 3  w i l d  t y p e  t w o  w e e k  o l d  m o u s e  h a i r  f o l l i c l e s  
4 h r s  a f t e r  e x p o s u r e  t o  4 G y
T h e  p o s i t i o n  o f  t h e  f l u o r e s c e n c e  s i g n a l  c o r r e l a t e s  w i t h  t he  p o s i t i o n  o f  
a p o p t o t i c  b o d i e s  v i s i b l e  i n  H & E  s t a i n e d  s e c t i o n .  M a g n i f i c a t i o n  X 4 0
Figure 4.14 In situ analysis of DNA strand breaks in p53 knockout two
week old mouse skin before nd; after exposure to 4Gy.
(A)
(B)
( A )  p 5 3  k n o c k o u t  t w o  w e e k  o l d  m o u s e  h a i r  f o l l i c l e s  b e f o r e  
e x p o s u r e  t o  r a d i a t i o n
( B )  p 5 3  k n o c k o u t  t w o  w e e k  o l d  m o u s e  h a i r  f o l l i c l e s  4 h r s  a f t e r  
e x p o s u r e  t o  4 G y .
N o  s t a i n i n g  w a s  s e e n  in  t h e  h a i r  f o l l i c l e s  o f  p 5 3  k n o c k o u t  m o u s e  
s k i n  b e f o r e  o r  a f t e r  e x p o s u r e  t o  4 G y .
F i g u r e  4 . 1 5  B r d U  i n c o r p o r a t i o n  in p 53  w i l d  t y p e  a n d  k n o c k o u t
a d u l t  m o u s e  s k i n  a f t e r  e x p o s u r e  t o  4 G y .
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( A )  p 53  h o m o z y g o u s  w i l d  t yp e  a d u l t  m o u s e  s k i n .
( B ) p 53 h o m o z y g o u s  k n o c k o u t  a d u l t  m o u s e  s k in .
B r d U  i n c o r p o r a t i o n  fa l l s  2 4 h r s  a f t e r  e x p o s u r e  to 4 G y  in p 5 3  
w i l d  t y p e  a d u l t  m o u s e  s k i n . i n c o r p o r a t i o n  r e t u r n s  to n o r m a l  
b a s a l  l e v e l s  4 8 h rs  a f t e r  i r r a d i a t i o n .  N o  c h a n g e  in B r d U  
i n c o r p o r a t i o n  is o b s e r v e d  in p 53 k n o c k o u t  m o u s e  s k in .
S ix  sk in  s e c t i o n s  w e r e  a n a l y s e d  p e r  t i m e  p o i n t .  S t a i n i n g  w a s  
p e r f o r m e d  in t r i p l i c a t e  for  al l  s a m p l e s .
B r d U  i n d e x  = T h e  n u m b e r  o f  B r d U  p o s i t i v e  c e l l s  p e r  s e c t i o n  
d i v i d e d  by  the  l e n g t h  in m i l l i m e t e r s  o f  t he  s e c t i o n .
F i g u r e  4 .16  B r d U  i n c o r p o r a t i o n  o f  p 53  h e t e r o z y g o t e  a d u l t  m o u s e
skin a f t er  e x p o s u r e  to 4 G y .
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( B ) B r d U  i n d e x  o f  p 5 3  h e t e r o z y g o t e  a d u l t  m o u s e  s k i n  a f t e r  
e x p o s u r e  to 4 G y .
p 53  h e t e r o z y g o t e  m o u s e  s k i n ,  l ike  p 53  w i l d  t y p e  a d u l t  m o u s e  s k i n  
s h o w s  a d r o p  in B r d U  i n c o r p o r a t i o n  2 4 h r s  a f t e r  e x p o s u r e  to 4 G y .
T h e  c h a n g e s  o b s e r v e d  in p 53  h e t e r o z y g o t e  m o u s e  s k i n  a f t e r  
r a d i a t i o n  a re  s i m i l a r  to t he  c h a n g e s  o b s e r v e d  in p 53  w i l d  t y p e  
m o u s e  s k i n  a f t e r  e x p o s u r e  to r a d i a t i o n  h o w e v e r  t he  m a g n i t u d e  o f  the  
c h a n g e s  in B r d U  i n c o r p o r a t i o n  is l e s s  t h a n  
o b s e r v e d  in p 53 w i l d  t y p e  m o u s e  s k i n .
(B)  Br d U  i n d e x =  T h e  n u m b e r  o f  B r d U  p o s i t i v e  ce l l s  p e r  s e c t io n  d i v i d e d  by the 
l e n g t h  o f  the  s e c t io n  in m i l l i m e t e r s .
T w o  s a m p l e s  w e r e  a n a l y s e d  pe r  t ime  po i n t .  B r d U  l a b e l l i n g  
a nd  d e t e c t i o n  w a s  p e r f o r m e d  as d e s c r i b e d  in c h a p t e r  2 
S t a i n i n g  w a s  p e r f o r m e d  in d u p l i c a t e  for  al l  s a m p l e s .
( A )
(B)
F i g u r e  4 . 1 7 .  B r d U  i n c o r p o r a t i o n  in p 5 3  wi l d  t y p e  a n d
k n o c k o u t  t w o  w e e k  old m o u s e  s k i n  b e f o r e  a n d  a f t e r  e x p o s u r e  to 4 G y .
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(A)  p 53 wi ld  type two  w e e k  old m o u s e  skin
( B)  p 53 k n o c k o u t  two  w e e k  old m o u s e  skin
BrdU i n c o r p o r a t i o n  falls  4 hrs a f t e r  e x p o s u r e  to 4 G y  in the f o l l i cu l a r  
ce l l s  of  p 53 wi ld  type  two  w e e k  old m o u s e  sk in .  I n t e r f o l l i c u l a r  ce l l s  
s how a d ro p  in BrdU i n c o r p o r a t i o n  2 4h r s  a f t e r  e x p o s u r e  to 4 G y .
No  c h a n g e  in Br d U  i n c o r p o r a t i o n  is o b s e r v e d  in p 53 k n o c k o u t  m o u s e  
skin at any  t ime  po in t  a f t e r  e x p o s u r e  to 4 G y .
Six skin s e c t io n s  we r e  a n a l y s e d  p e r  t ime  po in t .  BrdU l a be l l i ng  and  a n a l y s i s  
w a s  p e r f o r m e d  as d e s c r i b e d  in c h a p t e r  2 . / S t a i n i n g  w a s  p e r f o r m e d  
in t r ip l i ca te  for  all s a m p l e s .
BrdU i n d e x =  T h e  n u m b e r  o f  B r d U  pos i t ive  ce l l s  pe r  s ec t ion  d iv i d e d  
by the l ength  of  the s ec t ion  in m i l l i m e t e r s .
F i g u r e  4 . 18 .  B r d U  i n c o r p o r a t i o n  in p 53 wi l d  t y p e  a n d  k n o c k o u t
a d u l t  m o u s e  s k i n  a f t e r  e x p o s u r e  to T P A  a n d  4 G y .
( A ) p 53 wild type  and  k n o c k o u t  a d u l t  m o u s e  sk in p r e t r e a t e d  wi th  T P A  for  3 6 hrs be fo re  
e x p o s u r e  to 4 G y  ion i s ing  r ad i a t i o n .  Skin  s e c t i o n s  w e r e  r e m o v e d  4 hrs and 2 4 hrs a f t e r  
r a d i a t i o n  ex p o s u r e .
(B)  p 53 wild type and  k n o c k o u t  a d u l t  m o u s e  sk in p r e t r e a t e d  wi th  T P A  for  72 h ou r s  b e f o r e  
e x p o s u r e  to ion i s ing  r a d i a t i o n .  Sk in  s e c t io n s  we r e  r e m o v e d  4 hrs and  2 4 hrs pos t  r a d i a t ion  
t r e a t m e n t .
Both  p 53 wi ld type and  k n o c k o u t  a d u l t  m o u s e  skin  r e s p o n d  to T P A  t r e a t m e n t  wi th  an i n c r e a s e  
in i n t e r f o l l i c u l a r  cel l  p ro l i f e r a t i o n .  Br d U  i n c o r p o r a t i o n  falls  a f t e r  4h r s  in p 53 wi ld  type a d u l t  
m o u s e  skin p re t r e a t e d  wi th  T P A  for  3 6 hrs  p r io r  to i r r a d i a t i o n ,  p 53 wi ld  type a d u l t  sk in t r e a t e d  
wi th  T P A  for 7 2 hrs  p r i o r  to i r r ad i a t i o n  s h o w s  a d ro p  in p ro l i f e r a t i o n  2 4 hrs a f t e r  e x p o s u r e  to 
4 G y .  No  c h a n g e  in Br d U  i n c o r p o r a t i o n  is o b s e r v e d  in p 53 k n o c k o u t  m o u s e  sk in pre t r e a t e d  
wi th  T P A  be fore  b e ing  e x p o s e d  to 4 G y
T h r e e  sk in sec t io ns  w e r e  a n a l y s e d  pe r  t ime  point .  B r d U  l abe l l i ng  and  a n a l y s i s  
w a s  p e r f o r m e d  as d e s c r i b e d  in m a t e r i a l s  and  m e t h o d s .
S t a i n i n g  was  p e r f o r m e d  in t r ip l i ca te  for al l  s a m p l e s .
Br d U  index  = T he  n u m b e r  of  BrdU pos i t i ve  ce l l s  pe r  s ec t io n  d iv i d e d  by the l ength  in m i l l i m e t r e s  
o f  the sec t ion .
4.8 P53 response to ionising radiation and TPA treatment in adult mouse skin.
I r r a d i a t e d  s k i n  o f  a d u l t  m i c e  s h o w s  b o t h  a p o p t o s i s  a n d  ce l l  c y c l e  a r r e s t  in  d i s t i n c t  
c e l l u l a r  l o c a t i o n s .  T h e  c r e a t i o n  o f  p 5 3 - L a c Z  r e p o r t e r  m i c e  ( M a c C a l l u m ,  e t  a l  1 9 9 6 )  
a l l o w e d  a n a l y s i s  o f  p 5 3  t r a n s c r i p t i o n a l  a c t i v i t y  in a r e a s  o f  t h e  s k i n  a l r e a d y  i d e n t i f i e d  a s  
b e i n g  in a  s t a t e  o f  ce l l  c y c l e  a r r e s t  o r  a p o p t o s i s
M u c h  o f  t h e  d a t a  r e l a t i n g  t o  t h e  r o l e  o f  p 5 3  m e d i a t e d  t r a n s c r i p t i o n  c o m e s  f r o m  i n  v i t r o  
a s s a y s  u s i n g  ce l l  l i n e s  w i t h  u n c h a r a c t e r i s e d  g e n e t i c  b a c k g r o u n d ,  a s  a  c o n s e q u e n c e  o f  
i m m o r t a l i z a t i o n  a n d  r o u t i n e  t i s s u e  c u l t u r e .  T h i s  i n c l u d e s  t h e  w o r k  o f  Y o n i s h - R o u a c h ,  e t  
a l  ( 1 9 9 5 )  &  H a u p t ,  e t  a l  ( 1 9 9 5 )  w h i c h  w a s  c a r r i e d  o u t  o n  t r a n s f e c t e d ,  e s t a b l i s h e d  ce l l  
l ines.  T h e  f i r s t  g r o u p  f o u n d  t h a t  t r a n s c r i p t i o n a l  a c t i v a t i o n  b y  p 5 3  w a s  r e q u i r e d  f o r  p 5 3  
d e p e n d a n t  a p o p t o s i s ,  w h i l s t  t h e  l a t t e r  f o u n d  t h e  o p p o s i t e .  T h e  u n c e r t a i n t y  o f  t h e  g e n e t i c  
m a k e  u p  o f  t h e  c e l l s  u s e d  in t h e s e  s t u d i e s  a n d  t h e  e f f e c t  o f  u n r e g u l a t e d  p 5 3  t r a n s c r i p t i o n  
in t h e  ceil ,  m a y  e x p l a i n  t h e  c o n t r a d i c t o r y  r e s u l t s .  T h e  r e p o r t e r  m i c e  u s e d  in t h e  p r e s e n t  
s t u d y  p r o v i d e  a  s i m p l e  in  v iv o  m o d e l  w i t h  w h i c h  t o  s t u d y  t h e  r o l e  o f  p 5 3  m e d i a t e d  
t r a n s c r i p t i o n  in a  v a r i e t y  o f  n o r m a l  t i s s u e s  a n d  ce l l  t y p e s .
Ini t ial ly,  o u r  s t u d i e s  c o n c e n t r a t e d  o n  t h e  a n a l y s i s  o f  t h e  L a c Z  l i ne  R Z 2 . 8 ,  w h i c h  c o n t a i n s  
5 - 1 0  c o p i e s  o f  t h e  t r a n s g e n e .  H o w e v e r  s i m i l a r  r e s u l t s  h a v e  b e e n  o b t a i n e d  w i t h  a  s e c o n d  
l i ne  o f  m i c e  a g a i n  c a r r y i n g  5 - 1 0  c o p i e s  o f  t h e  t r a n s g e n e .
T h e  p r e s e n c e  o f  t h e  L a c  Z  t r a n s g e n e  w a s  a s s e s s e d  b y  P C R  ( F i g u r e  4 . 1 9 ) .  N o  L a c  Z  
e x p r e s s i o n  c o u l d  b e  d e t e c t e d  in u n i r r a d i a t e d  L a c Z  m i c e  o r  L a c  Z  p o s i t i v e  m i c e  w h i c h  
r e c e i v e d  4 G y  i o n i s i n g  r a d i a t i o n .  ( F i g u r e  4 . 2 0 A ) .  I t  is  p o s s i b l e  t h a t  L a c  Z  e x p r e s s i o n  m a y  
o c c u r  l a t e r  t h a n  ini t ial  p 5 3  i n d u c t i o n ,  s i n c e  it m a y  t a k e  a d d i t i o n a l  t i m e  f o r  s t a b i l i s e d  p 5 3  
p r o t e i n  t o  t u r n  o n  t h e  e x p r e s s i o n  o f  t h e  L a c  Z  g e n e .  H o w e v e r ,  e v e n  4 8 h r s  a f t e r  r a d i a t i o n  
e x p o s u r e  n o  L a c  Z  e x p r e s s i o n  c o u l d  b e  d e t e c t e d  in  e i t h e r  t h e  f o l l i c u l a r  o r  i n t e r f o l l i c u l a r  
e p i d e r m i s  o f  L a c  Z  p o s i t i v e  m o u s e  s k i n  ( F i g u r e  4 . 2 0 B ) .
P r e l i m i n a r y  e x p e r i m e n t s  u s i n g  u l t r a v i o l e t  r a d i a t i o n  a l s o  f a i l e d  t o  i n d u c e  t r a n s g e n e  
e x p r e s s i o n  in t h e  s k i n  o f  t h e  r e p o r t e r  m i c e .
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I t  is  c l e a r  f r o m  t h e  p o s i t i v e  s t a i n i n g  r e s u l t s  o b t a i n e d  f r o m  t h e  s k i n  o f  t r a n s g e n i c  m i c e  
c o n t a i n i n g  a  k e r a t i n  5 g e n e  p r o m o t e r  f u s e d  t o  t h e  L a c  Z  g e n e  ( D . S t r a t h d e e  U n i v e r s i t y  o f  
G l a s g o w ,  P h D  t h e s i s  1 9 9 6 )  t h a t  L a c  Z  c a n  b e  u s e d  a s  a  m a r k e r  o f  g e n e  a c t i v i t y  in  t h e  
s k i n  ( F i g u r e  4 . 2 1  A ) .
L a c  Z  s t a i n i n g  w a s  o b s e r v e d  in  a  n u m b e r  o f  o t h e r  t i s s u e s  f o l l o w i n g  r a d i a t i o n  i n c l u d i n g  
t h e  s p l e e n ,  s m a l l  i n t e s t i n e ,  a n d  s a l i v a r y  g l a n d  ( 4 . 2 2 B ) .  H o w e v e r ,  e x p r e s s i o n  w a s  a b s e n t  
in  t h e  k i d n e y  a n d  l i v e r  a f t e r  r a d i a t i o n .  T h i s  r e s u l t  h i g h l i g h t s  t h e  cel l  t y p e  s p e c i f i c i t y  o f  t h e  
p 5 3  r e s p o n s e  a n d  s u b s e q u e n t  d o w n  s t r e a m  e v e n t s  i n  v iv o .
I t  h a s  b e e n  s u g g e s t e d  b y  p r e v i o u s  s t u d i e s  t h a t  c h a n g e s  in  t h e  p h o s p h o r y l a t i o n  s t a t u s  o f  
p 5 3  m a y  a l t e r  t h e  t r a n s c r i p t i o n a l  a c t i v i t y  o f  t h e  p r o t e i n .  P h o s p h o r y l a t i o n  b y  C y c l i n  
A / c d k 2  a n d  C y c l i n  B / c d c 2  a l l o w s  p 5 3  t o  d i s c r i m i n a t e  b e t w e e n  d i f f e r e n t  D N A  b i n d i n g  
s i t e s  ( W a n g  e t  a l  1 9 9 5 ) .  T h i s  o b s e r v a t i o n  l ed  t o  t h e  s u g g e s t i o n  t h a t  p 5 3  m a y  h a v e  
a l t e r e d  t r a n s c r i p t i o n a l  a c t i v i t i e s  d u r i n g  t h e  S a n d  G 2 / M  p h a s e s  o f  t h e  cel l  c y c l e  w h e n  
t h e s e  c o m p l e x e s  b e c o m e  a c t i v e .  B a s e d  o n  t h e s e  o b s e r v a t i o n s ,  it w a s  d e c i d e d  t o  l o o k  a t  
L a c  Z  e x p r e s s i o n  in  T P A  t r e a t e d  L a c  Z  p o s i t i v e  m o u s e  s k i n  s i n c e  T P A  is k n o w n  t o  
p h o s p h o r y l a t e  p 5 3 .
I t  w a s  p r e d i c t e d  t h a t  T P A  i n d u c e d  a l t e r a t i o n s  in  p h o s p h o r y l a t i o n  o f  p 5 3  w o u l d  a c t  t o  
a l t e r  t h e  t r a n s c r i p t i o n a l  a c t i v i t y  o f  t h e  p r o t e i n  a n d  m e d i a t e  t h e  u p r e g u l a t i o n  o f  p 2 1  wafl. 
T h i s  w o u l d  g o  s o m e  w a y  t o  e x p l a i n  t h e  r a p i d  i n d u c t i o n  o f  a  ce l l  c y c l e  b l o c k  in i r r a d i a t e d  
T P A  t r e a t e d  a d u l t  m o u s e  s k i n  o b s e r v e d  a f t e r  4 h r s  in  t h e  B r d U  l a b e l l i n g  s t u d i e s .  
H o w e v e r  n o  L a c  Z  e x p r e s s i o n  w a s  d e t e c t e d  u p  t o  4 8 h r s  f o l l o w i n g  r a d i a t i o n  t r e a t m e n t  
o f  T P A  t r e a t e d  L a c Z  r e p o r t e r  m o u s e  sk i n s .  T h i s  w a s  c o n s i s t e n t  f o r  a  w i d e  r a n g e  o f  
e x p o s u r e  t o  T P A  ( 3 6 h r s - 7 2 h r s )  A d d i t i o n a l  r a d i a t i o n  t r e a t m e n t  f o l l o w i n g  T P A  t r e a t m e n t  
a l s o  f a i l e d  t o  i n d u c e  L a c  Z  e x p r e s s i o n .
A n a l y s i s  o f  t h i s  d a t a  is  o p e n  t o  d i v e r s e  i n t e r p r e t a t i o n .  H o w e v e r  i f  t h e s e  r e s u l t s  a r e  a  
t r u e  r e p r e s e n t a t i o n  o f  t h e  s k i n  a f t e r  D N A  d a m a g e ,  o u r  s y s t e m  r e p r e s e n t s  a  u n i q u e  
m o d e l  in w h i c h  t o  s t u d y  ce l l  c y c l e  a r r e s t  a n d  a p o p t o s i s  a s  a  c o n s e q u e n c e  o f  p 5 3  
i n d u c t i o n  i n d e p e n d e n t  o f  d o w n s t r e a m  t a r g e t  g e n e  a c t i v a t i o n .
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F i g u r e  4 . 1 9 a .  P l a s m i d  m a p  o f  p R G C  D F o s  L a c  I
S V 4 0
T intron -Poly  A
p R G C  A F O S  L A C Z  (6 , 9  K b )
pBSK (2.9 Kb)
C o n s t r u c t e d  b y  T . F r e b o u r g ,  S H  F r i e n d s  L a b o r a t o r y ,
M G H  c a n c e r  c e n t e r  B o s t o n  M . A
U S A
pRGC AFos Lac z ; Ribosome 
gene cluster containing a p53 binding 
site, the murine fos promoter and Lac Z
> Figure 4.19b. PCR analysis of a litter derived from a LacZ 2.2.2, FVB 
cross
 <_ _ _ _ _ _ _ T S H  p
 <----------  Lac  Z
P r i m e r s  l z l  C G C  T T T  A AT G A T  T T C  A G C  C
lz 2 A G T  T C A  A C C  A C C  A C C  G C A  T A G
P r i m e r s  h s p l  T C C  TC A A AG A T G  C T C  A T T  AG 
hsp2  G T A  A C T  C A C  T C A  T G C  A A A  GT
T h e  P C R  reac t ions  for each  allele were  p e r f o r m e d  s e p e r a t e l y  and  mixed  before  
r unn ing  on an agaros e  gel .  T he  PC R  r ea c t ions  for both  a l le les  were  p e r f o r m e d  
u n d e r  s t a n d a r d  c o nd i t i o ns  on a Perk in  E l m e r  G e n e  A m p  9 6 0 0  PC R  m a c h i n e .
E x p e c t e d  f r a g m e n t  si zes : Lac  Z 257
T S H P  386
Figure 4.20 H&E lac Z stained p53 reporter m ouse skin skin before and 4hrs after exposure to 4Gy
(A)
(A)  H & E /  L a c  Z  s t a i n e d  s e c t i o n  o f  p 5 3  R G C  d e l t a  F o s  L a c  Z  a d u l t  m o u s e  s k i n  
b e f o r e  e x p o s u r e  t o  4 G y .  ( M a g  X  4 0 )
(B)  H & E /  L a c Z  s t a i n e d  s e c t i o n  o f  p 5 3  R G C  d e l t a  F o s  L a c  Z  a d u l t  m o u s e  s k i n  4 h r s  
a f t e r  e x p o s u r e  t o  4 G y .  ( M a g  X 4 0 )
F igu re  4 .2 1 a  H & E  s ta in e d  K 5 -L a c  Z s ta in e d  sk in
tf
M a g n i f i c a t i o n  x 2 0
F i g u r e  4 . 2 1 b  H & E  s t a i n e d  L a c Z  r e p o r t e r  m o u s e  s a l i v a r y  g l a n d  1 8 h r s  a f t e r  
e x p o s u r e  to  4 G y
m
2  3*
M a g n i f i c a t i o n  x 4 0
4.9 The effect of radiation on mouse strains with mutations affecting skin 
morphology.
N u d e  m i c e  a r e  d e v o i d  o f  ha i r ,  a l t h o u g h  u n l i k e  h a i r l e s s  m i c e ,  t h e y  d o  h a v e  h a i r  f o l l i c l e s  
( F l a n n a g a n  1 9 6 6 ) .  R e c e n t  d a t a  l e n d s  s u p p o r t  t o  t h e  i d e a  t h a t  t h e  m u t a t e d  g e n e  
r e s p o n s i b l e  f o r  t h e  n u d e  p h e n o t y p e  c o d e s  f o r  a  t r a n s c r i p t i o n  f a c t o r  w h i c h  p l a y s  a  c r i t i c a l  
r o l e  in  k e r a t i n o c y t e  g r o w t h  a n d  d i f f e r e n t i a t i o n .  B r i s s e t t e ,  e t  a l  ( 1 9 9 6 ) ,  s u g g e s t e d  t h a t  
t h e  n u m b e r  o f  k e r a t i n o c y t e  s t e m  c e l l s  a n d  t h e i r  d i f f e r e n t i a t e d  p r o g e n y  m a y  b e  a l t e r e d  in 
n u d e  m o u s e  sk in .
W e  h a v e  s h o w n  t h a t  r a d i a t i o n  i n d u c e d  a p o p t o s i s  o c c u r s  in t h e  s k i n  o f  n o r m a l  m i c e  in 
t h e  m a t r i x  r e g i o n  o f  t h e  h a i r  fol l icl e,  h o w e v e r  t h e  s t e m  ce l l  c a p a c i t y  o f  h a i r  fo l l i c l e  m a t r i x  
c e l l s  in  v iv o  is u n c l e a r .  T h i s  c o n t r a s t s  w i t h  t h e  m o r e  c l e a r l y  d e f i n e d  m u r i n e  i n t e s t i n e  
m o d e l ,  in  w h i c h  t h e r e  is  a n  e s t a b l i s h e d  r e l a t i o n s h i p  b e t w e e n  i n t e s t i n a l  s t e m  c e l l s  a n d  
s u s c e p t i b i l i t y  t o  p 5 3  m e d i a t e d  r a d i a t i o n  i n d u c e d  a p o p t o s i s  ( M e r r i t t  e t  a l . , 1 9 9 4 ) .  U s i n g  
m o u s e  s k i n  a s  a  m o d e l ,  t h e  h y p o t h e s i s  o f  B r i s s e t t e  e t  a l  w a s  t e s t e d  u t i l i s i n g  r a d i a t i o n  
i n d u c e d  a p o p t o s i s  a s  a  m a r k e r  o f  s t e m  cel l  p o p u l a t i o n s .
F o l l o w i n g  e x p o s u r e  t o  4 G y  t h e  n u m b e r  o f  a p o p t o t i c  b o d i e s  in  t h e  n u d e  m o u s e  h a i r  
f o l l i c l e s  i n c r e a s e d  d r a m a t i c a l l y ,  r e a c h i n g  a  p e a k  4 h r s  a f t e r  r a d i a t i o n  t r e a t m e n t  ( F i g u r e  
4 . 2 2 ) .  A s  in  all  o t h e r  c a s e s ,  t h e  i n c r e a s e  in a p o p t o s i s  w a s  r e s t r i c t e d  t o  t h e  h a i r  f o l l i c l e s ,  
w h i l s t  p 5 3  s t a i n i n g  w a s  w i d e s p r e a d .  T h e  l o c a t i o n  o f  a p o p t o t i c  b o d i e s  in t h e  n u d e  m o u s e  
fo l l i c l e s  w a s  n o t  r e s t r i c t e d  t o  t h e  m a t r i x  cel l  p o p u l a t i o n  o f  t h e  fo l l i c l e ,  b u t  w a s  s p r e a d  
a m o n g s t  t h e  i n n e r  a n d  o u t e r  r o o t  s h e a t h  cel l  p o p u l a t i o n s  ( F i g u r e  4 . 2 3 ) .  M F 1  n u d e  m i c e  
c a r r y i n g  o n e  c o p y  o f  t h e  n u d e  m u t a t i o n  s h o w  a n  i n c r e a s e  in a p o p t o s i s  l e v e l s  
a p p r o x i m a t e l y  h a l f  o f  t h a t  o b s e r v e d  in m i c e  c a r r y i n g  t w o  n u d e  m u t a t i o n s  ( F i g u r e  4 . 2 4 .  ). 
I n  s i t u  D N A  l a b e l l i n g  w a s  u s e d  t o  c o n f i r m  t h e  p r e s e n c e  o f  a p o p t o t i c  b o d i e s  in t h e  h a i r  
f o l l i c l e s  o f  n u d e  m i c e  f o l l o w i n g  e x p o s u r e  t o  4 G y  ( F i g u r e  4 . 2 5 ) .  T h e  i n c r e a s e  in 
a p o p t o t i c  b o d i e s  o b s e r v e d  in n u d e  m o u s e  s k i n  w a s  n o t  r e l a t e d  t o  i n c r e a s e d  cel l  
p o p u l a t i o n s  in  t h e  n u d e  m o u s e  fol l icl e,  s i n c e  w i l d  t y p e  m o u s e  a n d  n u d e  m o u s e  f o l l i c l e s  
d i s p l a y e d  o n  a v e r a g e ,  s i m i l a r  n u m b e r s  o f  ce l l s
T h e s e  r e s u l t s  s u g g e s t  t h a t  n u d e  m o u s e  s k i n  m a y  h a v e  a n  a b n o r m a l  p a t t e r n  o f  c e l l u l a r  
d i f f e r e n t i a t i o n ,  a n d  g o  s o m e  w a y  t o  e n d o r s e  t h e  p r o p o s a l  t h a t ,  in t h e  h a i r  f o l l i c l e ,  cel l
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t y p e  s p e c i f i c  a p o p t o s i s  o c c u r s  a f t e r  e x p o s u r e  t o  i o n i s i n g  r a d i a t i o n  a n d  t h i s  m a y  b e  
r e l a t e d  t o  t h e  d i f f e r e n t i a t i o n  s t a t u s  o f  t h e  cell .  T h e  i n c r e a s e d  a p o p t o s i s  o b s e r v e d  in n u d e  
m o u s e  sk in ,  c o m p a r e d  t o  w i l d  t y p e  m o u s e  s k i n  a f t e r  e x p o s u r e  t o  r a d i a t i o n  m a y  b e  d u e  
t o  a b n o r m a l  ce l l  c y c l e  p a t t e r n s  in t h e  n u d e  m i c e  k e r a t i n o c y t e s .  F u r t h e r  e x p e r i m e n t s  a r e  
r e q u i r e d  t o  e l u c i d a t e  t h e s e  p r o p o s a l s
4.10 The hairless mouse.
H a i r l e s s  m i c e  h a v e  s k i n  d e v o i d  o f  ha i r ,  P r i m i t i v e  h a i r  f o l l i c l e s  a r e  h o w e v e r  p r e s e n t  in t h e  
s k i n  ( G o n z a l e z  e t  a l ,  1 9 9 4 ) .  W e  r e a s o n e d  t h a t ,  s i m i l a r  t o  n u d e  m i c e ,  h a i r l e s s  m i c e  
w o u l d  h a v e  a n  a b n o r m a l  f o l l i c u l a r  cel l  p o p u l a t i o n ,  a n d  t h a t  t h i s  m a y  b e  r e f l e c t e d  in 
r a d i a t i o n  s u s c e p t i b i l i t y .  T h e  p r i m i t i v e  h a i r  f o l l i c l e  s t r u c t u r e s  o f  h a i r l e s s  m i c e  s h o w  a  
s l i gh t  i n c r e a s e  in a p o p t o t i c  b o d i e s  4 h r s  a f t e r  4 G y  ( F i g u r e  5 . 4 ) .  T h e  i r r e g u l a r i t y  o f  t h e  
f o l l i c l e  s t r u c t u r e  h o w e v e r ,  m a d e  it i m p o s s i b l e  t o  e s t a b l i s h  a  p r e c i s e  l o c a t i o n  o f  t h e  
a p o p t o t i c  b o d i e s  w i t h i n  t h e  fo l l icl es .  M F 1  h a i r l e s s  m i c e  s h o w e d  a n  i n c r e a s e  in  a p o p t o t i c  
b o d i e s  s i m i l a r  t o  t h a t  o b s e r v e d  in 1 2 9 / N I H  p 5 3  w i l d  t y p e  m i c e  f o l l o w i n g  r a d i a t i o n  
( F i g u r e  5 .4 ) .  I t  is i n t e r e s t i n g  t o  n o t e  t h e  d i f f e r e n c e  in b a s a l  l e v e l s  o f  a p o p t o s i s  f o u n d  in 
u n i r r a d i a t e d  M F 1  w i l d  t y p e  a n d  M F 1  h a i r l e s s  1 m i c e .  A d u l t  h a i r l e s s  m i c e  h a v e  l o w e r  
l e v e l s  o f  a p o p t o s i s  t h a n  n o r m a l  c o n t r o l  M F 1  m i c e .  T h i s  m a y  b e  t h e  r e s u l t  o f  h a v i n g  
r e d u c e d  p o p u l a t i o n s  o f  c e l l s  w h i c h  u n d e r g o  a p o p t o t i c  cel l  d e a t h  in n o r m a l  
c i r c u m s t a n c e s ,  i .e  in t e l o g e n  p h a s e  o f  t h e  cel l  c y c l e ,  i n c l u d i n g  m a t r i x  ce l ls .
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F i g u r e  4 . 2 2 .  T h e  a p o p t o t i c  r e s p o n s e  in t h e  s k i n  o f  w i l d  t y p e ,  h e t e r o z y g o t e  a n d
h o m o z y g o u s  n u d e  M F 1  m i c e  to 4 G y .
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Adult Adult Adult Adult Adult Adult
M FI MF1 M FI MFI MFI MFI
+ /+ + /+ + /- +/- -/- nude -/- nude
control 4hrs, 4G y nude nude control 4hrs, 4G y
control 4hrs, 4Gy
A p o p t o t i c  i n d e x  o f  MF1 w i l d  t y p e ,  M F 1  + / -  n u d e ,  a n d ,  M F 1 -/- n u d e  
m i c e  4 h r s  a f t e r  e x p o s u r e  to 4 G y .
T h e  i n c r e a s e  in a p o p t o t i c  b o d i e s  o b s e r v e d  in h o m o z y g o u s  n u d e  m i c e  
4 h r s  a f t e r  4 G y  is s i g n i f i c a n t l y  g r e a t e r  tha n  the  i n c r e a s e  o b s e r v e d  in 
M F 1  w i l d  t yp e  a n d  M F l + / - n u d e  m i c e .
T h r e e  sk in  s e c t i o n s  w e r e  a n a l y s e d  p e r  t i m e  p o i n t .  S k i n  s e c t i o n s  w e r e  
s t a i n e d  w i t h  H & E .  A p o p t o s i s  w a s  s c o r e d  by  the  p r e s e n c e  o f  d a r k l y  
s t a i n i n g  a p o p t o t i c  b o d i e s .
A p o p t o t i c  i n d e x  = T h e  n u m b e r  o f  a p o p t o t i c  b o d i e s  p e r  sk in  s e c t i o n  
d i v i d e d  by  the  l e n g t h  o f  the  s e c t i o n  in m i l l i m e t r e s
Figure 4.23B. Arrow indicates apoptosis in the outer root sheath of a nude 
mouse hair follicle 4hrs after exposure to 4Gy.
F igu re  4 .2 3  p53 and a p o p to t ic  r e sp o n se  o f  n u d e  m o u s e  hair fo l l ic les  b e f o r e  and 4 h rs
after e x p o s u r e  to  4 G y .
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(A)  CIV15 s t a i n e d  a d u l t  n u d e  m o u s e  s k i n  4 h r s  a f t e r  4 G y .
(B)  11&.E s t a i n e d  a d u l t  n u d e  m o u s e  4 h r s  p o s t 4 G y .
T h e  h a i r  f o l l i c l e s  o f  n u d e  m o u s e  s k i n  s h o w  i n t e n s e  p 5 3  s t a i n i n g  a n d  w i d e s p r e a d  
a p o p t o s i s  4 h r s  a f t e r  4 G y .
Figure 4.24 In situ DNA labelling of homozygous nude mouse hair
follicles before and 4hrs after exposure to 4Gy.
(A)
(B)
( A )  H o m o z y g o u s  n u d e  m o u s e  h a i r  f o l l i c l e s  b e f o r e  e x p o s u r e  
t o  4 G y
( B )  H o m o z y g o u s  n u d e  m o u s e  h a i r  f o l l i c l e s  4 h r s  a f t e r  e x p o s u r e  
t o  4 G y .
T h e  p o s i t i o n  o f  t h e  f l u o r e s c e n c e  c o r r e l a t e s  w i t h  t h e  p o s i t i o n  o f  a p o p t o t i c  
b o d i e s  v i s i b l e  in  h a e m a t o x y l i n  &  e o s i n  s t a i n e d  s e c t i o n s .  M a g n i f i c a t i o n  X 4 0
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F i g u r e  4 . 2 5  T h e  a p o p t o t i c  r e s p o n s e  in t h e  s k i n  o f  w i l d  t y p e ,  h a i r l e s s  a n d  n u d e  M F I
b e f o r e  a n d  a f t e r  e x p o s u r e  to 4 G y .
Adult Adult
MFI MFI
control 4 hrs, 4G y
Adult Adult Adult Adult
MFI MFI MFI MFI
hairless hairless -/- nude -/- nude
control 4hrs, 4Gy control 4hrs, 4Gy
A p o p  to t ic i n d e x  o f  M FI w ild t y p e ,  M F I  h a i r l e s s ,  a n d .  M F I  n u d e  
m i c e  4 h r s  a f t e r  e x p o s u r e  to 4 G y .
T h e  i n c r e a s e  in a p o p t o t i c  b o d i e s  o b s e r v e d  in h o m o z y g o u s  n u d e  m i c e  
4 h rs  a f t e r  4 G y  is s i g n i f i c a n t l y  g r e a t e r  t h a n  the  i n c r e a s e  o b s e r v e d  in 
M F I  w i l d  t y p e  a n d  M F I  -/- h a i r l e s s  m i c e .
H a i r l e s s  m o u s e  sk in  s h o w s  a m o d e s t  i n c r e a s e  in a p o p t o t i c  b o d i e s  4 hrs  
a f t e r  4 G y  in c o m p a r i s o n  to M F I  w i l d  t y p e  c o n t r o l  m o u s e  skin
T h r e e  sk in  s e c t i o n s  w e r e  a n a l y s e d  p e r  t i m e  p o i n t .  S k i n  s e c t i o n s  w e r e  
s t a i n e d  w i t h  H & E .  A p o p t o s i s  w a s  s c o r e d  by the  p r e s e n c e  o f  d a r k l y  
s t a i n i n g  a p o p t o t i c  b o d i e s .
A p o p t o t i c  i n d e x  = T h e  n u m b e r  o f  a p o p t o t i c  b o d i e s  p e r  sk in  s e c t i o n  
d i v i d e d  by  the  l e n g t h  o f  the s e c t i o n  in m i l l i m e t r e s
5.1 p53 and apoptosis in DMBA, TPA treated adult mouse skin.
G i v e n  t h e  r a d i a t i o n  s p e c i f i c  p 5 3  r e s p o n s e  in  m o u s e  s k i n  e p i d e r m a l  c e l l s ,  a n d  t h e  
a c c u m u l a t i n g  d a t a  l i n k i n g  t h i s  c e l l u l a r  p h e n o m e n o n  t o  s t e m  c e l l s  a n d  d i f f e r e n t i a t i o n  
s t a t u s ,  w e  fe l t  w e  s h o u l d  i n v e s t i g a t e  t h e  r o l e  o f  p 5 3  d e p e n d e n t  a p o p t o s i s  in d a m a g e d  
ce l l s ,  p a r t i c u l a r l y  t h o s e  d a m a g e d  ce l l s  w h i c h  p o s s e s s  t h e  a b i l i t y  t o  f o r m  t u m o u r s  u p o n  
p r o m o t i o n a l  s t imu l i .
T h e  m o u s e  s k i n  t u m o r i g e n e s i s  m o d e l  is a n  i d e a l  s y s t e m  in w h i c h  t o  s t u d y  t h e  p r o g r e s s i o n  
o f  d a m a g e d  c e l l s  i n t o  m a l i g n a n t  c a r c i n o m a s .  V a r i o u s  c e l l u l a r  t y p e s  h a v e  b e e n  p r o p o s e d ,  
a s  b e i n g  t h e  c e l l s  o f  t h e  s k i n  t h a t  w h e n  d a m a g e d ,  e s c a p e  d e a t h  a n d  g o  o n  t o  f o r m  s k i n  
t u m o u r s .  T h e s e  i n c l u d e  c e l l s  o f  t h e  b u l g e  r e g i o n  o f  t h e  o u t e r  r o o t  s h e a t h  o f  t h e  fo l l i c l e ,  
t h e  m a t r i x  r e g i o n ,  t h e  i n t e r f o l l i c u l a r  e p i d e r m i s ,  a n d  t h e  i n n e r  r o o t  s h e a t h  o f  t h e  h a i r  
f o l l i c l e  ( S h e r e m e r  e t  a l,  1 9 8 6 ;  L e n o i r  e t  a l,  1 9 8 8 ;  C o t s a r e l i s  e t  a l,  1 9 9 0 ) .  B r o w n  e t  a l  
( M a n u s c r i p t  s u b m i t t e d  1 9 9 7 )  r e c e n t l y  p r o p o s e d  t h a t  a  c o n t i n u u m  o f  t a r g e t  c e l l s  e x i s t  in  
t h e  m o u s e  e p i d e r m i s ,  m o s t  p r i m i t i v e  cel l s ,  g i v i n g  r i s e  t o  v e r y  m a l i g n a n t  t u m o u r s ,  w h i l s t  
m o r e  d i f f e r e n t i a t e d  c e l l s  w o u l d  g i v e  r i s e  t o  l o w  r i s k  b e n i g n  s k i n  t u m o u r s .
A  D M B A / r a d i a t i o n / T P A  s k i n  c a r c i n o g e n e s i s  s t r a t e g y  w a s  d e v i s e d .  T h i s  w a s  u s e d  t o  
i n v e s t i g a t e  t h e  r o l e  o f  m a t r i x  ce l l s  a n d  o t h e r  ce l l  t y p e s  w h i c h  a r e  s u s c e p t i b l e  t o  p 5 3  
i n d u c e d  a p o p t o s i s  f o l l o w i n g  D N A  d a m a g e ,  in c h e m i c a l l y  i n d u c e d  m o u s e  s k i n  
c a r c i n o g e n e s i s  ( Q u i n t a n i l l a  e t  a l  , 1 9 8 6 ) .  p 5 3  w i l d  t y p e  a n d  k n o c k o u t  m i c e  w e r e  t r e a t e d  
w i t h  a n  i n i t i a t i n g  d o s e  o f  D M B A  a n d  lef t  f o r  o n e  w e e k  b e f o r e  b e i n g  e x p o s e d  t o  4 G y  
i o n i s i n g  r a d i a t i o n .  2 4 h r s  l a t e r  t h e  m i c e  w e r e  p r o m o t e d  w i t h  T P A  t w i c e  w e e k l y  f o r  2 0  
w e e k s .  O u r  h y p o t h e s i s  w a s  t h a t  l o s s  o f  D M B A  i n i t i a t e d  c e l l s  f r o m  ce l l  p o p u l a t i o n s  
s u s c e p t i b l e  t o  p 5 3  m e d i a t e d  r a d i a t i o n  i n d u c e d  a p o p t o s i s  w o u l d  r e s u l t  in f e w e r  t u m o u r s .  
L a c k  o f  p 5 3  in D M B A  - i r r a d i a t e d  p 5 3  k n o c k o u t  a n i m a l s  w o u l d  f a c i l i t a t e  t h e  
u n c o n t r o l l e d  p r o l i f e r a t i o n  a n d  u l t i m a t e  t u m o u r  f o r m a t i o n  o f  c e l l s  w i t h  m a l i g n a n t  
p o t e n t i a l .  F i r s t l y  t h e  e f f e c t  o f  i n d i v i d u a l  D M B A  a n d  T P A  t r e a t m e n t s  o n  m o u s e  s k i n  w a s  
a s s e s s e d .
L e v e l s  o f  p 5 3  i n c r e a s e d  in t h e  s k i n  o f  D M B A  t r e a t e d  p 5 3  w i l d  t y p e  m o u s e  sk in .  p 5 3  
s t a i n i n g  w a s  p a r t i c u l a r l y  i n t e n s e  h a l f  w a y  u p  t h e  h a i r  fo l l i c l e  ( F i g u r e  5. I B ) .  A p o p t o t i c
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b o d i e s  w e r e  a l s o  p r e s e n t  in t h i s  r e g i o n  o f  h a i r  fo l l i c l e  f i v e  d a y s  a f t e r  D M B A  t r e a t m e n t  
( F i g u r e  5 .1  A ) .  N o  a p o p t o s i s  w a s  o b s e r v e d  in p 5 3  k n o c k o u t  m o u s e  s k i n  t r e a t e d  w i t h  
D M B A .  T h e  n u m b e r  o f  a p o p t o t i c  b o d i e s  p e r  fo l l i c l e  in p 5 3  w i l d  t y p e  a n d  k n o c k o u t  
m o u s e  s k i n  f i v e  d a y s  a f t e r  t r e a t m e n t  w i t h  D M B A  is s u m m a r i s e d  in T a b l e  3.  p 5 3  w i l d  
t y p e  m o u s e  h a i r  f o l l i c l e s  s h o w e d  o n  a v e r a g e  10  f o l d  m o r e  a p o p t o t i c  b o d i e s  in  t h e  h a i r  
f o l l i c l e s  t h a n  w i l d  t y p e  a c e t o n e  c o n t r o l  s k in .  L e v e l s  o f  a p o p t o s i s  d i d  n o t  c h a n g e  in p 5 3  
k n o c k o u t  m o u s e  s k i n s  t r e a t e d  w i t h  e i t h e r  D M B A  o r  a c e t o n e  ( F i g u r e  5 . 2  B ) .
T P A  t r e a t m e n t  p r o d u c e d  a n  i n c r e a s e  in p 5 3  l e v e l s  in t h e  i n t e r f o l l i c u l a r  e p i d e r m i s  o f  p 5 3  
w i l d  t y p e  m o u s e  s k i n  ( F i g u r e  5 .3  A & B ) .  B o t h  p 5 3  w i l d  t y p e  a n d  k n o c k o u t  m o u s e  s k i n  
r e s p o n d e d  t o  T P A  t r e a t m e n t  w i t h  i n c r e a s e d  i n t e r f o l l i c u l a r  ce l l  p r o l i f e r a t i o n .  N o  
a l t e r a t i o n s  in t h e  l e v e l s  o f  a p o p t o s i s  w a s  d e t e c t e d  a f t e r  T P A  t r e a t m e n t  b e t w e e n  t h e  
s k i n s  o f  p 5 3  w i l d  t y p e  o r  k n o c k o u t  m o u s e  s k i n  ( F i g u r e  5 . 4 ) .
I n  a  c o m b i n a t i o n  o f  t h e s e  t r e a t m e n t s ,  f o r  t h e  r e a s o n s  o u t l i n e d  a b o v e ,  b o t h  p 5 3  w i l d  t y p e  
a n d  k n o c k o u t  m i c e  w e r e  i n i t i a t e d  w i t h  D M B A .  H a l f  o f  e a c h  g r o u p  o f  m i c e  t h e n  r e c e i v e d  
4 G y  o n e  w e e k  l a t e r .  Al l  a n i m a l s  w e r e  t h e n  t r e a t e d  t w i c e  w e e k l y  w i t h  T P A  f o r  t w e n t y  
w e e k s ,  a s  d e s c r i b e d  in  c h a p t e r  2.  T u m o u r  d e v e l o p m e n t  w a s  r e c o r d e d  w e e k l y  f o r  t h e  
d u r a t i o n  o f  t h e  e x p e r i m e n t .
p 5 3  w i l d  t y p e  m i c e  t h a t  r e c e i v e d  b o t h  r a d i a t i o n  a n d  D M B A  p l u s  T P A  d e v e l o p e d  m o r e  
p a p i l l o m a s  a n d  c a r c i n o m a s  t h a n  t h e i r  u n i r r a d i a t e d  c o u n t e r p a r t s  ( F i g u r e  5 . 5  A & B ) .  N o  
c h a n g e  in  t h e  r a t e  o f  m a l i g n a n t  p r o g r e s s i o n  w a s  o b s e r v e d  in t h e  p a p i l l o m a s  f r o m  e a c h  
g r o u p .  S i m i l a r l y ,  t h e  i r r a d i a t e d  p 5 3  k n o c k o u t  m i c e  d e v e l o p e d  m o r e  p a p i l l o m a s  t h a n  t h e  
p 5 3  k n o c k o u t  m i c e  t r e a t e d  w i t h  D M B A / T P A  a l o n e  ( F i g u r e  5 . 6  ). T h e  d i f f e r e n c e  in 
p a p i l l o m a  d e v e l o p m e n t  b e t w e e n  i r r a d i a t e d  a n d  u n i r r a d i a t e d  p 5 3  k n o c k o u t  is g r e a t e r  t h a n  
t h a t  o b s e r v e d  b e t w e e n  t h e  p 5 3  w i l d  t y p e  g r o u p s .  T h e  r e a s o n s  f o r  t h i s  a r e  u n c l e a r  
h o w e v e r ,  i t s h o u l d  b e  s t r e s s e d  t h a t  t h e  n u m b e r  o f  k n o c k o u t  m i c e  u s e d  in  t h e  s t u d y  w a s  
r e s t r i c t e d  t o  10  a n i m a l s  in e a c h  g r o u p  d u e  t o  t h e  r e s t r i c t e d  a v a i l a b i l i t y  o f  p 5 3  k n o c k o u t  
a n i m a l s .  T h e  w i l d  t y p e  m o u s e  s t u d y  w a s  c a r r i e d  o u t  u s i n g  g r o u p s  o f  t w e n t y  m i c e .
W e  d i d  n o t  d e t e c t  a n y  d i f f e r e n c e  in t h e  h i s t o l o g y  o f  t u m o u r s  b e t w e e n  i r r a d i a t e d  a n d  n o n  
i r r a d i a t e d  s e t s  o f  p 5 3  w i l d  t y p e  m i c e ,  a s  s u m m a r i s e d  in T a b l e  4 .  T h e  r a t i o  o f  p o o r l y
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d i f f e r e n t i a t e d  s p i n d l e  t u m o u r s  t o  t h e  m o r e  d i f f e r e n t i a t e d  s q u a m o u s  t u m o u r s  w a s  s i m i l a r  
in  b o t h  g r o u p s  o f  m i c e .  N o  c a r c i n o m a s  w e r e  a v a i l a b l e  f o r  e x a m i n a t i o n  f r o m  p 5 3  
k n o c k o u t  m i c e .
B a s e d  o n  t h e s e  r e s u l t s ,  i t c a n  b e  c o n c l u d e d  t h a t  m a t r i x  c e l l s  a r e  u n l i k e l y  t o  p l a y  a  p a r t  in 
D M B A / T P A  i n d u c e d  m o u s e  s k i n  c a r c i n o g e n e s i s .  H o w e v e r  t h i s  m a y  b e  a n  o v e r  
s i m p l i s t i c  i n t e r p r e t a t i o n  o f  o u r  d a t a ,  s i n c e  r a d i a t i o n  -  i n d u c e d  a p o p t o s i s  in ce l l s  o f  t h e  
i m m u n e  s y s t e m ,  p a r t i c u l a r l y  c y t o t o x i c  T  ce l l s  o f  t h e  s k i n  m a y ,  h a v e  a l l o w e d  m o r e  
i n i t i a t e d  c e l l s  t o  e v a d e  d e t e c t i o n  a t  e a r l y  s t a g e s  a n d  b e c o m e  e s t a b l i s h e d  a s  t u m o u r s .  I t  
h a s  b e e n  r e p o r t e d  p r e v i o u s l y  t h a t  d e n d r i t i c  e p i d e r m a l  T  ce l l s ,  w h i c h  a r e  s k i n  s p e c i f i c  
m e m b e r s  o f  t h e  t i s s u e  t y p e  y  5  T  ce l l  f a m i l y  in m i c e ,  a r e  c a p a b l e  o f  k i l l i ng  s e l e c t e d  
t u m o u r  ce l l  l i ne s  ( M o h a m a d z a d e h  e t  a l ,  1 9 9 6 ) .  T h i s  r e s u l t  r e i n f o r c e s  t h e  c o n c e p t  t h a t  
d e n d r i t i c  e p i d e r m a l  T  c e l l s  r e p r e s e n t  s k i n  r e s i d e n t  k i l l e r  c e l l s  t h a t  p l a y  a  r o l e  in l o c a l  
i m m u n o s u r v e i l a n c e  a g a i n s t  t u m o u r  d e v e l o p m e n t .  I f  t h i s  is i n d e e d  t h e  c a s e ,  a n y  e f f e c t  o f  
r a d i a t i o n -  i n d u c e d  m a t r i x  ce l l  d e a t h  o n  c a r c i n o g e n e s i s  w o u l d  b e  m a s k e d  b y  t h e  r e m o v a l  
o f  t h e s e  c e l l s
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Figure 5.1 A.
Arrow 1 indicates apoptotic bodies half way up the hair follicle of p53 wild type 
adult mice treated with DMBA.
Figure 5.IB
Arrow 2 indicates intense CM5 staining in the same position.
F ig u r e ^ !  CM5 staining and H&E stained adult mouse skin one week after exposure to DMBA.
(A)  H & E  s t a i n e d  P 5 3  w i l d  t y p e  a d u l t  m o u s e  s k i n  e p i d e r m i s  1 w e e k  a f t e r  e x p o s u r e  to  D M B A
(B)  C M 5  s t a i n e d  p 5 3  w i l d  t y p e  a d u l t  m o u s e  s k i n  e p i d e r m i s  1 w e e k  a f t e r  e x p o s u r e  to  D M B A
1 w e e k  a f t e r  e x p o s u r e  to  D M B A  , C M S  p o s i t i v e  c e l l s  a r e  p r e s e n t  h a l f  w a y  u p  t h e  h a i r  f o l l i c l e s  
o f  p 5 3  w i l d  t y p e  a d u l t  m o u s e  s k i n .  A p o p t o t i c  b o d i e s  a r e  a l s o  p r e s e n t  h a l f  w a y  u p  t h e  h a i r  
f o l l i c l e  1 w e e k  a f t e r  D M B A  t r e a t m e n t .
C M 5  s t a i n i n g  a n d  D M B A  t r e a t m e n t s  w e r e  p e r f o r m e d  a s  d e s c r i b e d  in m a t e r i a l s  a n d  m e t h o d s  
M a g n i f i c a t i o n  X 4 0
Figure £ .2  Comparison of  p53 wild type and knockout adult mouse follicles five days alter DMBA
treatment.
(A)  p 5 3  w i l d  t y p e  a d u l t  m o u s e  s k i n  f i ve  d a y s  a f t e r  D M B A  t r e a t m e n t .
(B)  p 5 3  k n o c k o u t  a d u l t  m o u s e  s k i n  f i v e  d a y s  a f t e r  D M B A  t r e a t m e n t .
F i v e  d a y s  a f t e r  D M B A  t r e a t m e n t  a p o p t o t i c  b o d i e s  a r e  v i s i b l e  h a l f  w a y  u p  t h e  
h a i r  f o l l i c l e s  o f  p 5 3  w i l d  t y p e  m o u s e  s k i n .
M agnifica tion  X 40
Table 3. Incidence of apototic bodies in p53 wild type and knockout mouse 
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Figure S 4 H&E stained p53 wild type and knockout adult mouse epidermis 36hrs after TP A
treatment.
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Chapter 6. Discussion
6.1 p53 and cellular immortalization
Normal diploid cells have a limited capacity to divide both in vivo and in vitro. In 
contrast, genetically transformed cells or cells transformed by chemical or biological 
agents appear to have lost the regulatory mechanisms of limited growth potential, thus 
becoming immortal. During routine growth, normal diploid cells undergo a period of 
rapid proliferation followed by progressive loss of replicative capacity, as reflected in 
slower population growth rates. The population finally reaches a state of growth arrest 
and almost all the cells fail to divide. Late passage non proliferating cells are 
characterised by increased size, cell spreading, and modified organisation of the 
cytoskeleton and the extra cellular matrix (Holliday et al, 1995).
The oncogenic products of DNA tumour viruses, such as the T antigen of SV40 and 
Polyoma Viruses, the E l A oncoprotein of some adenoviruses and the E7 oncoprotein of 
types -16 and -18 human papilloma viruses (HPV), together with some retroviral gene 
products and their activated cellular homologues (e.g. v-or c- myc, v- or c- fos) can 
overcome and cancel the proliferation block of senescent cells in several mammalian cell 
types, a process which is termed immortalization. As discussed in the chapter 1, p53 
serves as a cellular target for the gene products of many DNA tumour viruses. This led 
to investigation of the role of p53 in cellular immortalization.
It has been reported that cdc2, cyclin A, and PCNA are not induced in senescent cells 
(Stein et al., 1991), furthermore it has been shown that inactive cyclin E-cdk2 and cyclin 
D l- cdk2 complexes accumulate in senescent human diploid fibroblasts (Dulic et 
a l, 1993). The universal cyclin dependent kinase inhibitor p21w^ ,  which is 
transcriptionally activated by p53 has been implicated in cellular senescence. p21wfl^  was 
shown to be over expressed in senescent cells, which provided a link between p53 and 
cellular immortalization (Noda et al., 1994). An increase in p21wy7 levels would account 
for the defect in activities of cyclin cdk complexes and the absence of pRb 
phosphorylation at the Gl-S boundary. A single gene, named hic-5, has recently been 
isolated This gene can induce senescent like phenotype in immortal human fibroblasts 
(Shibanuma et a l, 1997). The induction of senescence by hic-5 is accompanied by an
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increase in y2 \wafl levels. Thus, two genes may work together to accomplish cellular 
senescence.
p53 mRNA levels do not change as cells age in vitro. In contrast, transcriptional activity 
increases several fold during ageing (Atadja et a., 1995). It would appear that the signals 
which link DNA damage to increased p53 expression are not activated when human 
fibroblasts begin to senesce. However DNA damage is widespread in senescing cultures 
as typified by the high number of chromosomal aberrations which increase during the 
serial passaging of cells.
The results presented here suggest that lack of p53 in keratinocytes in vitro is prohibitive 
for the increase in p21wq/7 protein levels observed in a large number of senescent cell 
populations. As a consequence a greater number of p53 knockout keratinocytes show 
increased ability to escape senescence compared to p53 wild type keratinocytes.
The role of other cyclin dependent kinase inhibitors which are not under the control of 
p53 in senescence should be considered in analysing why p53 knockout cells should 
enter the senescence pathway. These genes include pl5(ink4b/mts-2), p l6  
(ink4a/mts/cdkn2), p27(kip-l) and p57 (kip-2) . The p i 5 and p l6  genes have been 
located in human chromosomal region 9p21, adjacent to one another (Nobori et al, 
1994). Both genes have the ability to act as inhibitors of cdk4 and cdk6 and block 
proliferation in cells possessing functional RB. p27  is a potent inhibitor of cyclinD -cdk4 
and cyclin A- cdk2 activity, overexpression of which causes G1 arrest in Saos-2 cells 
(Toyosima et al, 1994). The p57 gene is a potent inhibitor of G1 and S phase cdks and 
has been found to be overexpressed in terminally differentiated cells (Lee et al, 1995). 
Most of the known cyclin dependent kinase inhibitors are overexpressed in senescent 
cells. To achieve a complete absence of senescence in vitro, it is probable that many 
genes need to be knocked out in various combinations depending upon the cell type. Our 
results suggest that p53 is only one of the many cellular products that is likely to be 
involved in the immortalization of mouse skin keratinocytes.
6.2 p53 and TGFJ31
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The TGFp’s are a large family of growth inhibitors for a diverse range of cell types. 
Interruption of the TGFpi signalling pathway can occur through multiple mechanisms, 
including mutational inactivation of the TGFpII receptor and post receptor changes in 
genes potentially mediating the TGFpl pathway (For review see Brattain et a l, 1996). 
During the late 1980s, it became apparent that most normal epithelial cells were inhibited 
by exogenous TGFpi treatment. Some cancer cells were also inhibited by TGFpi, but 
many were refractory to the polypeptide. For example, loss of TGFpi sensitivity was 
demonstrated to be associated with the progression of cultured colon carcinoma cells 
displaying early malignant properties to cells with late progression properties (Chantret 
e ta l, 1988).
It has been reported that some tumour cells not only lose responsiveness to growth 
inhibition by TGFpi, but gain the ability to produce the growth factor and be stimulated 
by it. However, carcinogenesis is not simply the result of losing responsiveness to 
negative growth regulation. A fully malignant cell must gain the ability to invade and 
display metastatic potential. TGFpi is believed to play a role in the cascade of events 
which leads to activation of proteolytic enzymes thought to be involved in progression 
to a more invasive phenotype. Therefore, a tumour cell which has lost responsiveness to 
the growth inhibitory actions of TGFpi and gained the ability to produce the growth 
factor is placed at a selective advantage for tumour progression.
Three major types of membrane bound TGFpl binding proteins have been identified. 
They are referred to as type I, type II, and type III receptors. Molecular cloning and 
functional analysis have shown that RI, and RII are serine/threonine kinases which are 
both necessary for TGFpi signalling (Wrana et al 1994, and references therein). The 
direct involvement of RI, and RII in TGFpi signalling would suggest that loss of RI, or 
RII expression could contribute to the loss of TGFpi the response, resulting in a growth 
advantage that could contribute to tumour progression. However, due to the stepwise 
nature of malignant tumour development, it seems likely that there may be a progressive 
loss of growth control in by TGFpl in cancer development involving membrane 
receptors, cytoplasmic proteins and nuclear factors involved in the signal cascade.
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Both mutations in, and loss of, the p53 gene have been correlated by previous studies 
with the loss of responsiveness to TGFpi. (Reiss et al 1993, Gerwin et al, 1992). 
However, others have shown that p53 status bears no relationship to the degree of 
responsiveness of a cell to TGFpi (Williams et al, 1994) Most studies on TGFP 
signalling have used cell lines which commonly have alterations in p53, as well as in 
other tumour suppressor genes and protooncogenes. This makes the interpretation of 
such results difficult. The utilisation of our p53 knockout keratinocytes has allowed us 
to conclude that loss of wild type p53 does not lead to a decrease in responsiveness to 
the growth inhibition by TGFpi. Perhaps the most convincing evidence for this is that 
p53 wild type and knockout primary keratinocytes show no difference in response to 
TGFpl. Primary cultures less likely to have additional acquired significant genetic 
alterations due to the short time they spend in culture.
Since p53 knockout animals develop show no defects in skin development, it seems 
likely that other cellular pathways exist to compensate for a lack of p53 in growth 
regulation (Donehower et al, 1992).
Although the signal transduction pathways that mediate TGFpi induced growth 
inhibition have not been fully characterised, TGFpl is thought to maintain the product of 
the Retinoblastoma gene in an hypophosphorylated state and block cells in late Gl. 
Furthermore, TGFpl reduces the expression of cdk4 and Cyclin E, but not that of 
cyclin D. This prevents subsequently activation of both Cyclin D-cdk4 and Cyclin E- 
cdk2 complexes. Alterations in the levels of the universal cyclin dependent kinase 
inhibitor p21 wafl have been proposed to be responsible for changes in cyclin D, and 
cyclin E kinase complex regulation.
Cellular p21w3/^protein levels rise following exposure to TGFpl. ( Li et al, 1995) We 
observed an increase in y2 \waf l  in both p53 knockout and wild type keratinocytes after 
TGFpl treatment. Therefore expression of p21w ?/^may represent an important mediator 
of TGFP 1 activity in both p53 wild type and knockout keratinocytes. The lower basal 
levels of y2 \waf lm  p53 knockout mouse keratinocytes, compared to p53 wild type
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keratinocytes, is probably due to the lack of transcriptional activation in the p53 
knockout cells. However in p53 knockout keratinocytes, p21 waf l  levels are capable of 
rising to levels comparable to those observed in p53 wild type keratinocytes following 
TGFpl treatment. This non p53 mediated pathway has the ability to produce levels of 
p2jwfl/7 capabie of blocking cell cycle progression.
Given the broad spectrum of cdks which p21 waP  is capable of inhibiting, it is not 
surprising that more than one level of control exists over its regulation. Although
ip2\waf l  appears to be controlled by more than one cellular pathway it is not the only 
cdk inhibitor to be involved in TGFpi arrest. p27^z/ ^  has been shown to be unregulated 
in certain cell types after TGFpl treatment (Ravitz et a l, 1996). Again it is hardly 
surprising that more than one mechanism operates in response to TGFpi since growth 
regulation by this factor is of extreme importance for both normal development and 
normal tissue homeostasis. Other members of this family may yet be identified. It is 
unlikely that should any TGFpi regulated cdks be discovered, they will be solely under 
the control of p53.
Our results do not rule out a role for mutant p53 in TGFpl signalling. Attempts to 
introduce a gain of function mutant p53 construct were hampered by its toxic effect on 
both knockout and wild type keratinocyte cell lines. One attractive possibility is that 
mutant p53 confers resistance to TGFpi by interfering with wild type p53 mediated 
down regulation of cdk4 leading to the accumulation of unphosphorylated pRb and 
subsequent cell cycle arrest (Ewan et al, 1995). However, in the p53 knockout 
keratinocytes p53 mediated regulation of cdk4 is absent and other mechanisms of 
regulation, which may or may not be affected by the presence of mutant p53 are likely to 
be present. An extension to this study would be to analyse the response of primary 
keratinocytes from mutant p53 transgenic animals to the growth inhibitory actions of 
TGFpi.
The effect of p53 dosage and the presence of mutant H  ras on TGFpl signalling was 
investigated. This was in response to the growing number of accounts linking H  ras to 
the TGFpl signalling cascade. Changes in the expression levels of mutant H  ras have
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been linked to loss of responsiveness to TGFpi in mouse skin carcinogenesis (Haddow 
et al, 1991). More direct evidence for the role of mutant H  ras in TGFP signalling 
comes from studies on cell lines which show increased H ras activity within 10 minutes 
of exposure to TGFpl (Mulder et al, 1992).
Curiously, after infection with mutant H  ras both p53 wild type and knockout 
keratinocytes displayed cytoplasmic as well as membrane bound forms of mutant H ras, 
(data not shown). This may be a consequence of overexpression of H ras protein in 
these cells or an artefact of the fixation procedure used. After infection with mutant l i ­
ras the keratinocyte cell lines showed a limited drop in responsiveness to TGFpl. Our 
results do not conclusively elucidate the role of H-ras in TGFpi regulation, since the 
infection protocol could not ensure that each cell would produce comparable amounts of 
H ras protein.
It is possible that other cellular oncogenes and tumour suppressor genes cooperate with 
H  ras to induce an increased level of resistance to TGFpi. The MAD-related family of 
proteins are essential components in the signalling pathways of serine threonine kinase 
receptors for the TGFpi superfamily. It has been shown that the MADR2 gene is a 
tumour suppressor gene located on human chromosome 18q alongside DPC4, which is 
yet another potential component in TGFpi signalling. Mutations in MADR2 and/or loss 
of chromosome 18q are thought to function to disrupt TGFpi signalling in human 
colorectal cancer (Frank, et al 1997). The collaborative effect of ras mutation, p53 
mutations, and alterations in MAD related genes may well vary from one cell type to 
another. The availability of a range of knockout animals and skin targeted H  ras 
transgenic animals provide an ideal model with which to study the factors that co­
operate to induce total resistance to the growth inhibitory effects of TGFpl in mouse 
skin keratinocytes.
In summary, TGFpi signalling is a process which transfers instructions from the cell 
surface to the nucleus. Loss of any part of this signalling cascade is likely to induce a 
certain degree of resistance to TGFpl. The relative importance of each individual part 
of the cascade may differ from cell type to cell type. Such a scenario would go some way
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to explain the diverse and conflicting results published as to the role of H  ras, p53 and 
p21Wfl^ 7 and the TGFpi receptors in the response of a variety of cell types to TGFpl.
It is likely that wild type p53 is not an important constituent of the TGFpl signalling 
system in mouse skin keratinocytes. However, p53 may play a pivotal role in TGFpi 
signalling in other cell types. This idea is supported by the recent report that a 
proportion of progenitor cells in bone marrow of p53 knockout mice are unresponsive to 
growth inhibition by TGFpi (Sasaki et al, 1997)
6.3 p53 and cell survival after DNA damage.
After exposure to 4Gy radiation, y2 \waf l  protein levels rise in C5N cells. Recent 
results from this lab have also shown that p53 protein levels rise before detectable 
changes in p21 wafl levels. (I. Ganly, personal communication). There is no alteration in
$2\waf l  protein levels in NK cells after exposure to 4Gy. After radiation exposure, the
increased levels of y2 \waf l  probably lead to cell cycle arrest in G1 as a result of 
inhibition of cdk activity as previously discussed. Fluorescent activated cell sorter 
analysis has recently been performed on C5N and NK cells, and has revealed the 
existence of a G1 block in C5N but not in NK cells following exposure to low doses of 
ionising radiation.
BAX protein levels remain constant in C5N and NK cells after exposure to radiation. 
However, C5N cells show a drop in BCL2 protein levels 24hrs after exposure to 4Gy. 
BAX is widely accepted to counteract the anti apoptotic signal of BCL2. It has been 
proposed that when BAX homodimers predominate in a cell, the cell is susceptible to 
apoptosis; the opposite being the case for BCL2 homodimer excess (Oltvali et al., 
1993). Collectively, these results suggest that cultured keratinocytes do not enter the 
apoptotic pathway after exposure to 4Gy. In contrast, if p53 is functionally active, 
keratinocytes arrest in G1 as a consequence of p21w^  induction.
Kastan and colleagues carried out studies using a cell line (BAF) derived from the bone 
marrow of an adult mouse. As detailed in the chapter 1 the BAF cell line undergoes 
apoptosis in response to ionising radiation when IL3 is removed from the culture
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medium. In contrast, when IL3 is present and the cells are irradiated, they display a cell 
cycle block rather than entering the apoptotic pathway. No changes were found in BCL2 
or BAX to explain this phenomenon. However, p21wy7 levels were increased in the cells 
that entered the growth arrest state compared to the cells that entered the apoptotic 
pathway (Canman et al, 1995). This is to results showing that removal of p21vra^7 can 
cause a switch from growth arrest to apoptosis (Polyak et al, 1996)
In the context of this study, it would seem that modulation of p21wa-/7 levels dictates the 
response of p53 wild type keratinocyte cells to ionising radiation by facilitating a cell 
cycle block which is not evident in p53 knockout keratinocytes. In this regard it seems 
strange that both cell lines show comparable survival curves after DNA damage. 
Initially, this result was unexpected since thymocytes and hematopoietic cells from p53 
knockout mice had previously been shown to be more radio resistant than cells from p53 
wild type mice. The results presented suggest that p53 is not necessary for the relatively 
short term survival of mouse skin keratinocytes in vitro after DNA damage. It is likely 
that irradiated p53 knockout keratinocytes would show high levels of genetic lesions 
compared to irradiated p53 wild type keratinocytes after routine subculture.
6.4 p53 induction and cell death in vivo.
The stabilisation of p53 protein in response to genetic damage is well documented in 
vitro. p53 accumulation is thought to be part of a signalling pathway that induces either 
cell cycle arrest or apoptosis (Reviewed in Hansen and Oren 1997). In the present study, 
the effect of ionising radiation in mouse skin on the accumulation of p53, cell death, and 
cell cycle arrest was analysed. Early studies on the radiosensitivity of human and mouse 
keratinocytes suggested that when primary keratinocytes are routinely cultured they 
display increased radioresistance (Parkinson, et al 1986). Furthermore in vitro studies 
have provided evidence that human fibroblasts are more radioresistant than human 
keratinocytes (Beverstock and Simons, 1982). It has also been reported that human 
keratinocytes are more radiosensitive than mouse keratinocytes (Dover and Potten., 
1983). However the in vivo results presented in this study highlight the dangers of 
collectively labelling skin keratinocytes as more or less radioresistant than other cell 
types. It would appear that keratinocyte radiosensitivity is dictated by the differentiation 
status or cellular fate of the cell in vivo.
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Low dose irradiation of p53 wild type anagen adult and two week old 129/NIH mouse 
skin resulted in increased levels of p53 in both follicular and interfollicular cells of the 
epidermis. Furthermore 4hrs after 4Gy p53 dependent apoptosis was present only in the 
matrix region of the hair follicle. Surprisingly, no hair loss was observed in animals 
which were alive for up 40 weeks after 4Gy. Others recently reported maximal 
induction of apoptosis in the follicle matrix cells of adult Balb C mice 12hrs after 
exposure to radiation. Furthermore, they also reported that induction of apoptosis in the 
follicles was proportional to the dose of radiation received (Kim et al, 1997). In our 
study there was no significant difference in the extent of apoptosis induced by either 4- 
lOGy. Maximal apoptosis occurred 4hrs after exposure to radiation, and in p53 wild 
type two week old mouse skin levels remained high for 24hrs. We are presently re­
investigating the effect of exposure to lOGy with respect to hair loss in a 129/NIH 
background, since it is possible that failure to observe increased apoptosis after lOGy 
may have been due to increased phagocytotic activity of normal cells at increased DNA 
damage levels. The finding that p53 heterozygote mice display a degree of apoptotic 
response 75% of that found in wild type mouse skin after radiation suggests that loss of 
a single allele of p53 does not result in a 50% fall in p53 mediated apoptosis. This may 
reflects the importance in evolution of retaining the p53 response.
Merritt et al, (1994) analysed the response of the gastrointestinal tract of normal and 
p53 knockout mice to low doses of ionising radiation. The result of these studies led to 
the conclusion that p53 dependent apoptosis was restricted to the stem cell compartment 
of the small intestine. These results were soon confirmed in a separate line of p53 
deficient mice (Clarke et al, 1994). These observations led to the proposal that p53 plays 
a role in removal of damaged stem cells with the potential for uncontrolled growth and 
tumour formation.
In mouse skin, matrix cells are not the most favoured candidate for skin stem cells. The 
current generally accepted location for the stem cells of the skin is in the bulge region of 
the hair follicle (Cotsarelis et al, 1990). However our results suggest that matrix cells are 
the population specifically removed after radiation. The role of matrix cells in tumour 
formation will be considered later.
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6.5 p53, cell cycle status and entry into apoptosis.
p53 can trigger both cell cycle arrest and apoptosis. An important question is whether 
p53 induced G1 arrest and apoptosis are independent pathways or whether p53 induced 
apoptosis is a consequence of, or follows G1 arrest. p53 induced cell death in M l mouse 
myeloid leukaemia cells is not preceded by growth arrest, although cells in G1 are 
preferentially susceptible to apoptosis. In contrast, p53 dependent apoptosis in DPI 
murine erythroleukemia cells occurs only after G1 arrest (Guillouf et al, 1995). Thus, it 
seems likely that p53 induced apoptosis is, at least in some cases preceded by G1 arrest, 
but that this is cell specific. The results generated from in vitro studies on cell cycle 
kinetics and entry into apoptosis may not reflect the true situation in vivo, since tissue 
culture cells often display altered cell cycle patterns as a result o f serial passaging.
In our study using BrdU labelling we identified cells that were probably in S, G2 or M 
at the time of entering the apoptosis pathway were identified. This result suggest that at 
least a proportion of matrix cells can enter the apoptotic pathway from G2/M rather than 
Gl.
6.6 P53 and cell cycle arrest
The results obtained from BrdU labelling studies led us to conclude that the p53 
response in mouse skin varies not just in apoptotic response but also in cell cycle arrest 
patterns. A block in DNA synthesis 24hrs after exposure of normal adult mouse skin to 
ionising radiation was observed. This represents a relatively long time gap between 
initial DNA damage and cell cycle arrest, the reasons for which are unclear. The purpose 
of the cell cycle block is proposed to enable the cell to repair DNA damage before 
entering the next round of replication, and thus prevent propagation of genetic lesions 
(Lane, 1992; Kemp, et al 1993; Harvey et al, 1993; Greenblatt et al, 1994;). Cells 
entering S phase up to 24hrs after initial exposure must arrest at a downstream phase of 
the cell cycle to maintain genetic integrity. This raises the possibility that the 24hr block 
in BrdU incorporation which we observe is mediated by p53 at the G2/or M phase of 
the cell cycle.lt is interesting to note that a specific splice variant of p53 is elevated at
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G2/M of the cell cycle. (Lu et al, 1994). Analysis of irradiated skin sections with an 
antibody to this G2/M splice variant of p53 is presently underway.
Alternatively, the delay observed before cell cycle arrest becomes apparent may be as a 
consequence of a large proportion of skin cells having a long G1 phase, resulting in an 
extended time period before the cell encounters the Gl/S checkpoint. Early work by 
Potten et al, (1988) identified slow cycling cells in mouse epidermis however, little is 
known about the lengths Gl, G2 or S phase in vivo This alternative explanation 
remains a possibility.
By altering the proliferation and differentiation status of cells by TPA treatment in adult 
epidermis, we were able to induce a change in the pattern of cell cycle arrest after DNA 
damage. This is in contrast to the lack of change in apoptotic outcome after exposure of 
a cell to DNA damage. As discussed earlier, $2\wafl has been linked to p53 mediated cell 
cycle arrest at the Gl/S border. The change in timing of the proliferation block between 
irradiated acetone and TPA treated adult mouse skin may be due to p53 dependent 
changes in either p21w^  level or activity in the skin leading to changes in cell cycle 
kinetics. Unfortunately we were hindered in our attempts to examine p21w^  levels in our 
skin sections due to the lack of commercially available mouse specific antibodies for the 
protein. In this regard irradiation of p21wa^  knockout mice should facilitate a greater 
understanding of the role of P21 wa^  in mouse skin after DNA damage.
The generation of p53 -Lac Z reporter mice allowed an investigation of the role of p53 
transcriptional activity in both apoptotic and arrested cells in irradiated mouse epidermis. 
Cells which contain transcriptionally active p53 are identifiable in reporter mice by 
measuring beta galactosidase activity. However, the results obtained from the irradiated 
skin of these mice generated more questions than answers. No evidence of p53 
transcriptional activity was detected in the skin of reporter mice up to 48hrs after 
exposure to 4Gy radiation or 72hrs post TPA treatment. However, both these stimuli 
resulted in increased levels of p53 protein in mouse skin. Activity of the transgene was 
clearly detected in other tissues of irradiated mice, in the salivary gland for example. 
These observations may accurately reflect the transcriptional activity of p53 in the skin. 
However, it is also possible that the results are due to a unknown skin specific factor
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interfering with the regulation of the transgene. The p53 responsive element in the 
promoter region of the LacZ reporter transgene does not vary from the p53 consensus 
region of the p21Wfl^  gene. This observation and the results from other irradiated tissues, 
where transgene induction is detected suggests that the skin may be unique in its 
response to DNA damage and subsequent p53 stabilisation. TPA is known to stimulate 
Protein Kinase C, which is thought to play a major role in the phosphorylation of p53, 
mainly at the C terminus. Alterations in p53 phosphorylation status have been suggested 
to alter the transcriptional activity of the p53 protein (Meek, 1982). In view of our 
earlier observation that TPA followed by 4Gy radiation 36hrs later produced a drop in 
BrdU incorporation evident 4hrs after radiation treatment rather than at 24hrs, we 
investigated the effect of changes in transcriptional activity following TPA treatment of 
Lac Z  reporter mice. No transcriptional activity was detected in Lac Z  mouse skin 
treated with TPA and irradiated with 4Gy 36hrs later. This was for consistent up to 
48hrs post radiation treatment of the mice. This casts doubt on the earlier proposal that 
changes in p53 phosphorylation status as a result of TPA treatment caused altered 
transcriptional activity of the p53 protein, leading in turn to increased levels of p21vra;7 
protein in the epidermis. Okadaic acid, which acts as to block dephosphorylation also to 
failed to produce increased transcriptional activity in p53 LacZ reporter mouse skin.
The idea that p53 can induce apoptosis without transcriptional activation is highlighted 
in our recent collaborative study with Prof D.Lane, and Prof. P.Hall (research paper 
enclosed). p53 mediated apoptosis can occur in certain cell types despite the absence of 
transcriptional activation by p53. p53 mediated cell type specific apoptosis occurs in the 
spleen of irradiated LacZ reporter mice. Not all of the apoptotic cells in the spleen show 
p53 transcriptional activity after radiation exposure, although most cells do show 
elevated levels of p53 protein. Clearly, many levels of control must exist to regulate the 
p53 apoptosis pathway. These observations rule out a singular role for the cell death 
gene box which is transcriptionally activated by p53 in all incidences of apoptosis after 
DNA damage. Instead our results lend support to the idea that p53 induces apoptosis by 
acting directly on cell death systems or by transcriptional repression of cell survival 
genes such as bcl2.
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The majority of studies which have attempted to address the role of p53 transcriptional 
regulation in the apoptotic pathway have been performed on cell lines in vitro. Recently 
it has been demonstrated that p53 mediated apoptosis does not require transcription 
function in HeLa cells (Yonish-Rouach et al 1994: Haupt et al 1995). In contrast it was 
shown by the White laboratory that p53 mediated transcriptional activation was essential 
to the induction of apoptosis in their system (Sabbatini et al, 1995). These condradictory 
results may be a consequence of the different cell lines used in the individual studies. The 
in vivo work clearly shows there is cell type specificity in p53 mediated transcriptional 
activation and apoptosis. This means that individual cell lines derived from whole tissues 
may display individual specificity in the pathways leading to apoptosis. Additionally, 
cells in culture commonly acquire genetic lesions through serial culture, such lesions 
may manifest themselves as mutations in cell death/survival genes such as bcl2 and bax. 
Deregulation of cellular death/survival genes would be most likely to cause changes in 
the apoptotic signalling pathway in cultured cells.
If the lack of p53 transcriptional activation in skin, which is known to be cell cycle 
inhibited, is real and not do to vagaries of transgene expression, it has significant 
implications for the mechanisms of p53 mediated cell cycle arrest. It is of particular note 
that p21wa-/7 is not required for the G2 checkpoint response to ionising radiation. Normal 
cells in G2 respond to ionising radiation - within lhr the cells cease to enter mitosis 
(Paules et al, 1995). This being the case, the G2 checkpoint is likely to be transmitted 
by a protein synthesis independent signal transduction pathway. This is in agreement 
with our lack of p53 mediated transcriptional activation in normal adult mouse skin 
following exposure to radiation. Further supporting the idea that the arrest observed in 
normal mouse skin after exposure to ionising radiation is a G2 arrest. That our results 
accurately reflect the lack of transcriptional activity by p53 is strengthened by work on 
similar mice which utilise the mdm2 rather than the fo s  promoter. Similarly, these mice 
also show no transgene activity in the skin (Gottlieb et al, 1997). The regulation of 
p21wa^  and other downstream effectors of p53 is the subject of ongoing research.
6.7 Hair follicle, stem cells and apoptosis
Upon exposure to radiation, some cells in mouse epidermis die, and some cells enter a 
period of cell cycle arrest. In murine intestine epithelium, it has been postulated that the
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stem cell like cells of the intestinal crypts undergo apoptosis to prevent the repopulation 
of the intestine with progeny from a genetically damaged stem cell (Merritt et al, 1994). 
We examined the effect of removing matrix cells by radiation induced apoptosis on the 
development of chemically induced mouse skin tumours. It is widely accepted that a 
population of hair follicle cells with stem cell like characteristics are the target cells that 
interact with carcinogens and undergo cellular transformation. The role of matrix cells in 
this process is unclear as they do not fit the classical description of stem cells, in that 
they are rapidly proliferating, there are present in large numbers, and they are not long 
lived. Matrix cells have been proposed to be transit amplifying cells of the skin, 
equivalent to the committed progenitor cells of the hemopoietic tissue. A more 
acceptable location for the stem cell population of the skin is in the bulge region of the 
outer root sheath, where long lived slowly dividing cells have been identified (Laveker et 
al, 1993).
Expression of mutant H ras in the interfollicular population of mouse skin can bring 
about the development of benign papillomas with low progression frequency to 
carcinomas. When the same gene was targeted to the hair follicle it stimulated the 
development of tumours with a high frequency of progression to carcinomas. (Brown et 
al submitted 1997). This result led to the proposal that a continuum of target cell 
populations exist in the epidermis. The most primitive stem cells capable of giving rise to 
malignant tumours while the more differentiated cells capable of giving rise to low risk 
benign tumours. Based on this model matrix cells may have the capacity to give rise to 
tumours low risk skin papillomas. To test this hypothesis a DMB A/radiation/TP A 
protocol was devised to look at the effect of removal of matrix cells by radiation on 
mouse skin carcinogenesis.
Irradiation, rather than decreasing the tumour yield, actually increased the rate of both 
papilloma and carcinoma formation. This effect was observed in both p53 wild type and 
knockout mice. The possibility that radiation was acting as an additional initiating agent 
was eliminated by treating mice with 4Gy followed by 20 weeks TPA treatment, this 
regime produced no tumour development. Similarly DMBA followed only radiation 
treatment did not result in the formation of tumours, thus ruling out any effect of 
promotion by radiation. It is possible that matrix cell depletion stimulates the stem cells
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of the follicle to divide, thus creating a bigger target of stem cells for the initiating agent 
to act upon. This, in turn, would be expected to lead to greater tumour development 
only in p53 wild type mice where the matrix depletion phenomenon occurs. This model 
does not explain the increased incidence of tumour formation in p53 knockout mice.
Alternatively the result may be explained by death of cytotoxic T lymphocytes that 
present in the skin that are considered to be part of the skin immune surveillance system 
which acts to remove genetically damaged cells. This would be a valid model of 
explanation only if the radiation induced death of these cells is p53 independent. The 
possible involvement of the immune system makes analysis of our results difficult, as the 
effect of removal of matrix cells may be masked by the effect of removing the skins 
natural defence system.
Mice which lack circulating y 5 cytotoxic killer cells as a result of a homologous null 
recombination are now available (Chandler et al, 1995). It would be of interest to 
examine the effect of matrix cell depletion on skin carcinogenesis experiments in these 
animals. An alternative way to study matrix depletion, without the involvement of the 
immune system, would be to analyse the effect in nude mice which have no cytotoxic 
immune cells. There is however a drawback to using nude mice to answer this question.
In this study we have shown that nude mice have an abnormal number of hair follicle 
cells that are extremely sensitive to radiation induced apoptosis. The reason for this 
sensitivity is unclear. The recent discovery by Brissette et al,(1997) linking the HFH11 
gene, the gene which gives rise to the nude mouse phenotype, to cellular differentiation 
status offers a possible explanation. Nude mouse keratinocytes exhibit an altered 
differentiation behaviour in vitro, consistent with the abnormal keratinization process 
observed in nude mouse skin (Kopf-Maier et al, 1990). The altered pattern of 
differentiation in nude mouse skin under basal conditions is similar to that observed in 
wild type cells after exposure to TPA. In vivo treatment of mouse skin with TPA induces 
keratinocyte stem cells to divide and produce an increased number of transiently 
amplifying and more committed populations (Cotsarelis et al ,1990). Given the fact that 
nude mouse keratinocytes may be in a "TPA- primed state", the number of keratinocyte 
stem cells and their progeny may altered in nude mouse skin. If this is the case, the
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similarity of the mouse skin system and the intestinal model becomes more evident. If 
the nude mouse follicle does contain more stem cells than normal follicles the hypothesis 
that in the hair matrix, as in the intestinal epithelium, there is cell type specific apoptosis 
related to differentiation status as a result of radiation is strengthened. However, there is 
no evidence to suggest that matrix cells are the stem cells of the skin.
Radiation may causes matrix cells to initiate a programme of cell death which they are 
already primed to undergo, that is programmed cell death in the catagen phase of the 
hair cycle. This may also be comparable to the apoptotic response of thymocytes to 
radiation, since a large proportion of thymocytes are deleted through the apoptotic 
pathway during thymic ontogeny. In previous studies on the haematopoietic and 
intestinal system it has been shown that cells which have a high proliferation rate also 
show p53 induction and rapid induction of the apoptotic pathway. In this study we have 
shown that entry into the apoptotic pathway is independent of proliferation rate, since 
interfollicular cells stimulated to proliferate with TPA do not enter the apoptotic 
pathway after exposure to radiation. If the interfollicular cell population were to undergo 
apoptosis in response to DNA damage the end result would be desquamation, that is, 
skin falling off in sheets. It seems likely that the differentiation of a cell may play a major 
role in determining cell fate after DNA damage.
The role of matrix cells in the development of mouse skin tumours is presently being 
investigated in this laboratory. By targeting mutant H  ras to the matrix cell population, 
we hope to be able to establish the role of initiated matrix cells in the development of 
benign and malignant skin tumours.
No apoptosis was detected in either the basal layer, the outer root sheath, or the bulge 
area of normal mouse skin after exposure to radiation. All of these regions of the skin 
have been proposed as likely to contain stem cells. Therefore, there is a strong possibility 
that the true stem cells of the skin do not enter the apoptotic pathway as a consequence 
of radiation induced DNA damage. This specificity may be due to the proliferative 
status of the stem cell, or its location and micro environment in the tissue. Stem cells of 
the skin may be surrounded by survival factors that prevent their entry into the apoptotic 
pathway. Resistance of skin stem cells to cell death after radiation exposure may have
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evolved to protect the skin from degeneration as a result of constant exposure to 
radiation. This does not imply that the skin stem cells may be resistant to all types of 
genetic damage. Highly localised apoptotic bodies and p53 staining are present high in 
the hair follicle in response to DMBA treatment. This may represent apoptosis of the 
outer root sheath bulge cells after DMBA damage. If indeed this is the case, the cells 
which escape death after initiation are likely to be the cells capable of giving rise to 
highly malignant tumours. Cell specific death was absent in p53 knockout mouse skin 
treatment after DMBA treatment. Paradoxically, p53 knockout mice do not develop as 
many papillomas as p53 wild type mice in classical DMBA/TPA mouse skin 
tumorigenesis. This is unexpected since in the p53 knockout follicle a higher number of 
damaged cells would escape cell death and pass on potentially lethal mutations to 
subsequent daughter cells. However, it may be the case that the burden of genetic 
damage which remains unfixed in p53 knockout cells is too high and the cell dies by 
necrosis at a later time point. The effect of DMBA on mouse skin is an ongoing study 
in the laboratory.
In summary, we have shown specific cell populations in mouse skin respond to ionising 
radiation with either cell cycle arrest or apoptosis. This is in contrast to the results 
obtained from cell culture studies, which showed mouse skin keratinocytes show a 
uniform response to radiation by entering a period of G1 arrest. Our in vivo results are 
of significant importance in the evaluation of the sensitivity of individual cell types to 
DNA damaging agents, and are also relevant to the assessment of therapeutic treatment 
of tumours of varying origins. Assays of specific tumour responses to radiation may lead 
to improved therapeutic regimes by individualising tumour treatments based on the 
cellular origin of a specific tumour.
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